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Usage of complementary and alternative medicine (CAM) is common worldwide. 
The most commonly used CAM practice is herbal medicine. Other common practices 
are acupuncture and its related practices, exercise based practices like qigong, tai chi 
and yoga and massage based practices like osteopathy and therapeutic massages. 
Similar to other parts of the world, the population of older adults in Singapore has 
shown a significant increase in recent years and it is predicted that it will rapidly 
increase further in next few decades. Since ageing is associated with higher risk of 
multiple chronic diseases, it is important to improve our knowledge and understanding 
about the health issues in older adults. One of the significant health conditions in this 
age group is their mental health and one of the possible players in their general health 
and mental health is the usage of CAM. Therefore, we performed this study to 
investigate the usage of CAM among older adults and its association with and effect on 
mental health using a multistep translational approach.  
Hypothesizing a high prevalence of CAM usage among older adults and its 
association with a better neurocognitive performance, the baseline and four-year 
follow-up data from Singapore Longitudinal Ageing Study was analyzed to investigate 
the prevalence of the CAM usage and its associated factors. Among 4985 participants 
in baseline study who met the inclusion criteria, 2692 (54.0%) reported the usage of at 
least one type of CAM within the past 12 months. The usage of CAM was more 
common among younger female well-educated Chinese participants who lived in 
bigger houses and were suffering from one or two chronic medical conditions. 
Additionally, better physical and social activities and independency in cognitive and 
physical instrumental activities of daily living were associated with the higher 
xi 
 
likelihood of using CAM. The most common types of CAM were herbal medicine 
(1720, 34.5%), qigong (749, 15.2%) and acupuncture (493, 10.0%) and the most 
commonly used medicinal herbs were evening primrose oil (245, 4.9%), ginseng (241, 
4.9%) and ginkgo (222, 4.5%). The baseline neurocognitive assessment results were 
similar between the users of CAM and those who did not report its usage. However, 
after four years, CAM users and participants who reported using qigong showed a lower 
risk of developing cognitive decline. Besides indicating that CAM is an important and 
common player in the health of older adults, these results introduced qigong as a 
potential protective practice against the development of cognitive decline. The 
simplicity and affordability of qigong for older adults make it a promising cognitive 
protecting practice to be advised to older adults. 
Since herbal medicine was the most commonly used CAM practice, a telephone 
interview based study was designed to improve our understanding about the usage of 
medicinal herbs among older adults and factors associated with their usage including 
neurocognitive factors. Contacting 198 older adults participating in the Jurong Ageing 
Study, we found that 134 (67.7%) had used herbal medicine within the past 12 months. 
Herbal medicine usage was again more common among younger female participants 
who lived in bigger houses. The top three commonly used herbs were American ginseng 
(Panax quinquefolium), wolfberry (Lycium barbarum) and Chinese ginseng (Panax 
ginseng) with 69, 39 and 36 users respectively. Three Panax species were found to be 
among the six most commonly used herbs (P. quinquefolium, P. ginseng and P. 
notoginseng). This finding shows the importance of this genus as a part of the health 
system of older adults. The usage of none of the medicinal herbs was associated with 
the baseline neurocognitive status of participants. We also found that the majority 
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(57.8%) of medicinal herbs users were using them for their general health improvement. 
Among those who used them for specific medical conditions, the usage for diseases 
based on traditional medicinal concepts was the most common reason for usage 
followed by neurological problems and musculoskeletal conditions.  
Similar to reports from different countries, Panax species were the most common 
herbs used by participants in our study. Most of these herb users get these herbs from 
different shops over the counter and the information provided in their labels is the main 
source of information about each particular herbal product. Therefore, it is important to 
survey the products in the market containing these herbs to see how consistent their 
labels are with the local legislations. Therefore, all products containing the words 
“Panax” or “ginseng” found in five different shops in Singapore were surveyed. All the 
information provided in their labels was recorded and compared to local legislations. It 
was found that among 309 surveyed products, 188 were Chinese proprietary medicine, 
85 were health supplements and 36 were food supplements. P. ginseng was the most 
common herbal ingredient followed by P. notoginseng and P. quinquefolium. The 
information provided in the labels of more than 96% of CPM products, 84% of HSs 
and 88% of FSs was consistent with respective legislations. The indications reported in 
the labels of these products were also studied showing that after health conditions based 
on traditional medical concepts, circulatory system disorders, pain and neurological 
conditions were the most common indications claimed in the labels of the products. 
Considering the common usage of products containing Panax species for 
neurological purposes and the prevalent claim of being effective for neurological 
conditions, we chose one of the most abundant chemical constituents in major Panax 
species, ginsenoside Rg1 (a known neurostimulatory compound), for the next step of 
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the study. Considering the role of medial prefrontal cortex (mPFC) in decision making, 
cognition and behaviour, we hypothesized that ginsenoside Rg1 stimulates this brain 
locus. To investigate this hypothesis, three sets of experiments were performed. The 
first set of experiments revealed that three different doses of ginsenoside Rg1 (1, 3 and 
10 mg/kg) suppressed the long-term potentiation in mPFC in response to electrical 
stimulation of ipsilateral intermediate and ventral hippocampus. In the second set of 
experiments, the systemic administration of all the three single doses and the 
accumulative doses of ginsenoside Rg1 showed a similar pattern of suppressing the 
spontaneous firing rate of half of the pyramidal cells in medial prefrontal cortex. In the 
third set of experiments, the expression of an immediate early gene, c-Fos, in medial 
prefrontal cortex was dose-dependently decreased in response to systemic 
administration of ginsenoside Rg1 (1, 3 or 10 mg/kg). All together, these three sets of 
experiments show the suppressing effect of ginsenoside Rg1 on medial prefrontal 
cortical neurons for the first time. This effect may explain the anxiolytic effects of 
ginsenoside Rg1, which indirectly improve learning and cognition.  
In conclusion, a translational medical approach to the usage of complementary and 
alternative medicine was used in this study starting from getting information from 
community dwelling older adults about their trend of usage, continuing the survey 
focused on the usage of herbal medicine, collating information from available herbal 
products in the market and finally examining one of the possible mechanisms of 
neurological actions of one of the most abundant chemical constituents of the most 
commonly used herbal products. Such a study can open new windows to further 
research in the field of complementary and alternative medicine.  
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CHAPTER 1. Introduction 
Medicine has been developed by observation and research for millennia. Since 
prehistoric times, humans have observed and studied nature to find ways to maintain 
and improve their health and fight the diseases threatening their well-being. Ancient 
tribal medical men learnt from nature and promoted the use of various dietary and 
topical remedies for diseases (e.g. fruits, linseed oil). Such knowledge passed through 
generations and became more organized into medical systems. It was around 1030 AC 
when Avicenna wrote the Canon of Medicine establishing the foundation for 
experimental and evidence based medicine for the first time (Chen et al., 2012). 
Through new advances in science in last few centuries, researchers have started to have 
the advantage of the microscopic approach to understand the molecular and structural 
bases behind diseases and bio-systems. Rapid advances in molecular research made 
scientific approaches at micro and nano levels, which were far from daily clinical 
practices (Kulikowski et al., 2009). The bridge connecting the research in basic science 
(micro level) to clinical practice (macro level) is called translational medicine (Satoh et 
al., 2012).  
Translational medicine is a "feed-back-loop" with the aim of providing crucial 
information about the applicability of the methods and approaches in societal contexts 
and their success in improving human health (Sonntag, 2005). It is usually a journey 
from bed to bench to bed and beyond. Translational medicine starts from clinical 
observation of phenomena that attract attention from laboratory researchers. Laboratory 
researchers uncover molecular and cellular mechanisms, which can provide new 
approaches to clinical questions. Now it is the clinicians’ role to apply those laboratory 
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findings and examine their applicability and efficacy in clinical trials and practices. The 
next step is to extend the clinical applications into diverse medical settings (Sachar, 
2009). At each step, the feedback from clinics will go back to laboratories to improve 
the knowledge, deepen the understanding and optimize the applicability of new 
methods with respect to clinical settings.  
In the current work, a translational approach was begun from clinical observation 
of the pattern of usage of complementary and alternative medicine (CAM) in the 
community and factors associated with it to find the most common CAM types and the 
trend of their usage. Then, the journey was pursued to bench side to understand the 
possible mechanisms of action and suggest the future path of research to make the 
findings more practical and improve health in the society. 
1.1. Complementary and alternative medicine 
Complementary and alternative medicine (CAM) is often defined as the range of 
health care approaches with a history of use or origins beyond mainstream 
(conventional) medicine. It can be used either for specific conditions or overall well-
being. If CAM is used together with conventional medicine, it is referred as 
“complementary medicine” and if used in place of conventional medicine, it is called 
“alternative medicine”. The combination of CAM with conventional medicine is 
termed as “integrative medicine”, which is offered in many clinical settings in 
developed countries recently (NCCAM, 2013). Based on National Center for 
Complementary and Alternative Medicine (NCCAM) definitions, CAM can be 




Natural products include a variety of products such as herbs, vitamins and minerals 
and probiotics, which are generally marketed as ready to use dietary supplements. 
Herbal medicine as the most commonly used type of CAM (Robinson et al., 2011) will 
be discussed in detail in section 1.2. Two closely related CAM practices are naturopathy 
and aromatherapy. Naturopathy aims to support the body in order to heal itself through 
the use of dietary and lifestyle changes together with other CAM modalities such as 
herbs, massage and joint manipulation (NCCAM, 2013). On the other hand, 
aromatherapy is concerned with physiological and pharmacological effects of essential 
oils introduced by means of inhalation, olfaction and dermal application (van der Watt 
et al., 2008).  
Mind and body practices are very large and diverse groups of procedures or 
techniques administered or taught by a trained practitioner or teacher. They include 
acupuncture and moxibustion, massage therapy, meditation, movement therapies, 
relaxation techniques, spinal manipulation, osteopathic manipulation, tai chi, qigong, 
yoga, chiropractic, healing touch and hypnotherapy (NCCAM, 2013). In the following 
paragraphs, these CAM practices will be defined briefly. 
Using specific anatomical points on the body to aim the treatment or health 
maintenance is the basis of some mind and body practices including acupuncture, 
moxibustion, acupressure and reflexology. Acupuncture is one of the most ancient 
healing modalities dating back to 6000 BCE. Although originated from China, it is 
practiced worldwide today (Zhang, 2008). In this practice, solid filiform needles are 
placed in specific points of the body to promote the health and treat the illnesses (Wang 
et al., 2013b). Acupuncture is closely carried out together with moxibustion, which 
involves the direct or indirect application of ignited mugwort (Artemesia vulgaris) on 
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acupuncture points or other specific parts of the body to facilitate healing (Xiong et al., 
2013). Another related technique is acupressure, which is a deep and effective hands-
on treatment for many conditions. It includes massage of acupuncture points or other 
specific areas, which is relaxing and provides support for general health and well-being 
(Suhrabi et al., 2014). Another close technique is reflexology, which has originated 
from Chinese and Indian traditional medicine. It is based on a belief that the whole 
human body is represented on the feet (mostly the soles) and the internal organs can be 
treated by pressing particular areas of the feet (Ernst, 2009). 
In contrast to acupuncture and related practices that focus on specific points, there 
are other massage-based therapeutic approaches, which work with bigger body areas 
mainly focusing on the trunk. They include therapeutic massage, chiropractic, spinal 
manipulation and osteopathy. Therapeutic massage is defined as mechanical 
manipulation of body tissues with rhythmical pressure and stroking with purpose of 
promoting health and well-being (Weerapong et al., 2005). Chiropractic is a CAM 
approach that is involved in diagnosing and treating medical problems by adjustments 
made to spines and musculoskeletal system mainly by affecting the nervous system 
(Zhang, 2008). Spinal manipulation is a technique usually used as a part of chiropractic 
to achieve spinal adjustment by high velocity trusts with either a long or short lever-
arm (Ernst et al., 2001). Furthermore, osteopathy has similar basics trying to face 
illnesses by manipulating mostly the spinal cord via vertebrae and other bones (Howell, 
1999). 
There are some techniques that aim to improve the body performance and general 
health based on utilizing internal energy and individual physical abilities such as 
meditation, yoga, movement therapies, tai chi and qigong. Meditation is defined as a 
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group of complex emotional and attentional regulatory training regimes developed for 
different aims including the cultivation of well-being and emotional balance (Lutz et 
al., 2008a). Relaxation techniques include deep breathing, guided imagery and 
progressive muscle relaxation, which are used to maintain body natural response. 
Movement therapies are a broad range of Eastern and Western movement-based 
approaches such as Feldenkrais method, Alexander technique, Pilates, etc. (NCCAM, 
2013), which improve mind and body performance by sequences of movements and 
postures (Schmalzl et al., 2014). Tai chi, originated from China, is the mixture of deep 
breathing and relaxation with slow movement (Lee et al., 2012b). Similarly, qigong is 
a Chinese medical exercise, which combines static and dynamic physical exercises, 
breathing exercise and meditation (Lauche et al., 2013). Yoga, originated from 
Ayurveda, is an emotional harmonizing practice by the use of posture, isometric muscle 
contraction and breathing (Posadzki et al., 2009).  
In addition to those mentioned practices, there are some other CAM practices that 
are mainly based on religious or supernatural beliefs with minimal or no scientific 
justification. Spirit medium healing is a religious based healing approach indigenous to 
various ancient societies in which some healers try to improve health and treat diseases 
based on guidance and connection to gods (Koss-Chioino, 2005). Healing touch is 
another supernatural healing strategy, which claims to heal through some exchange or 
channeling of supra-physical energy (Astin et al., 2000). Hypnotherapy is a kind of 
healer-patient therapeutic interaction during which the patient experiences suggested 
changes in sensation perception, thought or behavior using intense concentration and 
focus while being fully conscious (Beebe, 2014). Homeopathy can also be categorized 
in the supernatural therapeutic group. It is based on the premise that diseases can be 
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treated by substances that produce the same signs and symptoms in a healthy individual. 
The remedies are usually prepared by sequential dilution of the originally harmful 
substances with vigorous shaking of solutions between dilution sequences (Shang et al., 
2005).  
Finally, traditional medical systems can be considered as the most complete sets of 
CAM. These systems have been developed in different ancient societies over time and 
adapted by others during cultural and scientific exchanges. They usually include both 
“natural product therapy” and “mind and body approaches”. For example, Traditional 
Chinese Medicine (TCM) is a defined medical system with more than 2500 years 
history, which has been used successfully to diagnose, treat, and prevent illness 
(Robinson et al., 2011). It includes both natural products and some mind and body 
practices such as acupuncture, tai chi and qigong. Natural products in TCM include 
both crude Chinese medicinal material (CMM) and Chinese Proprietary Medicines 
(CPM). The CMM includes any herbs, animals and minerals subject to simple process 
such as cutting and drying while CPMs are CMMs, which have been formulated into 
end products as capsules, tablets, powders and other dosage forms (Koh et al., 2000).  
1.1.1. Global usage of complementary and alternative medicine 
Many people around the world use CAM for their health maintenance or medical 
purposes. In a majority of developing countries, 70-95% of citizens use traditional and 
herbal medicines to address their primary health care needs and concerns (Robinson et 
al., 2011). In some developed nations, 70-90% of people have reported using traditional 
medicine under the title of “complementary”, “alternative”, or “nonconventional” 




Figure 1.1. Global prevalence of CAM usage in selected developing and developed 
countries (adapted from Robinson et al., 2011). 
The reports on the prevalence of CAM usage are very diverse in different countries. 
Based on the National Centre for Complementary and Alternative Medicine (NCCAM) 
reports, 38% of Americans use some forms of CAM. In an online survey performed in 
2006, 46.2% of US adolescents had used dietary supplements excluding vitamins 
(Wilson et al., 2006). In some other western countries, reports show much less 
prevalence of usage. Ramsay et al. (2005) reported this prevalence in the UK as about 
20%. In eastern countries, the usage of CAM is very common. In South Korea, the 
prevalence of CAM usage in general population was 75% in 2006 (Kang et al., 2012), 
which is comparable to studies on general population from Singapore where 76-86.5% 
of population uses some kinds of CAM (Koh et al., 2004; Lim et al., 2005). In 
Singapore, herbal medicine has been reported as the most commonly used CAM type 
used by 73.4% of general population of adults followed by non-herbal TCM (72.3%) 
and massage therapy (35.5%) (Koh et al., 2004). In a parallel study, 84.3% of 
pharmacists working in Singapore reported usage of some form of CAM. Among them, 
herbal medicine, non-herbal TCM and massage were the three most commonly used 
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forms among them with 72.0%, 56.8% and 35.3% popularity respectively (Koh et al., 
2003). In another local study, the most common CAMs used by ambulatory patients 
with chronic diseases were TCM (37.8%), traditional dietary therapy (29.7%) and 
acupuncture (27.5%) (Lee et al., 2004b). 
Furthermore, some special social or medical groups show more interest in the usage 
of CAM than the general population. For example, in a survey conducted in 2006, the 
usage rate of applicants for cosmetic medical interventions was more than twice the one 
of general American population (Heller et al., 2006), 78.5% of Korean “cancer patients” 
were using CAM in any form in 2004 (Kim et al., 2004a) while the prevalence of CAM 
usage in general population was 75% (Kang et al., 2012) and in the United Kingdom 
where the prevalence of CAM usage is about 20%, 26.9% of “patients starting warfarin” 
were taking some form of CAM (Ramsay et al., 2005).  
This global high prevalence of usage makes a big and expanding market for CAM 
products and services such as traditional medicines. It is estimated that the growth rate 
of traditional medicine product sale in the last decade stands somewhere between 5-
18% per annum (Robinson et al., 2011). Nowadays, CAM has a very big market all 
around the world, although it is not the same across different countries. In Brazil, herbal 
products form 7% of pharmaceutical industry and cost US$400 million per year 
(Auricchio et al., 2007). In China, traditional herbal preparations constitute 30-50% of 
the total medicines consumption. Its sales value in China was equal to US$14 billion in 
2005 (Robinson et al., 2011). At the same time, Australians spent US$1.86 billion (Xue 
et al., 2007) and the Japanese spent over US$1 billion (Holtz, 2008) only on herbal 
medicines excluding animal or mineral products or other CAM services.  
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1.1.2. Reasons and purposes for usage of complementary and alternative 
medicine 
There are complex and interrelated psychosocial and cultural factors impacting on 
the usage of CAM. These factors include dissatisfaction with conventional treatments, 
personal beliefs and preferences, and economic factors (Lee et al., 2004b). Some 
patients are not satisfied with their conventional treatments because of their efficacies, 
side effects, or costs. On the other hand, CAM and natural products are advertised to 
be safe with therapeutic potentials (Foroncewicz et al., 2011). Moreover, they seem to 
be cheaper because they are easily available over the counter without the need for 
prescription (Foroncewicz et al., 2011). Their availability is even increasing rapidly 
because there is less regulatory requirement for their safety and efficacy than 
requirements for conventional drugs and treatment protocols (Bardia et al., 2007). 
Moreover, some people prefer to have more control on their own treatment and find 
CAM more consonant with their personal values, religious and health philosophies (Lee 
et al., 2004b). 
The purpose of using CAM varies in different societies and groups of people. For 
example, in Australia, general health improvement was reported as the most common 
reason (69.6%) for herbal medicine usage. However, some people use them to treat 
certain diseases such as colds, flu, cough, fever, skin conditions, and gastrointestinal 
conditions, sleep disorders, menopausal symptoms, urinary or bladder problems and 
anxiety or depression (Zhang et al., 2008a). In a study on Korean breast cancer patients, 
the main reasons of using CAM were to boost immune system (53.2%), promote health 
(46.8%) and prevent recurrence (37.7%) (Kang et al., 2012). In another study on Korean 
cancer patients, only 7% of them were using CAM for its anti-cancer effect and the 
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majority were using these products and practices as a nutritional support (19.1%) or to 
strengthen the body (17.8) (Kim et al., 2004a). Although the study designs are 
dissimilar, it can be concluded that general health improvement is the main purpose of 
using various CAM practices. However, some people use them to treat their illnesses 
especially when the conventional medicine is not easily affordable or its efficacy is 
suboptimal.  
1.1.3. Risks associated with the usage of CAM 
Some incorrect general beliefs may impair the proper usage of CAM products and 
can be considered as potential harms to users. For example, there are common 
misconceptions that “everything natural is good” or “no matter how consumed, if 
something comes from nature does not harm the consumer”. In addition, people do not 
usually assume CAM products (e.g. the medicinal plants) as drugs although 
theoretically they are (Avello et al., 2010). Since herbal medicine are actual drugs with 
real effects, they are not free of adverse effects as well. There are several reports of 
different adverse effects of herbal products some of which very serious and dangerous. 
These adverse effects can be mild such as diarrhea or severe and life threatening such 
as bleeding tendency and organ failure. For example, bleeding tendency has been 
reported as a potential adverse effects of several herbs such as evening primrose oil 
(Wedig et al., 2008), Serenoa repens (Villanueva et al., 2009), Angelica sinensis, 
Zingiber officinale (ginger), Panax ginseng, Panax notoginseng, Panax quinquefolium, 
Glycyrrhiza glabra (licorice), etc. (Cordier et al., 2012). The other frequently reported 
serious adverse effect is hepatic injury which has been reported as a potential side effect 
of Rhubarb (Rheum rhabarbarum) (Wang et al., 2014c), Cimicifuga racemosa (Enbom 
et al., 2014), Gynura segetum (Zhou et al., 2014), Tripterygium wilfordii (Zhao et al., 
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2014), etc. Renal toxicity is another life threatening side effect of some herbal products 
which has been reported from Callilepis laureola (Watson et al., 1979), Dioscorea 
quinqueloba (Kang et al., 2015), Aristolochia indica (Michl et al., 2013), etc. 
Ordinary people can hardly believe that CAM may interfere with any conventional 
medicine they might use. These incorrect beliefs may increase the risk of inappropriate 
use of CAM products which can cause severe and dangerous interactions and side 
effects. For example in a study conducted in the UK, 26% of patients on warfarin were 
using CAM products among which 58% could interact with warfarin (Ramsay et al., 
2005).  
Therefore, all consumers, manufacturers, medical practitioners, policy makers, and 
anybody else involved in the usage of CAM have to improve their knowledge about 
risks and benefits of using these products in order to minimize the adverse effects of 
CAM use and improve the general health of society. Therefore, Singapore government 
has implemented several legislations to control the production, marketing and 
advertisement of CAM products (section 1.2.2). 
1.1.4. Professional health practitioners interactions with patients using 
CAM 
People generally hide their usage of complementary medicines from their 
physicians. It may be because of physician indifference or opposition toward CAM use, 
physicians’ overemphasis on scientific evidence, or patients’ anticipation of a negative 
response from the physicians (Kang et al., 2012; Tasaki et al., 2002). For instance, only 
29.6% of Korean breast cancer patients who were using alternative medicines besides 
their conventional drugs had let their physicians know about it (Kang et al., 2012). 
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Another study in Korea showed a big gap of understanding between physicians and the 
cancer patients hiding their CAM usage from their health providers. Although 85% of 
cancer patients were using CAM because they thought that they are nontoxic, the 
oncologists estimated that only 24% of them are in favor of CAM because of their 
safety. In the same study, 86% of oncologists thought that their patients hide their CAM 
usage from them because they are afraid of discouragement or disapproval by the 
physicians while only 27% of patients were afraid of that and the most common (48%) 
reason for not disclosing this usage was that their physician never asked about it (Kim 
do et al., 2008). This problem is global and cross-cultural. In the UK, 92.2% of patients 
taking herbal medicine and warfarin together did not mention this usage to their 
conventional healthcare professionals (Smith et al., 2004). This proportion was 57.1% 
in Singapore (Goh et al., 2011). In other studies in Singapore, the reporting rate of 
concurrent usage of CAM and conventional medicine to physicians was only 16.3% in 
patients with chronic diseases (Lee et al., 2004b) and 30.4% in general population (Koh 
et al., 2004). This problem is not limited to the ordinary people and can also be seen 
among health care personnel. Among pharmacists participating in a survey in 
Singapore, 70.5% of those who used CAM and conventional medicine together did not 
consult a doctor about it (Koh et al., 2003).  
Professional health care providers have easier access to available information 
sources about herbal products, scientific studies on them and their evidence-based 
indications, contraindications and adverse effects if any. On the other hand, ordinary 
people hardly use such information. Hence, lack of a sustained patient-physician 
relationship impairs the accessibility of the patients to this important knowledge and 
puts the CAM users at the risk of inappropriate treatment or adverse effects such as 
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herb-drug interactions (Bardia et al., 2007; Smith et al., 2004). In a survey conducted 
in the US, less than 10% of American athletes using health supplement gained their 
information from health professionals (Froiland et al., 2004). In Singapore, just 7% of 
athletes using supplements had consulted with a health professional and their major 
source of information was media such as television and magazines (25%) (Tian et al., 
2010). Zhang et al. (2008) reported that more than half of herb users in Australia self-
selected their medicines and only 27.4% had consulted with an herbalist and 8.2% with 
a medical practitioner (Zhang et al., 2008a). These reports emphasize that health 
professionals should consider the hidden usage of CAM by their patients to prevent 
adverse effects, drug-herb interactions or other risks of undisclosed usage of such 
products to their patients especially when dealing with high risk patients such as older 
patients and those under treatment with narrow therapeutic window drugs (e.g. warfarin 
and digoxin). 
1.2. Herbal medicine 
Herbal medicine is the most common CAM used worldwide in almost all reports 
(Chu et al., 2013; Posadzki et al., 2013a; Posadzki et al., 2013b; Robinson et al., 2011). 
Based on WHO definition, herbal medicine includes herbs, herbal materials, herbal 
preparations and finished herbal products that contain active ingredients from parts of 
plants. Herbs include crude plant material such as leaves, flowers, fruit, seed, stems, 
wood, bark, roots, rhizomes or other plant parts, which may be entire, fragmented or 
powdered. Herbal materials include, herbs, fresh juices, gums, fixed oils, essential oils, 
resins and dry powders of herbs. In some countries, these materials may be processed 
by various local procedures, such as steaming, roasting, or stir-baking with honey, 
alcoholic beverages or other materials. Herbal preparations are the basis for finished 
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herbal products and may include comminuted or powdered herbal materials, or extracts, 
tinctures and fatty oils of herbal materials. They are produced by extraction, 
fractionation, purification, concentration, or other physical or biological processes. 
They also include preparations made by steeping or heating herbal materials in 
alcoholic beverages and/or honey, or in other materials. Finished herbal products 
consist of herbal preparations made from one or more herbs. If more than one herb is 
used, the term mixture herbal product can also be used. They may also contain 
excipients in addition to the active ingredients (Zhang, 2000).  
Excipients are substances other than the active principal ingredients added 
intentionally to the medicinal formulations for different purposes such as improving the 
taste and dosage formula (Pifferi et al., 2003). In this study, substances like sweeteners, 
artificial colors, flavors, stabilizers, water, oils, resins, caramel, etc. were considered as 
excipients except those with specific traditional medical uses such as “dragon’s blood”, 
which is a resin with medical uses (Zhao, 2004). 
Based on Chinese Materia Medica, some natural products with non-plant origins 
can also be considered as herbs such as those from animal origins and minerals (Bensky 
et al., 2004; Zhu, 1998). However, finished products or mixture products to which 
chemically defined active substances have been added, including synthetic compounds 
and/or isolated constituents from herbal materials, are not considered to be herbal 
(Zhang, 2000). 
Since medicinal herbs are usually consumed orally, their chemical constituents deal 
with absorption, distribution, metabolism and excretion processes in the body. 
Therefore, the safety issues regarding their usage are more magnificent compared to 
other CAM practices. Many factors affect the risks and benefits of using natural 
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products. For example, dosing is usually difficult to measure because in traditional 
prescription it is not measured very accurately. In addition, active substances are not 
uniform even in well prepared commercially available products in the market (Avello 
et al., 2010). 
One of important risks associated with usage of herbal medicine is the potential for 
interaction with other herbs, conventional drugs and food elements. These interactions 
can be due to two main mechanisms namely pharmacodynamics interaction and 
pharmacokinetic interaction. Pharmacodynamics interaction is modification of 
pharmacological effect of one chemical entity by another one without altering its 
concentration in the tissue fluid (by affecting the target molecule, competing in the 
receptor-ligand interaction, etc.) while pharmacokinetic interaction is based on changes 
in the concentration of a chemical entity in its site of action due to presence of another 
active chemical agent (by affecting absorption, distribution, metabolism or excretion). 
Such interactions are more important for drugs with narrow therapeutic range (small 
difference between minimum effective dose and maximum safe dose) and steep 
concentration-response curve (a small change in concentration causes a significant 
change in effect) such as antithrombotic, anti-arrhythmic, antiviral and antiepileptic 
drugs; lithium; and several antineoplastic and immunosuppressant drugs (Rang, 2012). 
There are several reports of potential interactions between conventional drugs, herbs or 
food elements as well as herbal medicine and other herbs (either used as another herbal 
medicine or used as a food item). Grape fruit which can be used either as herbal 
medicine or as a food can change the hepatic metabolism of many drugs such as 
important cardiovascular agents, CNS modulators, antiviral drugs, etc. (Bailey et al., 
2004; Libersa et al., 2000; Rodriguez-Fragoso et al., 2011). Similar interactions through 
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altering hepatic or enteric metabolism have been reported from other citrus fruits like 
sour (Seville) orange, sweet orange and pomelo, pomegranate, grape, mango and 
cranberry affecting warfarin, antihypertensive and other drugs (Paine et al., 2007; 
Rodriguez-Fragoso et al., 2011). It is shown that Evodia rutaecarpa and herbal 
preparation Wu-Chu-Yu-Tang can dose-dependently decrease the theophylline 
concentration in blood (Jan et al., 2005). The interaction between digoxin and St. John’s 
wort can also be dangerous (Dasgupta, 2008; Rang, 2012). 
Different toxic and pathogenic materials may contaminate the herbal remedies. A 
group of pathogenic impurities are toxic botanicals such as Spartium juncium, 
Aristolochia fangchi, Aristolochia manshuriensis, Teucrium species and species 
containing tetrahydropalmatine or belladonna alkaloids. Microorganisms can grow and 
release microbial toxins in the herbal products and cause microbial poisoning. Usage 
of pesticides and fumigation agents can chemically contaminate the herbal products. 
Soil pollutions by radioactive material and toxic metals are another source of herbal 
pollution. Finally, there is always a risk of adulteration with synthetic pharmaceuticals 
and animal substances (Koh et al., 2000).  
Another risk in using herbal preparations for treatment is unproven therapeutic 
indications. Although usage of many herbs has a long history and is documented in 
ancient medical books, the available scientific evidence is not enough in most cases. 
This lack of scientific proof is extended to undisclosed toxicities and potential 
interaction of the chemicals constituents of herbal preparations with each other and with 
concomitantly taken conventional drugs. Besides, incompatibilities with patient-related 
factors (e.g. age, sex, genetic background and the function of the organs responsible for 
metabolism and excretion of the chemicals in herbal preparations such as the liver or 
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kidneys) may cause adverse effect in susceptible consumers. It is difficult to standardize 
treatments because of lack of enough scientific literature for most of herbs. Finally, the 
concomitant usage of regular drugs with the herbal preparations without disclosure to 
medical practitioner increases the risk of herb-drug interaction and other adverse effects 
(Simaan, 2009).  
Considering the great accessibility of medicinal plants and the misconceptions 
about their safety and efficacy, the lack of sufficient supervision and control on their 
production, sale and advertisement can encourage improper self-medication and may 
cause severe health issues (Avello et al., 2010). 
1.2.1. Regulations for herbal medicine and other health products 
Despite thousands years history of usage of medicinal herbs and most other CAM 
practices, the history of regulating their usage is short (Robinson et al., 2011). People 
and policy makers have various approaches to such products. It is reflected on the 
diverse terminology used to address them. They are sometimes referred as self-
medications, faith-healing practices, home remedies, dietary supplements, health foods, 
functional foods, phytoprotectants, folk medicines, etc. (Adib, 2004; Robinson et al., 
2011). Consequently, diverse legislations are used to regulate their marketing in 
different countries. Various legislative approaches for such products compared to 
conventional medicine include: 
 Exemption from all regulatory requirements for herbal or traditional 
medicine 
 Exemption from all regulatory requirements for herbal or traditional 
medicine concerning registration or marketing authorization 
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 Regulatory requirements similar to conventional medicine with certain 
types of evidence not required for herbal or traditional medicine 
 Herbal or traditional medicine subject to all regulatory requirements 
 Herbal or traditional medicine subject to all regulatory requirements 
concerning registration or marketing authorization (Zhang, 1998). 
By increasing the worldwide prevalence of CAM usage, the importance of having 
proper regulation for their production and marketing has become more highlighted. 
Hence, from 1986 to 2007, the number of World Health Organization (WHO) members 
having some type of policy in place regarding regulation and registration of CAM 
products and services increased from 14 to 110 (Robinson et al., 2011). 
The global need to have regulatory issues on the usage of alternative medicine, 
especially herbal medicine, led in the creation of the “international regulatory 
cooperation for herbal medicine (IRCH)” coordinated by WHO in 2006. The mission 
of IRCH is to protect and promote public health and safety through improved regulation 
of herbal medicines (Robinson et al., 2011). For this, IRCH has recommended the 
inclusion of proven traditional remedies into national drug policies and regulatory 
measurements. By integration of traditional medicines into national health care 
systems, development of technical guidelines and international standards will 
rationalize the use of traditional medicine and improve the dissemination of information 
on its various forms (Zhang, 1998). By 2009, twenty two countries including Singapore 
had joined IRCH (Robinson et al., 2011). 
Having long history of usage and tradition of herbal medicine in Eastern countries 
such as Japan, China and Korea has made traditional medicine including herbal 
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medicine an important part of health care system in these countries (Cheung, 2011). 
Despite common roots and similarities in traditional medical care in these countries, the 
corresponding regulations and their legal processes are different (Cha et al., 2007; 
Sarfaraz, 2007).  
In China, the Drug Administration Law is implemented, which says that traditional 
herbal preparations are generally considered “old drugs” and, except for new uses, are 
exempt from testing for efﬁcacy or side effects. The Chinese Ministry of Public Health 
oversees the administration of new herbal products (Sarfaraz, 2007). On the other hand, 
in Japan, traditional medicine is regulated in the same way as conventional medicine 
and relevant laws are applied. The Ministry of Health, Labor and Welfare (MHLW) is 
responsible for writing the policies and developing the structure of the National Health 
Care Plan, and provides national oversight (MHLW, 2012). Traditional Japanese 
medicine, called kampo, is similar to and historically derived from Chinese medicine 
but includes traditional medicines from Japanese folklore as well. The Japanese herbal 
medicine industry establishes regulations to manufacture and control the quality of 
extract products in kampo medicine. These regulations comply with the Japanese 
government’s Regulations for Manufacturing Control and Quality Control of Drugs 
(Sarfaraz, 2007). Recently, herbal products are specified as designated drugs by the 
Pharmaceutical and Food Safety Bureau to implicate a better control (MHLW, 2013). 
In Korea, current regulations on herbal medicine are legislated to improve quality 
control of imported herbal products, to require the use of real names in distribution of 
herbal medicine and use of standardized herbal medicine, to provide and improve the 
standards in decoction facilities outside clinics and traditional medical hospitals and to 
prohibit sale of herbal and other traditional medical products manufactured or packed 
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without national legislations (MOHW, 2014). Finally, Singapore Parliament passed the 
“TCM practitioners act” in 2000 to improve the standards of TCM services in 
Singapore. Since that time, some TCM services are allowed to be offered in hospitals 
(Lee, 2006). The TCM products are subject to several legislations which will be 
elaborated in section 1.2.2. 
1.2.2. Singapore regulations for herbal medicine and other health products 
Under Singapore legislations, herbal products are classified under the 
“complementary health products” category (HSA, 2012d). Health products are any 
substance, preparation or device represented for, likely to be taken for, or belonging to 
a category of products ordinarily intended for use by humans solely or principally for a 
health related purpose. These categories include conventional (Western) medicines, 
medical devices, complementary health products and cosmetic products. 
Complementary health products include “Chinese Proprietary Medicine”, “Other 
Traditional and homeopathic Medicine” and “Health Supplement” (MOH, 2010). 
Health products are legislated by Health Sciences Authority (HSA) under the 
“Medicines Act” and its regulations, the “Health Product Act” and its regulations, the 
“Poison Act” and its rules, the “Medicines (Advertisement and Sale) Act”, the “Sale of 
Drugs Act”, and the “Tobacco (Control of Advertisement and Sale) Act” (HSA, 2012d).  
Under the Medicines Act, “medicinal product means any substance or article (not 
an instrument, apparatus or appliance) manufactured, sold, supplied, imported or 
exported or to be used as an ingredient in the preparation of a substance or article, to be 
administered to one or more human beings or animals for medicinal purposes”. A 
medicinal purpose means treating or preventing diseases, diagnosing diseases or 
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determining the existence, degree or extent of a physiological condition, contraception, 
anesthesia, or preventing or interfering with the normal operation of a physiological 
function (MOH, 2008a). 
HSA also governs the advertisement and labeling of the products. Under the Health 
Products Act, false or misleading advertisement can cause conviction to a fine not 
exceeding $20,000 or to imprisonment for a term not exceeding 12 months or both. An 
advertisement shall be taken as false or misleading if it falsely describes the health 
product or gives any false information concerning it, or it is likely to create an erroneous 
impression regarding the formulation, composition, design specification, quality, 
safety, efficacy or uses of the health product (Health product act, 2007). 
Herbal products can be marketed as either health or food products and each of these 
have their own specific regulations. Therefore, categorization of a product into different 
health product categories or food supplements is at ultimate importance for assessment 
of a product. This process can sometimes be very challenging (Federici et al., 2005). 
The first step is to differentiate health products from food supplements. Under 
Singapore regulations, health products are under purview of Health Sciences 
Authorities (HSA) while Agri-Food and Veterinary Authority (AVA) regulates foods 
and supplements of food nature. In order to facilitate classification, HSA and AVA have 
developed a classification algorithm (Figure 1.2) (HSA, 2012a).  
Health products will be further classified. Chinese proprietary medicines and health 
supplements are the major categories of health products besides conventional (western) 
medicine. In following sections, the regulations corresponding to Chinese proprietary 




Figure 1.2. Classification tree for products in the food-health products interface 
(HSA, 2012a). 
1.2.2.1. Chinese proprietary medicines 
Under the Medicines Act, any medicinal product used for therapeutic purposes 
according to TCM methods can be a CPM. Such a product should be manufactured into 
a finished product and all its ingredients should be derived from plants, animals, or 
minerals. In addition, the product or all of its active ingredients should be described in 
current editions of any recognized Chinese Pharmacopoeia. These products shall not 
include any injectable medicinal product, any item specified in the poisons list in the 
Poison Act (MOH, 2008a, 2008b), or any chemically defined isolated constituents of 
plants, animals or minerals. Other prohibited ingredients include any synthetic drugs, 
more than certain amounts of toxic heavy metals (Arsenic 5 ppm, Copper 150 ppm, 
Lead 20 ppm, and Mercury 0.5 ppm) and microbial contamination, amygdalin, 
pangamic acid or its salts, danthron, suprofen or its salts, rhodamin, or any other 
substance except listed on the labels (MOH, 2008a).  
Furthermore, labels should be in English and they have to have additional labels 
showing that they are categorized as CPM: "Allowed for sale as a Chinese Proprietary 
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Medicine based on information submitted to the Authority.  Consumer discretion is 
advised. 根据向当局提呈的资料允许作为中成药销售。谨慎选用。" (HSA, 2010; 
MOH, 2002). Other labeling requirements are listed in Table 1.1 (HSA, 2010). 
Table 1.1. Labling requirement for CPM products (HSA, 2010) 
No Parameter Inner label Outer label Package insert 
1 Trade and brand name Needed Needed Needed 
2 Product name Needed Needed Needed 
3 Batch number Needed Needed - 
4 Expiry date Needed Needed - 
5 Names and quantities of ingredients Needed - - 
6 Importer’s or wholesaler’s name and address - Needed Needed 
7 Manufacturer’s name and address - Needed Needed 
8 Assembler’s name and address - Needed - 
9 Allowed for sale as CPM - Needed - 
10 Dosage - - Needed 
11 Indication - - Needed 
12 Contraindications - - Needed 
13 Side effects - - Needed 
14 The frequency and method of administration - - Needed 
     
Under Singapore legislations, CPM products should not make exaggerated 
therapeutic claims. They are also not allowed to make any claim directly or indirectly 
referring to any of 19 serious health conditions namely diabetes, hypertension, cancer, 
blindness, cataract, drug addiction, epilepsy or fits, paralysis, deafness, kidney diseases, 
leprosy, tuberculosis, menstrual disorders, sexual function, infertility, impotency, 
frigidity, insanity, conception and pregnancy (HSA, 2010; MOH, 2008a). 
As CPM products contain natural ingredients with complex chemical 
constituents, it is very difficult to assess them in the same way as synthetic conventional 
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medicines containing known chemical substances that can be easily identified and 
assessed for purity or the presence of contaminants (MOH, 2002). To have a better 
control on quality of CPM products, all importers are required to submit documents 
showing safety of products for each batch imported. In addition, “Good Manufacturing 
Practice (GMP) Audit” program is implemented by HSA for local and international 
manufacturers (MOH, 2002).  
1.2.2.2. Health supplements 
Health supplement refers to a product which is used to supplement a diet, with 
benefits beyond those of normal nutrients, and/or to support or maintain the healthy 
function of the human body (HSA, 2012b). It includes “quasi-medicinal products” 
(including vitamins and nutritional preparations from natural sources), “traditional 
medicines” (other than CPM, Jamu, Ayurvedics, homeopatics), and “health foods” with 
vague and general medicinal claims. Health supplements contain vitamins, minerals, 
amino acids (either natural or synthetic) and/or substances derived from natural sources 
including non-human animals and botanical materials. They are presented in 
pharmaceutical dosage forms such as capsules, soft gels, tablets or liquids. Furthermore, 
health supplement cannot include any product as a sole item of a meal or diet or any 
injectable and sterile preparation (HSA, 2012b). 
Health supplements should not contain any ingredient other than listed on the label, 
any human part or substances derived from human body, any substances listed in 
schedules of the Poison Act, any restricted substances more than certain limits (for 
example 30 mg Iron or 200 mg Potassium per unit dose), any prohibited substances 
(e.g. Atropa belladona, Artemisia species, Aconitum napellus, etc.), any active 
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substance which is a chemically-defined isolated constituent of plants, animals or 
minerals, any microbial contamination above certain limits (total aerobic microbial 
count limit is 105 per g or ml and yeast and mould limit is 500 per g or ml), or any 
substance that may adversely affect the health of consumer. Furthermore, the heavy 
metals (similar to CPM) and microbial loads should not exceed some specific levels 
(HSA, 2012b; Koh et al., 2000).  
The labeling also should comply with certain regulations. For example, the 
information should be in English and clearly and legibly printed. The other labeling 
requirements for health supplements in Singapore are listed in Table 1.2.  
Table 1.2. Labeling requirements for health supplements (HSA, 2012b) 
No. Basic supplemental facts and other required information 
1 Name 
2 Name and quantity of all active ingredients 
3 Name of inactive ingredients (e.g. sweeteners, preservatives, colorants, etc.) 
4 Recommended daily allowance and daily dosage 
5 Instructions on proper usage 
6 Pack size 
7 Expiry date 
8 Batch number 
9 Name and address of manufacturer, packer and dealers 
10 Mandatory precautionary label or statement where necessary 
  
Furthermore, health supplements are not allowed to claim having any therapeutic 
effect for any specific medical condition. In addition, there should not be any direct or 
indirect reference to 19 prohibited diseases listed in “section 1.2.2.1”. In addition, under 
HSA regulations, they are not supposed to imply to be effective in improvement of 
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performance in studies, making the consumer smarter, or improving IQ or memory; 
there should not be any direct or indirect suggestion for prevention, retarding or 
reversing the physiological changes associated with ageing; any implication that a 
product can induce sexual virility is prohibited; and any claims of having no adverse 
effects, being 100% safe or being safe because of being a natural product are banned 
(HSA, 2012b). Moreover there are 31 objectionable terms and claims which should not 
be found in their labels such as “no side effects”, “guaranteed”, “sensational relief”, 
“effective”, “boost/enhance immunity”, “increase/improve memory”, “anti-ageing”, 
“longevity”, “arousal”, “libido”, etc. (HSA, 2012b).  
1.2.2.3. Food supplements 
Under AVA regulations, all food products including food supplements (FS) should 
be packed properly and the basic information listed in Table 1.3 is expected to be 
declared in English on the labels (AVA, 2011).  
Table 1.3. Labeling requirements for food supplements (AVA, 2011) 
No. Basic information needed 
1 Name or description of product 
2 Statement of ingredients 
3 Declaration of foods and ingredients known to cause hypersensitivity 
4 Declaration of net content in package 
5 Name and address of local manufacturer or importer 
6 Country of origin 
               Additional information 
7 Expiry date 
8 Any sweetening agent added or sugar free foods 
9 Special purpose foods 
10 Low calorie, diabetic or infants’ foods 
11 Nutritional labeling 
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Furthermore, food products are not allowed to make any of prohibited claims 
including false or misleading statements, claims for therapeutic or prophylactic actions, 
and claim that health or improved physical conditions may be achieved by consuming 
any food or food supplement (AVA, 2011).  
1.3. “Ginseng” and Panax species 
One of the most worldwide popular herbal products that is marketed as either health 
or food products is “ginseng”. In different countries from East to West it is one of the 
top highly used herbal products. It was the first ranked herbal and third ranked 
complementary health product used by Korean breast cancer patients (Kang et al., 
2012). In another study in South Korea on cancer patients, “Korean red ginseng” was 
the most commonly used (35.6%) type of CAM (Kim et al., 2004a). In Singaporean 
polyclinic, patients on warfarin reported using “ginseng” as the most common TCM 
product sharing its rank with cordyceps and essence of chicken (Goh et al., 2011). 
Furthermore, among American university athletes, 89% consumed health supplements. 
Out of 26% of them who used herbal supplements, “ginseng” was the most popular 
ingredient (13%) (Froiland et al., 2004). In a similar study in Singapore, the prevalence 
of health supplement usage was 76.8% and “ginseng” stood at the second rank of herbal 
ingredients with 4.8% popularity (Tian et al., 2010). In Turkey, 16.5% of university 
students reported using non-vitamin non-mineral supplements where “ginseng” was 
second most popular one (36.4%) (Ayranci et al., 2005). Among American adolescents, 
“ginseng” was the second most popular herbal supplement with 17.4% use just after 
green tea with 21.5% (Wilson et al., 2006). This popularity has made “ginseng” the 
second highest selling herbal supplement in the United States (Jia et al., 2009a).  
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This wide global consumption has made its market one of the biggest herbal 
markets in the world. The total world export value of ginseng was reported over USD 
350 million in 2010, which was predicted to increase to USD 400 million in 2012 
(Smith et al., 2014). The next section will briefly review “ginseng” and other species in 
Panax genus. 
The word “ginseng” comes from the Chinese term for Panax ginseng, Ren Sheng 
(human root). It is named because of its characteristic shape, which resembles the 
human body (Radad et al., 2006). “Ginseng” is a general name mostly referred loosely 
to several species of Panax genus (Jia et al., 2009a) including Chinese/Korean ginseng, 
American ginseng etc. 
1.3.1. Panax species 
Panax is a genus from Araliaceae family. The word “Panax” comes from Greek 
words “pan” (all) and “axos” (cure). This name was applied because of the wide range 
of therapeutic use of Panax species in TCM (Jia et al., 2009a). This genus consists of 
several species found in various regions across the world (Efloras; IPNI, 2012; "Plants 
database," 2012) (Table 1.4). In addition, there are some other plants from other 
families or genera (Table 1.5) that are sometimes referred as “ginseng” or “ginseng” 
alternatives. However, their botanical, chemical and pharmacological characteristics 




Table 1.4. Species of Panax genus with their local names and geographical 
distributions (Bensky et al., 2004; Chan et al., 2011; Efloras; IPNI, 
2012; Jia et al., 2009a; WHO, 2002) 






Panax schinseng Nees, Ren Shen, Chosen ninjin, 
ginseng, bang chui, Di Jing, Li Shen, Ren Xian, 
Shen Cao, Ginsengwurzel, hakusan, higeninjin, 
hongshen, hunseng, jenseng, jenshen, jinpi, kao-
li-seng, Korean ginseng, minjin, nhan sam, 
ninjin, ninzin, niuhuan, Oriental ginseng, otane 
ninjin, san-pi, shanshen, sheng-sai-seng, t’ang-
seng, tyosenninzin, yakuyo ninjin, yakuyo 
ninzin, yehshan-seng, yuan-seng, yuanshen, 
goryo insam 
North East China 
and North Korea, 










Sanqi, Sanchi, Tienqi, Tienchi, Jin Bu Huan, Pan 
long Qi, Sanshichi, samchil 







American ginseng, Xi Yang shen, seiyojin, 
seoyangsam, Quang Dong Ren Shen, Hua Qi 
Shen, Mei Zhuo Ren Shen, Xi Shen, Xi Yang 
Ren Shen, Yang Shen 
North America, 
cultivated in North 
China 
4 Panax japonicus Japanese ginseng or Zhu Jie Shen 
A big territory from 





Xia Ye Zhu Jie Shen 
China (Guizhou, 
Sichuan, Yunnan), 
Bhutan, North East 













Zhu Jie Shen or Yuan Bian Zhong 
East China, Japan, 























Jia Ren Shen 
Nepal and eastern 
Himalayas 
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Table 1.5. List of the non-Panax species which are sometimes referred as 
"ginseng" (D'jang, 1999; Jia et al., 2009a) 
No. Scientific name Common name 
1 Angelica sinensis Female ginseng, aka Dong Quai 
2 Eleutherococcus senticosus Siberian ginseng 
3 Eurycoma longifolia Malaysian ginseng, Tongkat Ali 
4 Gynostemma pentaphyllum Southern ginseng, aka Jiaogulan, five-leaf ginseng 
5 Lepidium meyenii Peruvian ginseng, aka Maca 
6 Oplopanax horridus Alaskan ginseng 
7 Pfaffia paniculata Brazilian ginseng 
8 Pseudostellaria heterophylla Prince ginseng 
9 Withania somnifera Indian ginseng, aka Ashwagandha 
   
The following sections give an overview of the three most commonly used species 
among Panax genus (P. ginseng, P. quinquefolium and P. notoginseng) (Kim, 2012) 
and their chemical compositions. 
1.3.1.1. Panax ginseng 
Panax ginseng C.A Meyer (Araliaceae) or Radix ginseng is one of the most 
commonly used plant worldwide and is generally called “ginseng” (CPC, 2010) or Ren 
Sheng (Chang et al., 2000). Its other vernacular names are listed in Table 1.4. This plant 
grows in cool climates in Northern Hemisphere (Jia et al., 2009a) and the wild plant 
can be found in North East China, North Korea (Chang et al., 2000), Japan and East 
Siberia (WHO, 2002).  
The leaves and roots can be consumed as herbal medicines, which taste sweet and 
bitter and are “warm” in nature (CPC, 2010). The most traditionally used preparation 
is the dried root (WHO, 2002). If preparation is from cultivated plants, it is called 
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Yuanshen or garden ginseng. Linxia Shanshen or Zihai is preparation derived from wild 
plants (CPC, 2010). In addition, based on the preparation process, it is subcategorized 
as white (raw) P. ginseng or red (steamed). Radix ginseng rubra (also known as red 
ginseng or Hongshen) is the steamed then dried root of cultivated P. ginseng, which is 
stronger and “warmer” in nature than white (raw) P. ginseng (Bensky et al., 2004; CPC, 
2010). There are plenty of published reviews on P. ginseng (Chan, 2012; Choi, 2008; 
Jia et al., 2009a; Jia et al., 2009b; Lee et al., 2011c). 
1.3.1.2. Medical usage and pharmacological activities of P. ginseng 
Panax ginseng has been used at least for 5000 years. The first description of its 
medicinal use goes back to “Shen Nong Ben Cao Jing”, the earliest Chinese 
pharmaceutical monograph written during the Qin and Han Dynasties (221 B.C.-220 
A.C.) (Song et al., 2009). In Chinese Pharmacopoeia, a wide range of traditional usage 
has been reported for “Ren Shen” including reinforcing the vital energy, improving 
collapse and restoring normal pulse, promoting the production of body fluid, calming 
nerves, and benefitting spleen and lung (CPC, 2010). In addition, it has been used for 
many indications in folk medicine such as cough, fever, tuberculosis, rheumatism, 
vomiting of pregnancy, hypothermia, dyspnea and nervous disorders (WHO, 2002). 
The most reported neurologic actions for P. ginseng in TCM are tranquilizing the mind 
and replenishing wisdom (CPC, 2010) (anxiolytic and improving cognition, 
respectively). Based on the Chinese pharmacopeia, it is also indicated for vexation, 
fright palpitation, restlessness (CPC, 2010) (anxiety or hyperactivity) and mental 
confusion (CPC, 2010) (cognition problems or attention deficit). The traditional usage 
of steamed P. ginseng is quite different from the raw form. It is traditionally used for 
tendency to collapse, cool limbs, weak pulses, unusual bleeding, etc. (CPC, 2010). 
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Many scientists have tried to study pharmacological effects of Chinese ginseng. In 
a review by Colins (2011), papers published in “Chinese Medical Journal” between 
years 2000 and 2009 were evaluated and it was found that the most studied herb was P. 
ginseng (16.1% of publications on TCM) (Collins, 2011). The studied pharmacological 
activities of P. ginseng are presented in Table 1.6.  
One of the most interesting properties of this herbal medicine is its adaptogenic 
effect (Kitts et al., 2000). Adaptogenic effect is a controversial concept referring to the 
capability of a substance to normalize body activities and reinforce systems affected by 
stress. It includes the protection against different environmental and emotional assualts 
(HMPC, 2008). Panax ginseng has known effects in enhancing tissue oxygen uptake 
(Bahrke et al., 2000), cellular glucose uptake (Wang et al., 1998) and corticosterone 
secretion (Kitts et al., 2000), concurrently  with immuno-modulatory effects 
(Christensen, 2009; Ni et al., 2010; Yoo et al., 2012), which all can empower the body 
to tolerate environmental assaults. 
1.3.1.3. Panax notoginseng  
Panax notoginseng (Burk.) F.H. Chen is another famous species from the family 
Araliaceae. Its dried root (Radix notoginseng) is called Sanqi or Tianqi, which has a 
long history of traditional medical usage. The branch root is called “Jintiao” and the 
rhizome is known as “Jiankou” (CPC, 2010). Notoginseng is mainly produced in 
provinces of Yunnan and Guangxi of China (Chang et al., 2000). It tastes sweet and 
mildly bitter and is “warm” in nature (Bensky et al., 2004; CPC, 2010). A number of 
published reviews are available on P. notoginseng (Chen et al., 2008b; Ng, 2006; Zeng 
et al., 2012). 
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Table 1.6. Reported pharmacological activities of P. ginseng 
Pharmacological effects Type of study 
Cardiovascular system 
Treating chronic pulmonary heart disease Clinical trials (Li et al., 2011a) 
Treating angina pectoris (better than 
nitrates) 
Clinical trial (Jia et al., 2012) 
Improvement in ischemic and congestive 
heart diseases 
Clinical trials (Lee et al., 2011c) 
Anti-hypertension Clinical (Choi et al., 2011) 
Alcoholism Improving withdrawal symptoms Clinical (Tomczyk et al., 2012) 
Coagulation system Increasing clotting time Case report (Stanger et al., 2012) 
Neurologic system 
Improving cognition in 4 out of 6 studies Clinical trials (Lee et al., 2011c) 
Improving signs of Alzheimer’s disease In vivo (Kurz et al., 2011) 
Improving cerebral blood flow after 
stroke 
Clinical trials (Lee et al., 2011c) 
Immune system 
Anti-inflammation 
In vitro and in vivo (Lee et al., 
2011a) 
In vivo (animal) (Wang et al., 
2011b) 
In vitro (Wang et al., 2011b) 
Immuno-modulation Clinical (Vogler et al., 1999) 
Cancer 
Preventing gastric cancer 
In vitro and animal (Won et al., 
2011) 
Improving hepatocellular carcinoma Clinical (Wu et al., 2009) 
Controlling growth and invasion of brain 
tumor and anti-angiogenesis 
In vitro (Wang et al., 2011b) 
Metabolism 
Anti-hyperglycemic activity 
In vitro and in vivo (Wang et al., 
2011b) 
No convincing data on anti-
hyperglycemic activity 
Systematic reviews (Kim et al., 
2011; Lee et al., 2011c) 
Anti-hyperlipidemic activity In vivo (Cho et al., 2006) 
Anti-obesity activity In vitro (de la Garza et al., 2011) 
Inhibiting liver enzymes 
In vitro and in vivo (Choi et al., 
2011) 
Respiratory system 
Improvement in chronic obstructive 
pulmonary disease (COPD) and 
respiratory infections 
Clinical trials (Lee et al., 2011c) 
Reproductive system 
Improvement in erectile dysfunction and 
sexual satisfaction 
Clinical trials (Ho et al., 2011; Jang 
et al., 2008) 
General health No effect on physical performance  Clinical trials (Lee et al., 2011c) 
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1.3.1.4. Medical usage and pharmacological activities of P. notoginseng 
Panax notoginseng is traditionally used to improve blood circulation and remove 
blood clots, disperse swelling and relieve pain (CPC, 2010). This plant is also used for 
different kinds of heart disease and chest pain (Zhao, 2004). In addition, it is indicated 
for different bleeding related disorders such as hemoptysis, hematemesis, epistaxis, 
menorrhagia and spotting as well as chest pain, abdominal pain, and swelling and pain 
caused by injuries (CPC, 2010). Many studies have tried to evaluate its pharmacological 
effects and mechanisms of actions listed in Table 1.7. 
Table 1.7. Reported pharmacological activities of P. notoginseng 
Pharmacological effects Type of study 
Cardiovascular system 
Anti-atherosclerosis In vivo (Zeng et al., 2012) 
Treating myocardial ischemia Animal (Shi et al., 2011) 
Neurological effects 
Facilitating improvement after 
ischemic stroke 
Clinical (Chen et al., 2008b) 
Pain 
Alleviating pain caused by cervical 
disc degeneration 
Clinical trials (Cui et al., 2010) 
Immune system Anti-inflammatory 
In vitro (Spelman et al., 2011) 
In vivo (Zeng et al., 2012) 
   
1.3.1.5. Panax quinquefolium 
Panax quinquefolium L. or “American ginseng” is another species from the family 
Araliaceae (Zhao, 2004). Its dried root (Radix Panacis quiquefolii)  is called Xi Yang 
Shen (Chang et al., 2000). It is originated from North America but it is successfully 
cultivated in North China. Similar to other Panax species, it tastes sweet and mildly 
bitter. On the other hand, in contrast to the other two major species, it is “cool” in nature 
(Bensky et al., 2004). There are some published reviews on P. quinquefolium (Qi et al., 
2010, 2011; Vuksan et al., 2001). 
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1.3.1.6. Medicinal usage and pharmacological activities of P. quinquefolium 
This plant is traditionally used for cough, hemoptysis, thirst, irritability and debility 
(Zhao, 2004). As it is “cool” in nature, it can be used for internal hotness and dryness 
as well as fatigue, wasting thirst (diabetes mellitus), and dry mouth and throat (Bensky 
et al., 2004). Its neurologic indication is vexation (CPC, 2010) (irritability and anxiety). 
There are recent reports on its pharmacological activities including effects on 
cardiovascular and central nervous system, anti-diabetic effects, anti-tumor activities 
and immunomodulatory properties (Shi et al., 2012b) as well as effects on post-
menopausal syndrome (Shou et al., 2011) (Table 1.8).  
Table 1.8. Reported pharmacological activities of P. quinquefolium 
Pharmacological effects Type of study 
Cardiovascular 
system 
No effect on ischemic and congestive heart 
diseases 
Clinical trials (Lee et al., 2011c) 
Anti-ischemic, anti-hypertensive, anti-
arrhythmic 
In vitro (Qi et al., 2011) 
Neurologic effects 
Enhancing memory and anti-Alzheimer’s 
diseases 
In vitro (Qi et al., 2011) 
Anti-Parkinsonism In vitro (Qi et al., 2011) 
Cancer 
Protecting against colon cancer In vitro (Qi et al., 2011) 
Anticancer In vitro (Qi et al., 2011) 
Metabolism 
Anti-diabetic effects in 4 out of 5 studies Clinical trials (Lee et al., 2011c) 
Anti-diabetic Clinical trial (Kasuli, 2011) 
Anti-obesity In vitro (de la Garza et al., 2011) 
Respiratory system 
Relieving from acute respiratory infections and 
common cold 
Clinical trials (Lee et al., 2011c) 
Coagulation 
system 
Reducing anti-coagulant effect of warfarin Clinical trial (Shi et al., 2012b) 
Gynecological 
disorders 
Alleviating menopausal syndrome Clinical trial (Shou et al., 2011) 
General health No effect on physical performance  Clinical trials (Lee et al., 2011c) 
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1.3.2. Chemical components of Panax species and their pharmacological 
effects 
In 1854, the first chemical compound was extracted from P. quinquefolium, which 
was a saponin. Since then, many individual substances have been isolated from 
different Panax species (Kim, 2012) including more than 180 saponins (Christensen, 
2009) and other chemical constituents such as polysaccharides, polyacetylenes, 
peptides and amino acids (Kim, 2012). The saponins from Panax species are generally 
called ginsenosides (Table 1.9).  
1.3.2.1. Saponin components of Panax species (ginsenosides) 
The major pharmacologically active ingredients of the Panax species are 
ginsenosides. With a few exceptions, they share a similar basic structure, which is a 
saturated 1,2-cyclopentanoperhydrophenanthrene steroid nucleus. Based on their 
skeleton of aglycones, they can be classified into two main groups namely dammarane-
type and oleanane-type. The dammarane-type group consists mainly of three types 
classified according to their genuine aglycone moieties: protopanaxadiol (PPD), 
protopanaxatriol (PPT), and ocotillol, whereas ginsenosides of the oleanane-type are 
classified according to their aglycone oleanolic acid. Other types of ginsenosides 
isolated from ginseng species include panaxatriol-type and dammarenediol-type 
ginsenosides (Christensen, 2009). Most of the abundant ginsenosides belong to either 
the PPD or PPT groups (Figure 1.3). If two hydroxyl groups are attached to the back 
bone it will be categorized as protopanaxadiols while protopanaxatriols  are 
ginsenosides with three hydroxyl groups attached to their backbone (Lu et al., 2009).  
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Ginsenosides I, Ginsenosides II, 
Ginsenosides III, F2, Ra1, Ra2, Ra3, 
Rb1, Rb2, Rb3, Rc, Rd, Rg3, Rg5, 
Rh1, Rh2, Rh3, Rk1, Rk2, Rs1, Rs2, 
Rs3, Rs4, Rs5, notoginsenosides (A, 
B, C, D,  Fa, Fc, Fe, K, L and R4), 
quinquenosides (R1, Rs1, Rs2, I-V) 
Protopanaxatriol 65 
Ginsenosides F1, F3, F4, F5 La, Re, 
Rf, Rg1, Rg2, Rg6, Rh4, Rh5, Rh6, 
Rh8, Rh9, Rk3, Rs6, Rs7 




Vinaginsenoside R1, R2, R5, R6, 
R14 
Oleanane-type 10 
Ginsenosides Ro, Roa, R15 
vinaginsenoside R10, R11 
pseudoginsenoside F11 
Modified ginsenosides 15 
Ginsenoside Rh7 





Panasans A-E, poanaxans F-H, 
panaxan I-U, ginsenan PA and PB, L-
arabinose, D-galactose, L-rhamnose, 
ginesan S-IA and S-IIA, quiquifolan 
A-C 
Polyacetylenes 
Trifolin, panasenoside, panaxynol, 
panaxydol, PQ-1-3,  
Alcohols 
Pansinsanol A & B, ginsenol, 
senecrassidiol 





Figure 1.3. Basic structure of major ginsenosides. A) Protopanaxadiols; B) 
Protopanaxatriols. Adapted from (Christensen, 2009). 
Differences in ginsenoside composition in various species of Panax genus lead to 
their different pharmacological properties (Kim, 2012). The next sections will briefly 
review most abundant ginsenosides. 
1.3.2.1.1. Ginsenoside Rg1 
Ginsenoside Rg1 is one of the most abundant saponins in major Panax species and 
the representative constituent of P. ginseng and P. notoginseng. The Rg1 content of P. 
notoginseng (~40 mg/g) is much higher than P. ginseng (~4 mg/g). It is also one of the 
most studied ginsenosides (Cheng et al., 2005; Collins, 2011; Lu et al., 2009; Wan et 
al., 2007).  
Ginsenoside Rg1 has three hydroxyl groups and belongs to PPT category 
(Figure 1.3). The R2 and R4 substitutes are glucose and the other two are Hydrogen. 
After oral consumption, it undergoes two-step deglycosylation hydrolysis by gut 
bacteria. First step of deglycosylation produces ginsenoside Rh1 by through 
substitution of R4 glucose by hydrogen or ginsenoside F by substitution of R2 one. The 
hydrolysis of the other glucose group will produce 20(S) PPT (Hasegawa et al., 1996). 
Oxygenation is another major metabolic change occurring on orally taken Rg1 in the 
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gut resulting in the formation of mono-oxygenated Rg1 and mono-oxygenated PPT. All 
of these primary and secondary metabolites are measurable in blood, urine and feces 
with different abundances after oral consumption of ginsenoside Rg1 (Wang et al., 
2014b). 
Since the relative oral bioavailability of ginsenoside Rg1 is very low (2.5%) (Tan 
et al., 2013), other routs of administration have been considered by researchers. One of 
these alternative routes is intranasal administration. Intranasal administration of Rg1 
leads in a higher concentration in blood and other tissues at each time point. Compared 
with intragastric administration, intranasal administration results in a shorter tmax (0.08 
versus 1 h), a higher Cmax (16.65 versus 11.29 μg/ml), and a higher area under the 
concentration-time curve (AUC) (592.91 versus 101.70 μgċh/ml) in the brain (Bai et 
al., 2012). Other alternative routes of administration are intraperitoneal (IP) and 
intravenous (IV). Although these methods of administration bypass the problem of low 
absorption of ginsenoside Rg1 from gastrointestinal tract to the blood, limited 
penetration into blood brain barrier causes very low brain concentrations after systemic 
administration. IP injection of Rg1 can cause maximum brain concentration in 30 
minutes with rapid clearance in 4 hours. After 24 hours it is hardly detectable in brain. 
The maximum brain concentration is very low therefore the mechanism of action is 
most probably extra-cranial (Moore et al., 2011). Therefore, some researchers consider 
intracerebroventricaular (ICV) administration of ginsenoside Rg1 to study its direct 
effect on central nervous system (Wang et al., 2001b; Wang et al., 2009c; Xu et al., 
2007). 
Despite low bioavailability and limited body distribution of ginsenoside Rg1, many 
pharmacological effects have been reported for this compound. These pharmacological 
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effects include anti-cancer effects (Leung et al., 2006; Ma et al., 2006; Wang et al., 
2009a), immunoregulatory effects (Cheng et al., 2005; Lee et al., 2004a), effects on 
cardiovascular conditions (Deng et al., 2009; Wang et al., 2010d; Zhu et al., 2009), 
hypoglycemic effects (Huang et al., 2010) and neurological effects (Table 1.10).  
Table 1.10. Studied pharmacological activities of ginsenoside Rg1 
Pharmacological activities 
Potential mechanisms 
Effect category Effect on 
Neurology 
Alzheimer’s disease 
Inhibiting amyloid beta induced cell apoptosis (Li et al., 
2012a) via estrogen receptor-α and glucocorticoid 
dependent anti-protein nitrogen pathways (Wu et al., 
2012b) and caspase-3 pathway (Wei et al., 2008), 
modifying the metabolism of amyloid protein precursor by 
affecting NF-ᵏB (Chen et al., 2012a), decreasing βamyloid 
synthesis via suppression of PPARᵞ-regulated activities 
(Chen et al., 2012b), improvement of spatial learning and 
memory with up-regulating NGF in basal forebrain (Wu et 
al., 2011), neuro-protective effect against hydrogen 
peroxide (Liu et al., 2011b), protecting against βamyloid 
cytotoxicity by inhibiting β-secretase activity (Wang et al., 
2009b), anti-apoptotic by inhibiting JNK and caspase-3 
(Chen et al., 2003a), inhibiting amyloid beta toxicity via 
acetylcholine esterase and choline amine transferase in 
hippocampus (Wang et al., 2001a) 
Memory 
Protective effects on hippocampal nerves against electrical 
injury (Chen et al., 2011b), restoring learning deficit 
caused by morphine toxicity via NMDA signaling (Qi et 
al., 2009), improvement of signal transduction via NO 
synthesis and increasing acetylcholine and its receptor in 
CNS as well as anti-apoptotic effects (Cheng et al., 2005). 
Cognition Increasing glutamate release (Liu et al., 2010) 
Dopaminergic 
neuroprotection 
Up-regulation of Bcl-2, activation of Akt phosphorylation 
and inhibition of ERK1/2 phosphorylation (Ge et al., 2010) 
Parkinsonism 
Dopaminergic neuroprotectionby inhibiting depressing 
nuclear transduction of P-ERK1/2 (Shi et al., 2009), or 
activating estrogen receptor (Xu et al., 2008), P38 
signaling pathway (Wang et al., 2008a) or insulin like 
growth factor (Xu et al., 2009), inhibiting dopamine 
induced apoptosis (Chen et al., 2003b) 
Stroke 
Decreasing hypoxic ischemic brain damage by inhibiting 
caspase-3 mechanism (Wang et al., 2010a) and regulation 
of hypoxia inducible factor-1α (Tang et al., 2011) 
Anti-depressant 
Activating BDNF pathway and up-regulating hippocampal 
neurogenesis (Jiang et al., 2012) 
To be continued on the next page 
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Angioneogenesis via hypoxia inducible factor-1 α (Wang 
et al., 2010d), myocardial protection by anti-oxidant 
activity and intracellular calcium homeostasis (Zhu et al., 
2009) 
Coarctation of aorta 
Inhibition of ventricular hypertrophy by inhibition of 






Insulin-like activities on adipocytes causing glucose 
uptake (Huang et al., 2010) 
Immune system Immunoregulatory 
Enhancing the proliferation of lymphocytes and production 
of IL-2, increasing cAMP and cGMP in lymphocytes 
(Cheng et al., 2005), enhancing CD4+ activity and 





white blood cell 
count 
Promotion of myelopoiesis via cytokine regulation 
(Raghavendran et al., 2012) 
Red and white 
blood cell 
regeneration 
Postponing hematopoietic stem cell senescence (Zhou et 
al., 2010) 
Anti-coagulant 
By inhibiting platelet aggregation (Liu et al., 2006b) and 





Up-regulation of hypoxia-inducible factor-1α (Leung et 
al., 2011), regulating fibroblast growth factor receptor-1 
(Cheung et al., 2011) 
Angiogenesis 
Inhibiting TNF induced vascular smooth muscle 
proliferation (Gao et al., 2011; Ma et al., 2006) and 
vascular endothelial growth factor (Wang et al., 2011a) 
induction via PI3K/Akt pathway (Leung et al., 2006) 
Anti-proliferative 
effects 
Cell cycle arrest and apoptosis more than other saponins 










Inhibition of renal interstitial fibrosis (Xie et al., 2010b) 
Diabetic 
nephropathy 
Anti-inflammatory effects such as reducing transforming 
growth factor β-1 (Ma et al., 2010b) 
Male sexual 
dysfunction 
Maintaining testosterone level and nitric oxide mediated 




Antagonizing the effect of UV on fibroblasts (Zhou et al., 
2012), attenuating the G1 growth arrest in fibroblast 
induced by UV (Wang et al., 2011c) 
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Different scientists have tried to evaluate the effects of ginsenoside Rg1 on nervous 
system. Some of them study its protective function against different environmental 
insults such as hypoxic injury to brain after stroke (Tang et al., 2011; Wang et al., 
2010a) or chemical and electrical injury (Chen et al., 2011b; Qi et al., 2009; Wu et al., 
2012b). Some others suggest molecular pathways affected by ginsenoside Rg1 which 
are involved in neurological diseases or normal function such as the role of Rg1 on 
brain derived neurotrophic factor and its role in depression (Jiang et al., 2012), the effect 
of Rg1 on glutamate release to improve cognition (Liu et al., 2010) or enhancement of 
signal induction to improve memory (Cheng et al., 2005). Beside these molecular in 
vitro studies, animal based in vivo experiments would be useful to determine the 
neurological effects of ginsenoside Rg1 and the potential mechanisms involved. Some 
studies have reported positive effects of ginsenoside Rg1 on memory of different 
cognitively impaired animal models using Morris Water Maze (Li et al., 2011c; Li et 
al., 2012b; Qi et al., 2009; Wang et al., 2010b; Zhang et al., 2012b) or other 
neurobehavioral tests (Fang et al., 2012; Wang et al., 2010b; Wu et al., 2011; 
Yamaguchi et al., 1995). Some others used other neurobehavioral studies to verify the 
effects of ginsenoside Rg1 on depression (Carr et al., 2006; Cha et al., 2005; Jiang et 
al., 2012; Wu et al., 2012a). An alternative way of studying the neurological effects of 
Rg1 in vivo is via electrophysiological studies. In vivo electrophysiology evaluates the 
electrical charges in various brain regions and neurological pathways. Wang and his 
colleagues used perforant path-dentate gyrus excitability to suggest hippocampus as the 
main site of action for neurological effects of ginsenoside Rg1 (Wang et al., 2001b; 
Wang et al., 2009c). Qi et al. also focused on hippocampus and most specifically the 
CA1 stratum radiatum of the right hippocampal hemisphere in response to stimulation 
of the Schaffer collateral-commissural pathway (Qi et al., 2009). Other scientists also 
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focused on hippocampus in their electrophysiological studies to study the neurological 
effects of ginsenoside Rg1 (Mook-Jung et al., 2001; Xu et al., 2007). So far, almost all 
electrophysiological studies on ginsenoside Rg1 have been limited into the 
hippocampus. 
Despite the long list of studies evaluating the pharmacological effects of 
ginsenoside Rg1, there are few reports on its toxicity study. Saw et al. studied the 
possible toxic effect for rg1 in HepG2-C8 cells observing no toxic effects in vitro (Saw 
et al., 2012). Park et al. also studied the toxicity of 4-weeks oral administration of 
combination of ginsenoside Rg1 and Rb1 in rats which revealed no toxic effect on any 
organ (Park et al., 2013). The only toxic effect of this ginsenoside was reported by Liu 
et al. who investigated the 48-hour exposure of rat embryo to different concentrations 
of ginsenoside Rg1. They observed several teratogenic effects in high concentrations 
of ginsenoside Rg1 (more than 30-50 g/ml) (Liu et al., 2006a). Generally, ginsenoside 
Rg1 is a safe compound with more protective than toxic effects on different cell lines. 
1.3.2.1.2. Ginsenoside Rb1 
Another highly abundant saponin is ginsenoside Rb1, which can be found in all 
three major Panax species. Although ginsenoside Rb1 is the most abundant saponin in 
P. quinquefolium (~25 mg/g) and its representative chemical constituent, P. 
notoginseng is the major source of this molecule (~30 mg/g) (Cheng et al., 2005; Wan 




Table 1.11. Studied pharmacological activities of ginsenoside Rb1  
Pharmacological activities 
Potential mechanisms 
Effect category Effect on 
Neurology 
Cognition Regulating voltage gated calcium channels (Lin et al., 2012) 
Memory 
Increasing cell survival in hippocampus (Liu et al., 2011a) 
and increasing acetylcholine and its receptor in CNS (Cheng 
et al., 2005) 
Alzheimer’s disease 
Protecting cells from Aβ injury functioning as an ROS 
scavenger (Xie et al., 2010a),  decreasing Aβ(1-42)-induced 
neurotoxicity and tau hyperphosphorylation (Zhao et al., 
2011) 
Stroke 
Neuroprotective against ischemia by immunomodulatory 
effects affecting interleukins (Zhu et al., 2012) and 
regulation of BDNF and caspase-3 (Gao et al., 2010), 
inhibition of neuronal apoptosis (Yang et al., 2008) 
Depression  
Increasing 5-HT level (Yamada et al., 2011) in brain by 





inhibition of HB-EGF (Lu et al., 2012) 
Hypertension 
Vasodilation by activating NO via modulating the 
PI3K/Akt/eNOS pathway and l-arginine transport in 
endothelial cells (Pan et al., 2012) 
Myocardial 
infarction 




Protecting endothelium from hemocystein induced 
dysfunction by increasing NO and via PI3K/Akt activation 




Increasing cell cycle rate in PC12 cells (Lee et al., 2010b) 
Hypoglycemic 
effect 
Stimulation of glucose transport into insulin sensitive cells 






Inhibiting lipid peroxidase activity and scavengering effects 





Inhibition of interstitial fibrosis, tubular injury and collagen 
deposition as well as anti-oxidant effect (Xie et al., 2009b) 
Diabetic 
nephropathy 
Inhibition of fibronectin expression due to hyperglycemia 
via the inhibition of MAPK-Akt signaling cascade 
Renal cell 
protection 
Inhibition of ROS release induced by TGF-beta1 via 
suppression of p47phox expression (Xie et al., 2009a) 
Male sexual 
dysfunction 
Maintaining testosterone level (Lian et al., 1998) 
  To be continued on the next page 
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Cont. Table 1.11. 
Cancer 
Skin cancer 
Protection against UV induced apoptosis and induction of 
DNA repair (Cai et al., 2009) 
Anti-proliferative 
effects 
Cell cycle arrest and apoptosis more than other saponins 
from P. notoginseng (Wang et al., 2009a) 
   
Ginsenoside Rb1 belongs to the PPD group and has two disaccharide groups 
attached to its PPD backbone. The R1 group is kojibiose and the R2 group is isomaltose 
(Christensen, 2009). After oral consumption, some part of ginsenoside Rb1 will be 
deglycosided to ginsenoside Rh2 in acidic environment of stomach. The hydrolysis 
process continues by the gut intestine to produce ginsenosides Rd, F2, compound K and 
20(S)PPD. The overall bioavailability of ginsenoside Rb1 is much less than ginsenoside 
Rg1 (1:10) (Takino, 1994). 
Despite very low bioavailability, several pharmacological activities have been 
reported for ginsenoside Rb1. Some of these activities are the effect of secondary 
metabolites such as ginsenoside Rd or compound K. The reported pharmacological 
activities of ginsenoside Rb1 include neurologic effects (including neuroprotection and 
neurostimulation), anti-atherosclerosis, immunomodulatory effects, etc. Table 1.11 has 
summarized the studied pharmacological activities of ginsenoside Rb1. 
1.3.2.1.3. Differences in saponin components of the three major Panax species 
Although the majority of ginsenosides can be found in almost all Panax species, 
their compositions in different Panax species are not similar (Table 1.12). This causes 
different pharmacological properties and medicinal indications (Kim, 2012). In 
addition, ginsenoside composition can help differentiating the species from each other. 
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Table 1.12 shows a comparison between the three major Panax species based on their 
main saponin compositions. 
Table 1.12. Comparison between the main saponins in three major Panax species 
Chemical component P. ginseng P. notoginseng P. quinquefolium 
Protopanaxadiol + ++++ ++ 
Protopanaxatriol ++ ++++ + 
The most abundant saponins Rg1, Rb1, Rb2 Rg1, Rb1, Rd Rb1, Re, Rd 
Octylotype saponins + - ++ 
Characteristic saponin Rf R1 F11 
Rg1/Rb1 >1 >1 <0.4 
+: presence, ++ significant presence, ++++ abundant presence, -: absence. Note that these signs are 
used for comparison purpose and it is not representing the exact quantity of the components. 
 
 One of the most important distinctive properties of these plants may be the 
Rg1/Rb1 ratio. Although Rg1 and Rb1 are among the most abundant saponins found in 
all three major species, their respective ratio is different in American “ginseng” 
compared to the other two major species. In other words, the Rg1/Rb1 ratio is less than 
0.4 in American “ginseng” and more than 1 in P. ginseng and P. notoginseng 
(Christensen, 2009; Kim, 2012). In the available literature, Rg1 is reported as a strong 
neuro-stimulant while Rb1 has both neuro-stimulatory and neuro-inhibitory effects. 
Therefore, the lower Rg1/Rb1 ratio of P. quinquefolium compared to P. ginseng 
provides an explanation for the calming effect of “American ginseng” compared to the 
“Chinese ginseng” (Chen et al., 2008a). Based on Chinese material medica, Chinese 
“ginseng” is “warm” in nature (stimulatory) while American “ginseng” is “cool” 
(calming) (Bensky et al., 2004).  
In addition to inter-species differences of the chemical profiles, processing of plants 
(such as steaming and drying) has a great impact on chemical and pharmacological 
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properties of the Panax species by structural transformation of some ginsenosides 
leading in altering the composition of extracts (Jia et al., 2009a; Smith et al., 2014; Toh 
et al., 2010). The traditional and most usual method of processing ginseng is steaming 
(Christensen, 2009). The alternative methods of plant processing include puffing (Yoon 
et al., 2010) and fermentation (Lim et al., 2010b). Table 1.13 shows some examples of 
changes in chemical composition of P. ginseng observed after processing. Such changes 
have been used to make Panax ginseng stronger and alter its pharmacological 
indications (CPC, 2010). 
Table 1.13. Effects of some processing methods on selected saponins content of P. 
ginseng (Christensen, 2009; Lim et al., 2010b; Yoon et al., 2010) 
Processing method Effect 
Steaming 
Decrease in amount of Rb1, Rb2, Rg1, Rg2, Rc, Rd, Re 
Increase in amount of Rh1, Rh2, Rg5, Rg6, Rs 1-7, Rk1-3 
Release of malonyl group attached to Rb1, Rb2, Rc, Rd, etc. 
Puffing dried root 
Decrease in amount of Rg1, Rb1, Rb2, Rc, Re 
Increase in amount of Rg3 
Fermentation1 
Decrease in Rb1, Re, Rc 
Increase in Rb2, Rb3, Rd, , Rg1, Re 
1 Fermentation by a microbial mixture of Bacillus species including B. subtilis, B. licheniformis, B. 
senorensis and B. circulance for 15 days. 
 
 
1.3.2.1. Non-saponin components of Panax species 
Besides saponins, Panax species have other chemical components (Table 1.9) 
including polysaccharides, polyacetylenes, alcohols, vitamins, peptides, and amino-
acids, which may play some role in their pharmacological activities. Although 
polysaccharides are more studied than other minor ingredients isolated from the Panax 
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species, the chemical structures of many of them have not been clearly elucidated, yet. 
It is known that acidic polysaccharides are more abundant in P. ginseng compared to 
the other two major species (Kim, 2012).  
Some pharmacological effects of polysaccharides have been studied such as 
immunomodulatory and anti-cancer effects. For example, ginsan, an acidic 
polysaccharide, is shown to have immunostimulatory effects (Kitts et al., 2000; Wang 
et al., 2013c). In an animal experiment on influenza-A infection, polysaccharide 
fraction of P. ginseng improved the survival rate of animals comparable to the saponin 
fraction and total extract. Furthermore, polysaccharide fraction showed better anti-
inflammatory effects on lung pathology (Yin et al., 2013). On the other hand, Fan et al. 
and Cai et al. reported anti-proliferative properties for composite polysaccharides from 
Panax ginseng (Cai et al., 2013; Fan et al., 2013). Rhamnogalacturonan I a 
polysaccharide backbone of petins from Panax species has aslo been studied as an 
inhibitor of cancer progression (Gao et al., 2013). Additionally, positive effects on 
diabetes and dyslipidemia have been reported for different polysaccharides from P. 
ginseng (Kwak et al., 2010; Niu et al., 2012; Wang et al., 2003) 
1.3.3. Neurological effects of major Panax species and ginsenosides 
Neurological effects are among most important pharmacological properties of 
Panax species. These herbs have been traditionally used for several neurological 
conditions reported in section 1.3.1 (CPC, 2010). Table 1.14 has summarized the 
studied neurological properties of three major species and more abundant saponins. 
Particularly, the memory improvement and mood stabilizing effects are often reported. 
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Table 1.14. Neurological effects of Panax species and selected constituents 




Clinical (Chen et al., 2011a; 
Scholey et al., 2010) 
Review (Qi et al., 2011) 
Increasing cell survival, extending 
neurite growth and inhibiting cell 
death (Qi et al., 2011), Inhibition of 
uptake of MPTP, suppression of 
oxidative stress, attenuation of 
MPP+induced apoptosis, potentiation 
of nerve growh factors, activation of 
IGF-1 receptor signaling pathway (Qi 
et al., 2011). 
Memory 
Clinical (Chen et al., 2011a) 
Animal (Sloley et al., 1999; 
Wang et al., 2004) 
Review (Qi et al., 2011) 
Parkinsonism Review (Qi et al., 2011) Increasing cell survival, extending 
neurite growth and inhibiting cell 
death (Qi et al., 2011), Inhibition of 
uptake of MPTP, suppression of 
oxidative stress, attenuation of 
MPP+induced apoptosis, potentiation 
of nerve growh factors, activation of 
IGF-1 receptor signaling pathway (Qi 
et al., 2011). 
Attention 
Clinical (Lyon et al., 2001) 
Review (Rucklidge et al., 
2009) 
Mood and stress Review (Qi et al., 2011) 
Psychosis  





Animal (Zhong et al., 2011) 
Cell line (Choi et al., 2010) Increasing the level of 5-HT and 
norepinephrine, modulating Na and 
Ca channels, increasing nestin and 
brain-derived neurotrophic factor 
(Cui et al., 2011). 
Memory 
Animal (Chuang et al., 2008; 
Hsieh et al., 2000; Zhou et al., 
2007) 




Clinical (Kennedy et al., 2004; 
Neri et al., 1995; Reay et al., 
2010; Tian et al., 2003; 
Wesnes et al., 2000) 
Animal (Hsieh et al., 2000; 
Lee et al., 2010a; Nishijo et 
al., 2004; Nishiyama et al., 
1996; Nishiyama et al., 1994a, 
1994b; Nishiyama et al., 
1994c; Petkov et al., 2003; 
Petkov et al., 1993; Wang et 
al., 1995; Xie et al., 1996; 
Yun et al., 2007; Zhong et al., 
2000) 
Review (Jesky et al., 2011; 
Ma et al., 1991; Perry et al., 
2011; Petkov et al., 1992) 
Enhancing the phosphatase activity of 
calcineurin affecting tau 
phosphorylation (Tu et al., 2009), 
antagonistic effects on morphine 
receptors to decrease morphine 
dependency (Seo et al., 2008), 
regulation of Ca current in neurons 
(Rhim et al., 2002), inhibiting 
nicotine induced DA surge in brain 
(Shim et al., 2000). 
Alzheimer’s disease 
Clinical (Heo et al., 2008; Lee 
et al., 2008b; Zhong et al., 
2007) 
Animal (Cong et al., 2007; 
Wang et al., 2006) 
Review (Perry et al., 2011) 
 To be continued on the next page 
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Clinical (Hartley et al., 2004; 
Kennedy et al., 2001, 2002; 
Scholey et al., 2002, 2004; 
Wesnes et al., 1997; Ziemba et 
al., 1999) 
Animal (Sanghavi et al., 2011) 
Enhancing the phosphatase activity of 
calcineurin affecting tau 
phosphorylation (Tu et al., 2009), 
antagonistic effects on morphine 
receptors to decrease morphine 
dependency (Seo et al., 2008), 
regulation of Ca current in neurons 
(Rhim et al., 2002), inhibiting 
nicotine induced DA surge in brain 
(Shim et al., 2000). 




Cell line (Liu et al., 2010) 
Animal (Liu, 1996; Liu et al., 
1996; Wang et al., 2010b) 
Review (Cheng et al., 2005; 
Perry et al., 2011) 
Promoting neurotransmitter release 
via a protein kinase II-dependent 
signaling pathway. 
Alzheimer’s disease 
Cell line (Chen et al., 2006; 
Chen et al., 2012b; Shi et al., 
2012a; Wang et al., 2009b) 
Animal (Fang et al., 2012; Li 
et al., 2011c; Shi et al., 2010) 
Peripheral nerve 
regeneration 
Animal (Ma et al., 2010a) 
Inhibiting 
neurodegeneration 
Review (Qi et al., 2011) 
Schwann cell 
neurotropic activity 
Cell line (Liang et al., 2010) 
Anxiety  Animal (Cha et al., 2005) 
Ginsenoside 
Rh1 (an Rg1 
metabolite) 




Cell line (Liu et al., 2011a) 
animal (Salim et al., 1997; 
Wang et al., 2010b) 
review (Cheng et al., 2005; 
Perry et al., 2011) 
Promoting neurotransmitter release via 
a cAMP-dependent protein kinase 
pathway (Qi et al., 2011), selective 
inhibition of voltage gated calcium 
channels (Lin et al., 2012), local anti-
inflammatory effects in brain via 
different interleukins (Zhu et al., 2012), 
anti-oxidant effect against Aβ induced 
inflammation (Xie et al., 2010a), 
stimulating cell survival in 
hippocampus (Liu et al., 2011a). 
Alzheimer’s disease 
cell line (Zhao et al., 2011) 
animal (Lee et al., 2001; 
Wang et al., 2011d) 
Depressant 
Animal (Yamada et al., 
2011) 
Promoting neurotransmitter release via 
a cAMP-dependent protein kinase 
pathway (Qi et al., 2011), selective 
inhibition of voltage gated calcium 
channels (Lin et al., 2012), local anti-
inflammatory effects in brain via 
different interleukins (Zhu et al., 2012), 
anti-oxidant effect against Aβ induced 
inflammation (Xie et al., 2010a), 
stimulating cell survival in 
hippocampus (Liu et al., 2011a). 
Neuroprotection Review (Qi et al., 2011) 
Schwann cell 
neurotropic activity 
Cell line (Liang et al., 2010) 
To be continued on the next page 
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Animal (Yamada et al., 
2011) 
Suppression of NF-ᵏ-B activation, pro-
inflammatory cytokine, mitogen-
activated protein kinase, reactive 
oxygen species, and mitogen-activated 
protein kinase, activation of 
peroxisome proliferator-activated 
receptor , increase of GLUT 
expression 
enhancement of PKA-dependent 
pathways 
Amelioration of insulin resistance 
through suppressions of endogenous 
glucose production 
and lipogenesis in the liver, and 
activated phosphorylation of AMPK in 
the HIT-T15 cells 
protective effects against beta-cell 
death, Inhibition of  expression of 
Interferon-ᵞ, Induction of apoptosis by 
activation of caspase-8, suppression of 
nuclear factor-kappa B (NF-κB) 
pathways, and Janus activated kinase 1 
(JAK1)-signal transducer and activator 
of transcription 3 (STAT3) signaling, 
suppressing matrix metalloproteinase-9 
(MMP-9) expression and inhibitting 
basic fibroblast growth factor (bFGF)-
induced angiogenesis (Wang et al., 
2011b). 
Memory cell line (Bae et al., 2010) 
Ginsenoside 
M1 (an Rb1 
metabolite) 
Alzheimer’s disease Animal (Tohda et al., 2004) 
Not reported. 
Memory cell line (Tohda et al., 2006) 
Ginsenoside 
Rb3 
Depression Animal (Xiang et al., 2011) 
Neuroprotective effects by enhancing 
anti-oxiant abilities and lowering the 
amount of free radicals (Xu et al., 
2005), inhibition of GABA 
exhaustion in nerves (Jiang et al., 
2011), inhibiting NMDA-induced 
calcium influx and glutamate-induced 
cerebral damage (Cui et al., 2011), 
decreasing the affinity of glycine for 
hippocampal receptor and delaying 
receptor activation (Xu et al., 2005), 
increasing brain-derived neurotropic 
factor, controversial effects on 
dopaminergic and neurepinephric 
pathways (Cui et al., 2011), 
increasing cell viability, inhibiting 
LDH release, inhibition of apoptosis 
and MMP, increase in Bcl-2 protein 
expression(Zhu et al., 2010). 
Memory Animal (Cui et al., 2011) 
Stroke recovery Animal (Cui et al., 2011) 




Cont. Table 1.14. 
Ginsenoside 
Re 
Cognition Animal (Liu et al., 2012b) 
H2O2 and hydroxyl radical 
scavenging (Qi et al., 2011). 





Animal (Li et al., 2010) Anti-inflammatory response via P38 
and JNK pathways (Yang et al., 
2012), anti-Alzheimer’s effects by 
enhancing the activity of protein 
phosphatase 2A on tau protein (Li et 
al., 2011b), neuroprotection against 
glutamate induced excitotoxocity by 
inhibiting Ca influx (Zhang et al., 
2012a). 
Stroke recovery Clinical (Liu et al., 2012a) 
Inhibiting 
neurodegener-ation 
Review (Qi et al., 2011) 
Neuro-protection 





Cell line (Chen et al., 2006) 
Review (Perry et al., 2011) 
Improvement of mitochondrial 
metabolism in nerves, decreasing 
mitochondrial permeability induced 
by Ca or H2O2 (Tian et al., 2009), 
neuro-protection by inhibiting 
voltage gated Na channels (Lee et al., 
2008a), protecting neurons from 
NMDA induced neuronal death by 
antagonistic effects on NMDA 
receptor (Kim et al., 2004b). 
Inhibiting 
neurodegeneration 
Review (Qi et al., 2011) 




Animal (Ma et al., 1993; 
Zhang et al., 2008b) 
Affects human nicotinic 




Memory Animal (Li et al., 1999) 
Neuronal excitatory effects by 
increasing the release of glutamate 
(Wang et al., 2011e), antagonistic 
effects to morphine induced memory-
loss and analgesia (Li et al., 2000). 
Combination 
Rg5/Rk1 
Memory Animal (Bao et al., 2005) Not reported. 
Ginsenoside Rh2 Memory Animal (Yang et al., 2009b) Not reported. 
Non saponin 
fraction of “red 
ginseng” 
Memory 





from P. ginseng) 
Memory 




Animal (Liubimov et al., 
1995) 
Not reported. 
    
 53 
 
1.4. The ageing world 
Ageing is a global concern. Decreasing fertility rate and increasing life expectancy 
are increasing the average age in different parts of the world. It is predicted that by the 
year 2050 the global population of people older than 60 years old will be doubled (Lutz 
et al., 2008b). Singapore is also a rapidly ageing society. In 2000, 7.2% of population 
were older than 65. This proportion increased to 9.0% in 2010 (Wong, 2010) and it has 
been predicted that the population of older adults aged 65 or more in Singapore will be 
doubled by the year 2025 (Yap et al., 2011). On the other hand, ageing is associated 
with multiple chronic disorders leading in usage of multiple drugs (Willison et al., 
2004). In addition, rate of chronic illness is also associated with higher usage of CAM 
(Feng et al., 2010).  
Among age related disorders, mental disorders in elderly are of extreme 
importance. Although they are quite common in this age group (more than 30%), the 
patients can hardly have access to specialized mental health care and primary care 
physicians are more involved in their psychological care (Lyness et al., 1999). The most 
common mental health issues among older adults include depression, dementia, 
anxiety, etc. Moreover, these disorders have huge coincidence. In the following 
paragraphs, these mental disorders will be discussed more. 
Cognitive decline is one of the most important mental health issues associated with 
ageing (Thies et al., 2013). The ultimate serious consequence of cognitive decline is 
dementia (American Psychiatric Association. et al., 2013). Dementia is a chronic 
progressive and incurable disorder with a significant psychosocial and economical cost 
for the affected patients, their families and the society. In 2010, the global prevalence 
of dementia was estimated as 35 million. Such a prevalence causes a global annual 
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financial burden of US$604 billion (Wimo et al., 2013). In Europe, 10.11 million people 
were suffering from dementia in 2008 and the total estimated cost of this problem to 
the European society was €177 billion (Wimo et al., 2011). Furthermore the risk of 
developing depression is higher in elderly patients with dementia (Samaras et al., 2013).  
Depression is the most common mental disorder appearing in the elder affecting 
approximately 13% of older adult population worldwide (Samaras et al., 2013). Both 
the new incidence and the relapse of depression are common in this age group where 
the episodes of depression are prolonged and the periods of remission are shorten. In 
addition, the risk of resistance to the treatment is higher in older adults (Porzych et al., 
2005). Not only depression is more prevalent among dementia patients (approximately 
35%), but also depression can accelerate the progress of cognitive decline and interferes 
with neuropsychological testing of the patients (Samaras et al., 2013). 
One of the most common symptoms accompanying the depressive disorders in the 
elderly patients is anxiety. Elderly patients with anxiety symptoms caused mainly by 
depression often complain of pain. Such patients usually suffer from lower self-esteem 
and the risk of suicidal thoughts and tendencies is higher (Porzych et al., 2005). 
Considering the financial and psychological burden of mental health problems in 
older adults, it is important to investigate the factors associated with higher likelihood 
of developing such problems as well as potential protective factors. Clinical and 
epidemiologic investigations besides bench based studies provide valuable information 
regarding the risk factors and potential protective and curative treatments. 
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1.5. Laboratory animals as models for mental health 
Since prehistoric times, human has considered animals and animal products as 
renewable natural resources to be used for food, clothing, transportation, recreation, 
sport and companionship (Bear et al., 2007). Similarly, usage of animal models in 
medical research has a history as long as the history of medicine. Throughout the 
history, the ethical and religious considerations and social prohibitions limited the 
experimental studies of human biology and pathology. In addition, sometimes it is not 
practical, economical or scientific to do the preliminary studies in human subjects. 
Therefore, most of our current basic knowledge of human biology, physiology, 
endocrinology and pharmacology has been derived from the studies using animals. In 
other words, animals have been used as “man models” for modeling human physiology 
and pathology to extrapolate the results from animal studies to understand human 
biology (Conn, 2008). 
Alike other fields of medicine, development in neuroscience is indebted to the gift 
of animal studies. Most of what we know about the nervous system comes from 
experiments on animals. Neuroscience experiments are conducted using many different 
species ranging from snails to monkeys. However, more than half of the animals used 
for neuroscience research are inbred rodents (mice and rats) (Bear et al., 2007). Except 
the cerebral cortex which has had huge development in human, all mammals share even 
small details in their nervous system. This similarity in the brains of mammals makes 
it possible to study brain function and detailed neuronal connections in animals and 
then extrapolate the results to the human. Furthermore, the simplicity of rodents’ brains 
compared to humans’ (especially in cerebral cortical area) makes it easier to study and 
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understand the function and relationship of different parts of the brain by studying the 
rodent brain first (Watson et al., 2010).  
In general, simpler nervous system, less ethical issues and more availability have 
made animal models an important research tool in neuroscience. For example, the 
possibility of genetic manipulation has provided suitable animal models for many 
human mutations and genetic variations responsible for neurological disorders 
(Donaldson et al., 2014). Techniques usually used for studying the brain includes thin 
sectioning of the brain and staining the brain sections, cell culture, hodology, molecular 
genetics, non-invasive imaging techniques, electrophysiology (Watson et al., 2010), 
behavioral studying methods and cognitive paradigms (Bear et al., 2007). In the next 
paragraphs, the most important techniques will be introduced briefly. 
1.5.1. Sectioning the brain and staining the sections 
Microscopic study requires very thinly sliced tissues. The brain is usually 
pretreated with chemical preservatives such as formaldehyde before sectioning. 
However, there are some techniques to cut the fresh or freshly frozen tissues. The 
sections are usually cut using a sophisticated machine named microtome (Watson et al., 
2010). The sliced tissues can be used for further studies such as microscopy or staining 
just after slicing or preserved using cryoprotectant material to be used later (Watson et 
al., 1986). A proper cryoprotectant solution can preserve the morphology and peptide 
immunoreactivity of freely floating slices in -20 centigrade for further processing after 
more than 20 years (Hoffman et al., 2004). 
Brain slices can be stained using routine methods like Nissle stain which is used 
for nuclei and ribonucleic acid (RNA) (Butskhrikidze et al., 2008) and luxul fast blue 
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method which stains myelin (Walker et al., 2014) or more sophisticated methods such 
as histochemical or immunohistochemical staining. They can be specific to particular 
proteins   or some other biological molecules like deoxyribonucleic acid (DNA) and 
specific glycoproteins. One of most commonly used ones is 4’,6’-diamidino-2-
phenylenindole dihydrochloride (DAPI) forms fluorescent complex with DNA and can 
visualize the nuclei (Lee et al., 2012a). There are different proteins as target of 
immunohistochemical staining. One of these molecules is c-Fos.  
Cellular Finkel–Biskis–Jinkins murine osteosarcoma oncogene homologue (c-Fos) 
is a cellular transcription factor (Milde-Langosch, 2005). C-Fos gene is one of the first 
identified immediate early genes. Immediate early genes are a class of genes which 
encode for a variety of cytoplasmic enzymes, secreted proteins and transcription 
factors. Their expression is low or undetectable in quiescent cells; but, they will be 
rapidly (in matter of minutes) transcribed in response to many extracellular signals. 
Their transcription is transient and independent of new protein synthesis leading in 
encoding a protein with a high turnover (Durchdewald et al., 2009; Healy et al., 2013; 
O'Donnell et al., 2012). So far, c-Fos have been identified to be involved in a variety of 
physiological and pathological activities including differentiation, proliferation, 
apoptosis and migration of different cell types including cancers, immune system, skin, 
bone and central nervous system (Durchdewald et al., 2009). Its expression in the 
central nervous system has been investigated in studies concerning anxiety, depression 
and other neurological disorders as well as pharmacological ones (Panhelainen et al., 
2012; Verma et al., 2007). Mapping its expression in response to the administration of 
neuroactive drugs can provide information on brain region specificity for drug effects 




Electrophysiology has been the gold standard in neuroscience investigation since 
the discovery of linkage between neuronal functions to electrical activity. Nowadays, 
electrophysiology is implicated in different scales of studies in neuroscience from 
molecular (single ion channel) to behavioral (hundreds of cells in neuronal networks) 
studies. Electrical charges in receptors, neurons or other regions in nervous system are 
transferred to sensitive amplifiers using metal, glass or silicon electrodes dedicated for 
optimal specific recordings (Merighi, 2011; Scanziani et al., 2009).  
The electrophysiology techniques are categorized into three main groups based on 
where the electrode is placed in the neural specimen. In the extracellular recording 
experiment, the electrode is inserted just outside the neuron of interest. In the 
intracellular recording, it is placed inside the neuron of interest. The third category 
includes patch clamp techniques where the electrode is opposed to the neural membrane 
forming a tight seal with a patch of the membrane. All these techniques can be used for 
either in vivo or in vitro recording. However, most in vivo studies use extracellular 
recording (Carter et al., 2010).  
Extracellular recording is based on changes in cell membrane potential during an 
action potential (a neuronal activity). This electrical change can be detected by the 
potential difference between a tip of electrode inserted close to cell membrane and a 
ground electrode placed in a distant extracellular position. During the neuronal rest, 
there is no difference in potential between these two electrodes. However, when an 
action potential arrives to the a nearby neuron, flow of the positive charges from the 
recording position toward the neuronal membrane causes a potential differences 
between the recording and ground electrodes. Similarly, when the action potential 
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passes by, the positive charges flow out from cell membrane toward the recording 
electrode and causes another change in the potential difference between the recording 
and ground electrodes. These changes in potential differences can be recorded and 
analyzed as a reflection of action potential (Carter et al., 2010; Bear et al., 2007).  
The advantage of extracellular recording to intracellular or patch recording is that 
it does not need the precise and delicate electrode positioning inside the neuron. On the 
other hand, it is impossible to measure localized potentials using extracellular recording 
or minor potential changes, which are not big enough to produce an action potential 
(subthreshold potential changes). What we usually record from extracellular electrodes 
is the local field potential, the sum of all postsynaptic activity within a volume of 
neuronal tissue (Carter et al., 2010). In other words, it measures the sum of action 
potential in a group of neighboring neurons instead of a single one. 
1.5.3. Behavioral studies 
Humans are the only animals who can express their emotions, feelings, perception 
and knowledge by the use of words. The only way to understand the emotional 
perceptual and cognitive process of other animals is to observe their behavior. There 
are a variety of different batteries of tests that probe animals for clues about their mental 
status. Behavioral studies not only characterize the animal behavior but also identify 
and describe the genetic, biochemical and cellular correlates of each behavior. 
Therefore, behavioral techniques are usually applied in combination with systems and 
molecular techniques descried before (Carter et al., 2010). 
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1.6. Summary  
Singapore is ageing. The increased prevalence of ageing indicates the importance 
of health concern of the elderly. Ageing is associated with higher risk of chronic 
disorders such as mental problem, higher usage of both conventional and 
complementary health remedies, and hence the higher risk of side effects and 
interactions. Therefore, it is very important to improve our understanding of usage of 
complementary and alternative medicine among older adults. 
The most commonly used type of complementary and alternative medicine is herbal 
medicine. Usage of herbal medicine is associated with higher risk of herb-drug, herb-
herb, and herb-food interactions compared to other complementary and alternative 
medicinal practices. Such risks are higher among older adults who are suffering from 
multiple chronic diseases and use poly-pharmacy. These facts show the importance of 
collating the information about trends of herbal medicine usage among older adults. 
Panax ginseng, the most commonly used herb worldwide, is the prototype herb of 
Panax genus. This herb and other related herbs (commonly known as “ginseng”) are 
commercially available in various forms from raw herb to fully processed 
pharmacological preparations. Since most of these preparations are sold over the 
counter without need to be prescribed, the information presented in their labels is the 
most precious source of knowledge for their users. Therefore, it is very important to 
investigate such products in the market and assess how much the information presented 
on their labels is consistent with local legislations and requirements. 
Not only is “ginseng” the most commonly used and the best sold medicinal herb 
worldwide, but also it is one of the best-studied ones. Several pharmacological activities 
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have been studied in Panax species including anti-cancer, immunomodulatory, 
hypoglycemic, anti-hypertensive, analgesic effects as well as effects on reproductive, 
respiratory and neurologic systems. The neurologic functions of these herbs include 
promising effects for Parkinsonism, Alzheimer’s disease, stroke and depression. 
A few hundred active components have been isolated from Panax species. Among 
them, ginsenosides are the most abundant ones and the main contributors to their 
pharmacological activities. Ginsenoside Rg1 is one of the most abundant ginsenosides 
with reported neurological effects such as memory enhancing, anti-Parkinsonism, anti-
depressant and neuroprotective activities. To the best of our knowledge, there is no 
study evaluating its effects on medial prefrontal cortex, an important brain region 
involved in data processing, decision making, working memory, anxiety and many 
other neurological functions. 
Animal studies are important techniques in evaluating neuropharmacological 
properties of different substances such as natural products. Several methods have been 
applied in animal based neuroscience studies. It makes animal studies an excellent 
platform for bench work in a translational medical approach. 
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CHAPTER 2. Significance, hypotheses and objectives 
Usage of complementary and alternative medicine is very common worldwide. 
Despite a long history of usage, there is a shortage in scientific approaches to the usage 
and efficacy of CAM practices. The translational medical approach is one of the best 
systematic approaches to biological research. This approach begins from clinical 
observations and continues the research to laboratory experiments. In this work, we 
follow the same path approaching the usage of CAM. The main hypotheses of this 
project are that the usage of CAM is common among older adults in Singapore and the 
usage of composite CAM or some of its specific types are associated with 
neurocognitive status of this age group. Therefore, we examine these main hypotheses 
in four continuous and interrelated steps. At the beginning, the information regarding 
usage of CAM and its subtypes by community dweller older adults is analyzed using a 
prospective cohort study. Then the usage of most commonly used CAM type, herbal 
medicine, by older adults in Singapore will be surveyed. The third step is to survey the 
various commercial products available in the local market containing the words 
“Panax” or “ginseng”. Finally, some of the neurologic effects of one of the most 
abundant chemical constituents of Panax species will be studied using rats. The specific 
hypotheses and objectives of the work are presented below. 
2.1. Usage of complementary and alternative medicine by older adults in 
Singapore 
Similar to most other parts of the world, the population of older adults in Singapore 
is increasing in recent years (Lutz et al., 2008b; Wong, 2010). This fact emerges a need 
to have a better understanding of older adults and their health situation. Usage of CAM 
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plays an important role in health maintenance of older adults because of its potential 
effects on overall health and particularly their mental health (Landin et al., 2008).  
The majority of older adults in Singapore are of Chinese ethnicity (Wong, 2010) 
and it is reported that CAM usage is more common among the Chinese population 
(Kennedy, 2005). Therefore, we hypothesize that CAM is commonly used among older 
adults in Singapore. Furthermore, there are several reports of positive neurocognitive 
effects of different CAM practices (Bai et al., 2013; Dos Santos-Neto et al., 2006; 
Gestuvo et al., 2012; Jung et al., 2013; Murray et al., 2004). Hence, we hypothesize that 
the usage of CAM is correlated with their mental health and its maintenance. The main 
objective of this part of the work is to evaluate the prevalence of usage of CAM and its 
main forms among older adults in Singapore and its associated factors including mental 
health. The second objective of this study is to assess the association of CAM usage 
with the development of cognitive decline in older adults after two years. 
2.2. Usage of herbal medicine among older adults in Singapore 
Herbal medicine is the most common type of CAM used worldwide as well as in 
Singapore (Robinson et al., 2011). Since medicinal herbs are mainly consumed orally, 
the risk of adverse effect and interaction with other herbs, conventional medicine and 
food is higher compared to other types of CAM such as acupuncture and qigong (Avello 
et al., 2010). Hence, it is important to improve our understanding on the trends of herbal 
medicine usage and factors associated with its usage in older adults. Additionally, there 
are reports of effectiveness of several herbs for neurocognitive improvement (Chang et 
al., 2008; CPC, 2010; Qi et al., 2011). Therefore, in the current work, we hypothesize 
that the usage of composite herbal medicine and the specific herbs among adults older 
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than 60 years old in Singapore is associated with specific demographic and health 
factors including neurocognitive status. The objectives of this part of the study are to 
collate the detailed information about the patterns of usage of herbal medicine among 
older adults in Singapore and to study factors (including neurocognitive assessment) 
associated with the usage of the most common herbs. 
2.3. Survey of the products containing the words “Panax” or “ginseng” in 
their labels 
Based on legislations in Singapore, health products other than Western medicines 
do not need premarketing approvals and licensing for their importation, manufacture 
and sales (MOH, 2008a). Hence, only dealers and sellers are responsible for the safety 
and quality of such health products (including herbal products)  (HSA, 2012b; MOH, 
2008a). To the best of our knowledge, all published studies on health products in the 
Singapore market have been focusing on adulterations and other prohibited and 
dangerous ingredients in such products (Koh et al., 2000; Yee et al., 2005) and there is 
no report evaluating their labeling information. Health and food products containing 
“ginseng” are well known and commonly used worldwide (Ayranci et al., 2005; 
Froiland et al., 2004; Kang et al., 2012; Smith et al., 2004). Most of these products are 
sold over the counter without any prescription. Hence, the information provided on their 
labels has an important impact on the selection of products by consumers. This 
information should be reliable, clear, and easy to understand by the ordinary people to 
avoid misunderstandings and inappropriate usage of such products. It is important to 
improve the knowledge and awareness of public as well as legislative bodies regarding 
the current situation of health products and level of compliance to local regulations. 
Accordingly, we hypothesize that the information provided on the labels of products 
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which have the words “Panax” and/or “ginseng” in their labels in the Singapore market 
is clear and comprehensive. The objectives of this part of the study are to collate and 
record information on the labels of the commercially available health and food products 
labeled with words “Panax” and/or “ginseng” in Singapore and to compare this 
information to the requirement provided by HSA and AVA. 
2.4. The effect of ginsenoside Rg1 on medial prefrontal cortex 
Ginsenoside Rg1 is one of the most abundant active compounds of most Panax 
species (Kim, 2012). There are several reports on neurological effects of this 
ginsenoside as a neurostimulatory and neuroprotective substance, which can enhance 
the memory and improve depression (Chen et al., 2008a; Huang et al., 2014). However, 
to the best of our knowledge, there is no report on its potential effects on medial 
prefrontal cortex. Medial prefrontal cortex is an important brain locus involved in 
working memory, cognition, decision making and anxiety (Farooq et al., 2013). Based 
on this, we hypothesize that ginsenoside Rg1 produces some of its neurological actions 
through increasing the activity of medial prefrontal cortex. To test this hypothesis, we 
use electrophysiological and histochemical approaches to study the effect of systemic 
administration of Rg1 on long-term potentiation in the hippocampal-medial prefrontal 
cortical pathway, the spontaneous firing rate of pyramidal cells in the medial prefrontal 





CHAPTER 3. Usage of complementary and alternative medicine 
by older adults in Singapore 
3.1. Introduction  
With decreasing fertility and increasing life expectancy, the proportion of older 
adults in most countries is expanding (Lutz et al., 2008b). Ageing is associated with 
multiple chronic disorders and increased drug treatment (Willison et al., 2004). Rates 
of chronic illness are also associated with higher usage of CAM (Feng et al., 2010). In 
a study in Australia, 46.3% of diabetic patients were using some forms of CAM to treat 
their medical conditions or for general health purposes (Manya et al., 2012). This 
prevalence was 55% in another study in the US (Odegard et al., 2011). Additionally, 
43.1% of British hypertensive patients reported usage of CAM (Gohar et al., 2008) 
while this proportion was 69.5% among Americans (Bell et al., 2006) and 39.1% among 
Nigerians (Amira et al., 2007).  
Singapore is also an ageing country. The population proportion of Singaporeans 
and permanent residents more than 65 years old has been increased from 7.2% in 2000 
to 9.0% in 2010 (Wong, 2010). Further increase in the population of older adults during 
the next few decades has been warned by population based studies (Yap et al., 2011). 
In older adults, both depression and cognitive impairment are common mental issues 
and the combination of these two conditions may aggravate each other (Guy G. Potter 
et al., 2007). Since psychological and mental status in this age group can be affected by 
CAM usage (Landin et al., 2008), the usage of CAM in older adults is becoming a 
global interest to research (McLaughlin et al., 2012). 
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There are reports of effectiveness of specific CAM forms (herbal medicine, qigong, 
acupuncture and relaxation) to improve the cognition in elderly using clinical trials and 
animal models (Bai et al., 2013; Dos Santos-Neto et al., 2006; Gestuvo et al., 2012; 
Jung et al., 2013; Murray et al., 2004; Oh et al., 2012). However, only few cross-
sectional studies can be found reporting the prevalence of this usage in populations and 
its relationship with cognitive status. Besides, the existing reports usually have small 
sample sizes. A study in Canada reported that 38.3% of patients of a dementia clinic 
used some kind of alternative medicine (44/115) and usage of CAM was not correlated 
with their cognitive status (Hogan et al., 1996). Another study in Germany on 139 older 
adults revealed that those suffering from cognitive impairment used more CAM (47%) 
than healthy participants (18%) (Landin et al., 2008).  
Similar to reports of CAM on the cognitive problems, the effectiveness of some 
CAM practices (e.g. acupuncture, qigong and herbal medicine) has been shown in 
depressive disorders (Tsang et al., 2002)(Dennis et al., 2013; Sarris et al., 2011). On 
the other hand, the association of CAM usage with depression is also under-studied. In 
a population-based study in England, usage of CAM was higher in participants (16 
years or older) suffering from anxiety and/or depression (Hunt et al., 2010). A national 
survey in Australia on older adults (older than 50 years old) reported higher rate of 
consultation with CAM practitioners in those suffering from depression or anxiety (Yen 
et al., 2013).  
One of the CAM practices which is common among older adults worldwide is 
qigong (Melchart et al., 1997). It is a Chinese medical exercise which combines static 
and dynamic physical exercises, breathing exercise and meditation (Lauche et al., 2013) 
Its simplicity and effectiveness in rehabilitation has made it more applicable than other 
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movement based therapies such as yoga and tai chi for older adults (Yost et al., 2013) 
who are at a higher risk of physical disabilities and are more susceptible to physical 
injuries. There are studies reporting positive cognitive effect for qigong in adult cancer 
(Oh et al., 2012) and middle-aged hypertensive patients (Lee et al., 2004c) as well as 
positive effects against pain, depression and anxiety in fibromyalgia syndrome patients 
(Creamer et al., 2000; Maddali Bongi et al., 2012). Since qigong is a combination of 
physical activity and meditation, it is difficult to study its effect using animal models. 
One way is to explain its positive cognitive effects using the known neurologic effects 
of physical exercise in animals. The hypothesized mechanisms for neuropsychological 
effects of qigong especially its anti-depressant effects include up-regulating 
monoamine neurotransmitters or reductions of adrenal glucocorticoid secretion by 
affecting amygdala. The other suggested mechanism of action is improving 
neurogenesis in the hippocampus by up-regulating brain-derived neurotropic factor 
(BDNF) or down-regulating cortisol (Tsang et al., 2008). Moreover, qigong as a 
moderate mindful physical activity can decrease the self-perceived functional limitation 
and increase the psychosocial resources, two factors suggested as psychological 
etiology of depression (Tsang et al., 2002). None of these theories can explain the 
neurocognitive effects of qigong properly. There is a shortage of enough evidence to 
support such theories and clinical observations and trials are needed to explain the 
effects.  
Therefore, there is a shortage of observational reports on the usage of CAM and its 
individual types in older adults and their relationship with the neurocognitive status and 
prognosis. This fact emerges a need to have a better understanding of older adults and 
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their mental health situation considering the usage of CAM as an important player in 
the health maintenance of this age group.  
3.2. Hypotheses and objectives 
Considering the ethnic diversity of population of the older adults in Singapore 
where the majority are Chinese (Wong, 2010) and high prevalence of CAM usage 
among Chinese people (Kennedy, 2005), we hypothesize that usage of CAM is 
common among adults older than 60 years in Singapore. Additionally, since there are 
reports of positive neurocognitive effects of several CAM practices (Bai et al., 2013; 
Dos Santos-Neto et al., 2006; Gestuvo et al., 2012; Jung et al., 2013; Murray et al., 
2004), we hypothesize that the usage of CAM in older adults is correlated with their 
mental health. To evaluate these hypotheses, the objectives of this part of the work are 
to assess the prevalence of usage of CAM and its main forms in a population-based 
sample of older adults in Singapore and its associated factors including mental health. 
The other objective of this study is to assess the association of CAM usage and its 
subtypes with the development of cognitive decline in older adults after four years. 
3.3. Methods 
The baseline data from Singapore Longitudinal Ageing Study I and II (SLAS) and 
4-year follow-up data from SLAS I were used to evaluate the usage of CAM among 
Singaporean older adults. The details of data collection were as follows. 
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3.3.1. Participants  
In SLAS, consecutive sampling method had been used to collect as many 
participants as possible. Baseline “SLAS I” was collated in 2003-2004 by a door-to-
door census recruiting Singaporeans and Permanent Residents aged 60 and above. By 
visiting all the housing units in a selected territory in South West Singapore, all 
participants older than 60 were identified. From each housing unit, an older adult was 
invited to participate in the study. After four years, the participants were recalled to 
assess any change in their cognitive status. “SLAS II” was the continuation of new 
participant recruiting performed in 2007-2008. For this part of study the recruitment 
territory was extended to the South Central and South East Singapore. The older adults 
were voluntarily invited to participate in the study by giving informed consent. The 
study protocol was approved by the National University of Singapore Institutional 
Review Board (NUS-IRB).  
3.3.2. The questionnaire  
For all participants, a questionnaire was used to evaluate their demographic 
information (age, sex, race, educational level, etc.), physical, social and productive 
activities, instrumental daily activity, past medical history and drug history, any history 
of using CAM within the past 12 months, and depression and cognition status (Ng et 
al., 2004; Niti et al., 2008).  
3.3.2.1. Usage of CAM 
The participants were asked about any usage of various types of CAM including 
herbal medicine (considering specific herbs: “ginseng”, “ginkgo”, “evening primrose 
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oil”, “garlic supplement”, “lingzhi”, “tianqi” and herbal tonics), acupuncture, 
acupressure and moxibustion, movement therapies such as Tai chi, Yoga, Qigong, etc., 
specific traditional medicines such as Jamu and Ayorvedic medicine, and other types 
of CAM including massage therapy, hypnotherapy, spirit medium healing, etc. Using 
any of these practices in past 12 month was considered as using CAM and was counted 
both as individual practice and as composite CAM practice. The collated information 
was recorded in a database for further analysis. 
3.3.2.2. Physical, social and instrumental daily activity 
Physical activity measurement was based on the frequency of involvement in any 
active sports, walking, swimming and regular exercise. For involvement in these 
activities, participant would be scored 2 (once a week or more), 1 (once a month to once 
a week) or 0 (less than once a month). 
 Social activity referred to how much the participant was involved in 16 social 
activities including hobbies, games, community work, religious activities, and daily 
activities such as shopping and cooking. For each activity, participant would score 2 
(once a week or more), 1 (once a month to once a week) or 0 (less than once a month). 
The highest possible social activity score was 32 and the lowest possible score was 0 
(Ng et al., 2008b). 
The instrumental activity of daily life (IADL) was measured by level of 
independency in 7 daily activities including house work, grocery shopping, cooking, 
short travelling, managing money, taking medicine and using telephone. The first four 
items are considered as physical IADL and the last three items were considered as 
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cognitive IADL. Being unable to manage any of these items without help was 
considered as either physical or cognitive dependency in IADL (Ng et al., 2006). 
3.3.2.3. Past medical history of chronic diseases 
Past medical history of chronic diseases were evaluated based on self-reporting 
history of hypertension, hypercholesterolemia, diabetes mellitus, cerebrovascular 
accidents, cardiovascular problems (including heart attacks, atrial fibrillation, heart 
failure, etc.), ophthalmologic problems (including cataract and glaucoma), renal failure, 
pulmonary system problems (including asthma and chronic obstructive pulmonary 
disease, tuberculosis, etc.), chronic musculoskeletal problems (including arthritis, 
osteoporosis, hip fracture, etc.), neurological problems (including dementia, 
Alzheimer’s diseases, Parkinsonism, depression, etc.), gastrointestinal issues (including 
dyspepsia, chronic reflux, chronic diarrhea or constipation, etc.), hyper/hypothyroidism 
and cancer. Participants were categorized based on the number of reporting chronic 
disorders into three groups namely having no history of chronic disorders, suffering 
from one or two chronic disorders and suffering from three of more chronic disorders. 
If a participant reported history of two similar interrelated disorders (such as both heart 
attack and heart failure or both osteoporosis and hip fracture), it was considered as a 
single chronic disease. 
3.3.2.4. Neurocognitive assessment 
The 30-itemed “Mini Mental State Exam (MMSE)” was used to evaluate cognitive 
status of the participants and 15-itemed “Geriatric Depression Scale (GDS-15)” was 
used for depression scoring. In addition, few other cognitive batteries were used to 
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further evaluate their cognitive performance including forward and backward digital 
span, 9-trial Rey auditory verbal learning test (RAVLT) and block design test. 
The MMSE is one of the most common used screening test for cognitive status. It 
consists of 30 short answer questions to assess the orientation of the examinee to time 
and place, the short term memory (immediate recall) by memorizing three simple 
unrelated words and the long-term memory (delayed recall) by recalling the same list 
of word after some time gap, the attention by subtracting 7 from 100 for 5 times (till 
65), the language by asking the name of familiar objects like pencil and watch, repeating 
a simple phrase read by the examiner, obeying simple tasks ordered by the examiners 
verbally and obeying a simple task written on a piece of paper as well as by the ability 
to make a complete sentence and finally the construction ability by recreating a simple 
construction drawn on a piece of paper. The maximum MMSE score is 30 and the 
minimum is 0. The higher MMSE score the less risk of dementia. Cutoff point for 
impression of cognitive impairment using MMSE test is 24 (Folstein et al., 1975; 
Rosselli et al., 2006). There are several reports on local validation and use of MMSE 
test in Singapore (Dong et al., 2012; Dong et al., 2013; Ng et al., 2007). 
The geriatric depression scale is a 15 itemed yes/no question list, which evaluates 
the feeling of the examinee during past few weeks. By answering each question the 
examinee will be scored either 0 or 1. The higher the GDS score, the higher the risk of 
depression. The cutoff point for GDS to be considered as positive for depression is 5 
(Li et al., 2012c; Lyness et al., 1997). This test has been validated and used locally (Lim 
et al., 2000; Nyunt et al., 2009). 
The Rey auditory verbal learning test is designed to evaluate verbal memory in 
participants. It measures the short term and long-term memory by memorizing 15 one 
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or two syllabus simple words. To do that, 15 unrelated unrepeated simple words (list 
A) will be read to the examinee one by one (1 second each word). After that, the 
examinee is supposed to recall them. For each correct recalling, one point will be given 
to him. This learning process will be repeated for 5 times. After the 5th trial, 15 other 
words (list B) will be read to the participant and he/she is asked to recall the new list 
(trial 6). After that, he/she will be asked to remember the first list of words (list A) 
without reading the list by the examinee (trial 7). Later, after 20-30 minutes gap, the 
participant is asked to recall the list (trial 8). Finally, a list of 50 shuffled words 
including list A, list B and 20 new words will be presented to the participant and he/she 
is supposed to recognize the words presented in the list A (trial 9). At each trial, the 
participant can use as much time as he/she wants to complete the trial by recalling the 
list. There are different measurements calculated based on scores gained for each trial. 
Trial 1 measures the immediate recall and trial 5 is the best learning experience. The 
sum of scores in trial 1 to 5 will be considered as total learning while the subtraction of 
score in trial 1 from that of trial 5 is called learning rate. The trials 6 and 7 assess 
proactive and retroactive interferences respectively. The trial 8 examines the delayed 
recall and trial 9 is named recognition measurement (Kreutzer et al., 2011; Poreh, 2006; 
Van der Elst et al., 2005). 
The Block Design (BD) test requires the examinee to use three-dimensional blocks 
to construct a model from a two-dimensional stimulus card. Blocks consist of sides that 
are all white, all red, or diagonally half red and white. Performance is timed. Although 
bonus points are awarded for speed, the score is either all or none, that is, a score is 
awarded only if the model is correctly produced within the prescribed time limit. 
Successful completion of the BD test requires a host of cognitive abilities including 
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speciﬁc analytic and synthetic problem-solving strategies (Kreutzer et al., 2011; Poreh, 
2006). 
MMSE, RAVLT, forward and backward digit span, and block design tests were 
used for the follow-up cognitive assessment. Any change in the corresponding scores 
was calculated and used for further analysis. Accordingly, any decrease in 4-year 
follow-up MMSE score compared to baseline test for at least two points was considered 
cognitive decline (Feng et al., 2012). Declined in short memory (trial 1 in RAVLT) was 
assumed when any decrease compared to the baseline score was observed. Decline in 
total learning results in RAVLT was deliberated when the total learning score was 
decreased for at least 4 scores after four years. Comparing the 4-year follow-up score 
in RAVLT recognition to the baseline score, any decrease for at least 8% was defined 
as decline in recognition test. Decline in forward digit span was when the participant 
performance in follow-up test was at least 2 scores less than his performance in baseline 
test. This cutoff point for backward digit span was 1 score and for block design test was 
2 scores. 
3.3.3. Inclusion and exclusion criteria 
The individuals with severe physical and mental disabilities limiting the completion 
of study were not recruited. All participants above 60 years old who were able to 
provide clear information about usage of CAM during baseline interview were included 
for this study. Any participants with incomplete MMSE or GDS tests or those with 
MMSE scores less than 18 were excluded from statistical analyses. For those 
participants participated in the four-year follow-up study, the minimum accepted 
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baseline MMSE was set as 24 in order to exclude those who were already suffering 
from cognitive impairment at the baseline. 
3.3.4. Statistical analysis 
Data from “SLAS I” was merged with “SLAS II” to obtain the final data pool. A 
participant was categorized as CAM user if he/she had reported any usage of at least 
one form of CAM within the last 12 months. The overall usage of composite CAM and 
its subtypes were analyzed among the participants. Then, the likelihood of using CAM 
in different demographic and sociophysical groups was analyzed using logistic 
regression models. At the same time the effect of neurocognitive assessment scores on 
the prevalence of CAM usage was studied. The “wald” value was used to compare the 
effect of each variable on this likelihood. Similar methods were used for major CAM 
practices to evaluate the association of demographic, life style and neurocognitive 
factors to the usage of common CAM practices. All statistical analyses were performed 
using SPSS-20 software (Statistical Package for Social Sciences, SPSS Inc, Chicago, 
IL, USA). 
3.4. Results and discussion 
3.4.1. Baseline data 
From SLAS I and SLAS II, 2680 and 2305 participants were recruited respectively. 
A total of 4985 participants who were 60 years old and above was included. The mean 
age of participants was 66.3 years (range 60-98). The demographic information of 
included participants is presented in Table 3.1. Most of the participants were female, 
Chinese with primary or secondary school educational level. 
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In this study, the demographic data is not consistent with population distribution. 
For example, the majority of the studied participants were female (62.7%) while based 
on the Census of Singapore in 2010, 52.7% of Singaporeans older than 60 are female 
(Wong, 2010). Ethnic diversity is also a bit different from census results. In census 
2010, 74.1% of Singapore population were Chinese, 13.4% were Malay, 9.2% were 
Indian, and 3.3% belonged to other ethnicities (Wong, 2010). However, in this study 
the percentages are 91.2%, 4.9%, 3.1% and 0.8% respectively. 
Table 3.1. Demographic distribution of participants in the baseline study (n=4985) 
Factor Number Percentage (%) 
Gender   
 Female 3124 62.7 
 Male 1861 37.3 
Race   
 Chinese 4546 91.2 
 Malay 243 4.9 
 Indian 157 3.1 
 Others 39 0.8 
Educational level   
 Nil 971 19.5 
 Primary or secondary 3410 68.6 
 Pre-university or university degree 592 11.9 
Housing type   
 1-2 room public apartment 892 17.9 
 3 room public apartment 1266 25.4 
 4-5 room public apartment, condominium or private landed 
 housing  
2819 56.6 
Total 4985 100 
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3.4.1.1.1. Prevalence of the usage of CAM 
Out of 4985 participants, 2692 (54.0%, 95% CI: 52.6% – 55.4%) reported using at 
least one type of CAM within the past 12 months (Table 3.2). The overall prevalence 
of the usage of CAM among older adults in this study showed slight increase compared 
to earlier local report on the same age group (44.6%) for which the participant were 
recruited in 2003-2004 (Feng et al., 2010). This minimal difference may be because of 
increasing usage rate. In addition, the sample size in this study is approximately 4.5 
times bigger than that of Feng et al. (2010). A bigger sample size makes the present 
results more reliable. On the other hand, some other studies have reported higher 
prevalence in general population of Singapore (Koh et al., 2004; Koh et al., 2003; Lim 
et al., 2005). This discrepancy can be explained by differences in response rate of older 
adults compared to younger adults, different time of carrying out the studies, different 
CAM usage trends between these two age groups and also different sample sizes. 
 Herbal medicine (34.5%) was the most commonly used type of CAM followed by 
Qigong (15.2%) and Acupuncture (10.0%). This finding is in agreement with other 
studies reporting herbal medicine as the most common type of CAM (Robinson et al., 
2011). In addition, Qigong and acupuncture are very common practices in Traditional 
Chinese Medicine, which are used worldwide (Melchart et al., 1997; Yang et al., 2002). 
In this study, “primrose oil”, “ginseng” and “ginkgo” were the top three herbs used 
by 4.9%, 4.9% and 4.5% of Singaporean older adults respectively. The terminology 
used for data collation about usage of herbal medicine was based on the common names 




Table 3.2. Prevalence of different forms of CAM used by Singaporean older adults 
CAM category 
SLAS I SLAS II Total 
No % No % No % 
Herbal medicine 1076 40.2 644 27.9 1720 34.5 
 Primrose oil 187 7.0 58 2.5 245 4.9 
 “Ginseng“ 185 6.9 56 2.4 241 4.9 
 “Ginkgo“ 171 6.4 51 2.2 222 4.5 
 Herbal tonics  189 7.1 15 0.7 204 4.1 
 “Lingzhi“ 72 2.7 44 1.9 116 2.3 
 Garlic supplement  76 2.8 16 0.7 92 1.9 
 “Tianqi “ 53 2.0 13 0.6 66 1.3 
Qigong  569 21.6 180 7.9 749 15.2 
Acupuncture  307 11.7 186 8.1 493 10.0 
Massage  195 7.4 202 8.8 397 8.0 
Tai chi  261 9.9 113 4.9 374 7.6 
Reflexology  132 5.0 102 4.4 234 4.7 
Ayurveda 0 0.0 37 1.6 37 1.6 
Yoga  52 2.0 31 1.3 83 1.7 
Meditation 0 0.0 34 1.5 34 1.5 
Moxibustion  29 1.1 15 0.7 44 0.9 
Jamu Malay medicine 17 0.6 21 0.9 38 0.8 
Acupressure  26 1.0 12 0.5 38 0.8 
Chiropractic 13 0.5 28 1.2 41 0.8 
Osteopathy  32 1.2 0 0.0 32 1.2 
Spirit medium healing 1 0.1 8 0.3 9 0.2 
Homoeopathy  1 0.1 1 0.1 2 0.1 
Aromatherapy  0 0.0 0 0.0 0 0.0 
Hypnotherapy  0 0.0 0 0.0 0 0.0 
Composite CAM use 1625 60.6 1067 46.3 2692 54.0% 
       
Usage of folk names limits the accuracy of the collected data. For example, ginseng 
is mainly used for Panax ginseng. Although there are several species in Panax genus, 
“ginseng” is the common name loosely used for almost all of them in folk medicine 
(WHO, 2002). Therefore, it is difficult to know the prevalence of usage of each of those 
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species. Tianqi is the Chinese name for P. notoginseng (CPC, 2010) (section 1.3.1.3), 
which was reported being used by 1.3% of the participants (66 individuals) in this study. 
It was beyond the scope of this study to differentiate different species of common herbs. 
A more specific study focusing on herbal medicine can be helpful to improve our 
understanding about the prevalence of the usage of each herb.  
3.4.1.2. The reason for using CAM 
Among 2692 CAM users, 2301 mentioned their reason for usage. The majority 
(1738, 75.6%) were using CAM to maintain their health and only 11.6% (268 
participants) were using it just for medical conditions. Two hundred and ninety five 
participants (12.8%) reported using CAM types for both reasons. 
This finding was consistent with studies in other countries (Kang et al., 2012; Kim 
et al., 2004a; Zhang et al., 2008a). For example, in a study carried out in Australia, 
69.6% of participants used CAM for general health improvement and not for any 
specific disorders (Zhang et al., 2008a). 
3.4.1.3. Factors affecting the prevalence of usage of CAM 
To study factors affecting usage of CAM, student t-test was used for continuous 
factors and chi square was used for categorical factors (Table 3.3). Using these 
unadjusted methods, we found that CAM users are younger Chinese female well-
educated participants who live in bigger houses and are suffering from one or two 
chronic medical conditions. Such participants were more physically and socially active 




Although there was no significant different between CAM users and non-users 
regarding their GDS, MMSE and forward digit span results, CAM users showed better 
performance in their other neurocognitive assessments including backward digit span, 
block design and different RAVLT measurements. 
Table 3.3. Unadjusted association of demographic and neurocognitive factors to 





Age 65.7  7.2 67.0  8.0 <0.001 
Gender   <0.001 
 Female 1899 (60.8%) 1225 (39.2%)  
 Male 793 (42.6%) 1068 (57.4%)  
Ethnicity   <0.001 
 Chinese  2539 (55.9%) 2007 (44.1%)  
 Malay  91 (37.4%) 152 (62.6%)  
 Indian  45 (28.7%) 112 (71.3%)  
 Others 17 (43.6%) 22 (56.4%)  
Educational level   <0.001 
 Nil  453 (46.7%) 518 (53.3%)  
 Primary or secondary  1858 (54.5%) 1552 (45.5%)  
 Pre-university or university degree  376 (63.5%) 216 (36.5%)  
Housing type    <0.001 
 1-2 room public apartment 363 (40.7%) 529 (59.3%)  
 3 room public apartment 661 (52.2%) 605 (47.8%)  
 4-5 room  public apartment or private or  
 landed house  1665 (59.1%) 1154 (40.9%)  
History of chronic diseases    <0.001 
 No history  554 (50.0%) 554 (50.0%)  
 History of one or two chronic diseases  1341 (56.9%) 1015 (43.1%)  
 History of three or more chronic diseases 797 (52.4%) 724 (47.6%)  
To be continued on the next page 
82 
 
Cont. Table 3.3    
Physical activity    <0.001 
 Once a month or less  141 (33.8%) 276 (66.2%)  
 Once a month to once a week  982 (47.8%) 1073 (52.2%)  
 Once a week or more  1548 (62.4%) 934 (37.6%)  
Social, productive and fitness activities
  10.36  4.38 8.13  3.84 <0.001 
Dependency in pIADL   <0.001 
 Yes 377 (48.4%) 402 (51.6%)  
 No 2309 (55.0%) 1889 (45.0%)  
Dependency in cIADL   <0.001 
 Yes 45 (38.1%) 73 (61.9%)  
 No 2641 (54.4%) 2218 (45.6%)  
GDS score 1.38  2.31 1.33  2.28 0.417 
MMSE score 27.70  2.48 27.34  2.73 0.059 
Forward Digit Span 11.49  3.14 11.28  3.43 0.137 
Backward Digit Span 5.52  2.32 5.22  2.31 0.002 
Block design 25.60  10.30 23.76  10.16 <0.001 
RAVLT short memory 4.61  2.00 4.32  1.90 0.001 
RAVLT total learning  43.32  10.39 40.84  10.68 <0.001 
RAVLT total recognition percent 89.14  10.69 86.79  12.06 <0.001 
    
 To have a better understanding of association of different factors to the usage of 
CAM, a logistic regression model was built. Since neurocognitive assessments had high 
multicollinearity, only MMSE was included in logistic regression model building. 
MMSE was chosen because it was the only test available for all of the participants. All 
the other test were available for only a small proportion of the participants. Table 3.4 
reports the results of logistic regression showing the association of different factors with 
the usage of CAM. 
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Among studied factors, gender had the highest impact on tendency to use CAM 
(wald = 119.4) where women were more than twice more likely to use CAM than men. 
This finding is consistent with other studies (Feng et al., 2010; Zhang et al., 2008a). 
The level of social, productive and fitness activity was the second most powerful 
predictor of usage of CAM (wald = 110.3). Social interactions can facilitate sharing 
information about CAM types and encourage the usage. In addition, the usage of CAM 
was significantly associated with the educational level. Similar results have been 
reported previously showing a better attitude of high educated people to use CAM (Seo 
et al., 2013; Willison et al., 2004; Zhang et al., 2008a).  
Table 3.4. Adjusted association of demographic and neurocognitive factors to use 
of composite CAM 
Factor Odds ratio 95% CI P value 
Age 1.00 0.99 – 1.01 0.509 
Female gender 2.14 1.87 – 2.45 <0.001 
Ethnicity   <0.001 
 Chinese  1   
 Malay  0.55 0.41 – 0.73 <0.001 
 Indian  0.33 0.23 – 0.49 <0.001 
 Others 0.44 0.22 – 0.90 0.024 
Educational level   <0.001 
 Nil  1   
 Primary or secondary  1.47 1.23 – 1.75 <0.001 
 Pre-university or university degree  1.96 1.50 – 2.56 <0.001 
Housing type    <0.001 
 1-2 room public apartment 1   
 3 room public apartment 1.45 1.21 – 1.75 <0.001 
 4-5 room  public apartment or private or landed house  1.48 1.24 – 1.75 <0.001 
History of chronic diseases    0.001 
 No history  1   
 History of one or two chronic diseases  1.32 1.13 – 1.54 <0.001 
 History of three or more chronic diseases 1.35 1.13 – 1.60 0.001 
To be continued on the next page 
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Cont. Table 3.4    
Physical activity    <0.001 
 Once a month or less  1   
 Once a month to once a week  1.66 1.30 – 2.10 <0.001 
 Once a week or more  2.52 1.99 – 3.20 <0.001 
Social, cognitive and religious activity level
  1.09 1.08 – 1.11 <0.001 
Dependency in pIADL 1.11 0.92 – 1.33 0.287 
Dependency in cIADL 0.69 0.45 – 1.06 0.089 
GDS score 1.03 1.00 – 1.06 0.029 
MMSE score 0.99 0.96 – 1.02 0.549 
    
Having a better access to the sources of knowledge about CAM practices can 
increase the usage of CAM among people with high levels of education. It was observed 
that being Chinese is a good predictor of higher prevalence of CAM use. The stronger 
culture of traditional medicine among the Chinese (Kennedy, 2005) may explain the 
higher usage of CAM in this ethnic group. Housing type is a reflection of economic 
status. It is reported that better economic status is associated with higher usage of CAM 
(Molassiotis et al., 2005). Consistently, we found that participants living in bigger 
housing types use more CAM. 
Consistent with previous reports (Feng et al., 2010), a higher prevalence of CAM 
usage was observed in participants suffering from medical conditions. Such participants 
may be looking for an alternative remedy for their chronic medical condition (Kim et 
al., 2013). Participants with better levels of physical activities were using more CAM. 
This association can be because of including some forms of movement and exercise in 
CAM such as “qigong”, “tai chi”, “yoga”, etc. which can be difficult to perform by 
those with limited abilities to manage their daily activities by themselves.  
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Although GDS had no association in unadjusted measurements, participants with 
higher GDS scores were more likely to use CAM in logistic regression model. It 
suggests that such older adults may use CAM to control their emotional instability. On 
the other hand, there was no significant correlation between CAM usage and MMSE 
score or physical or cognitive IADL. The association of cognition and usage of CAM 
is inconsistent in available literature. Some studies have reported higher usage of CAM 
in those suffering from cognitive disorders and depression (Hunt et al., 2010; Landin et 
al., 2008; Purohit et al., 2013) and some others could not find any association (Hogan 
et al., 1996). Differences in the study designs and definitions of CAM may explain such 
inconsistencies. The lack of association in our findings might be due to our exclusion 
criteria where all participants with severe mental and physical impairment were 
excluded. Furthermore, considering some reports on positive effects of CAM practices 
on cognitive status (Bai et al., 2013; Gestuvo et al., 2012; Jung et al., 2013), it can be 
hypothesized that some of participants with minimal and subclinical cognitive 
impairment use CAM to improve their condition. At the same time, some other 
participants with normal cognitive functions use CAM to prevent development of 
cognitive decline. Therefore, both groups of participants use CAM with similar 
prevalence. Such hypothesis should be examined in future by more sophisticated 
observational projects or longitudinal prospective studies. 
In this study, age lost its association with the CAM use after controlling for other 
confounders.  Although this finding was in contrast with a previous report (Feng et al., 
2010), the lack of association was not unexpected. Ageing is associated with both 
limitation in physical abilities and increase in risk of suffering from multiple medical 
conditions. Limitation in physical abilities decreases the involvement in active CAM 
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types such as Qigong and Yoga. Suffering from medical problems increases the 
likelihood of using CAM to improve health. Therefore, although the pattern of CAM 
usage changes by age, the overall prevalence of CAM usage will not be changed 
significantly. For further confirmation of lack of correlation between age and 
prevalence of CAM use, participants were categorized in three age ranges to check any 
possible cluster effect of age on CAM usage, which failed to show any statistically 
significant effect (p=0.597).  
3.4.1.4. Factors affecting the prevalence of usage of herbal medicine 
Herbal medicine was the most common type of CAM used by our participants. It 
is also repeatedly reported as the most common CAM type in several studies (Asadi-
Pooya et al., 2014; Barnes et al., 2008; Corey et al., 2014; Italia et al., 2014; Sait et al., 
2014). Considering the risks associated with its usage and the general trend of hiding 
its usage from conventional health providers (section 1.1.3 and 1.1.4), it is important 
for medical practitioners to consider the possibility of their usage in their patients. 
Knowing the factors associated with higher usage of herbal medicine is helpful to find 
those who are more likely herbal medicine users and be prepared for possible risks. 






Table 3.5. Unadjusted association of demographic and neurocognitive factors to 
use of herbal medicine 
Factor 
Herbal medicine usage P 
value Yes No 
Age 65.4  7.3 66.7  7.7 <0.001 
Gender   <0.001 
 Female 1231 (39.4%) 1891 (60.6%)  
 Male 489 (26.3%) 1372 (73.7%)  
Ethnicity   <0.001 
 Chinese  1683 (37.0%) 2861 (63.0%)  
 Malay  12 (4.9%) 231(95.1%)  
 Indian  15 (9.6%) 142 (90.4%)  
 Others 10 (25.6%) 29 (74.4%)  
Educational level   <0.001 
 Nil  260 (26.8%) 711 (73.2%)  
 Primary or secondary  1206 (35.4%) 2202 (64.6%)  
 Pre-university or university degree  250 (42.2%) 342 (57.8%)  
Housing type    <0.001 
 1-2 room public apartment 230 (25.8%) 662 (74.2%)  
 3 room public apartment 430 (34.0%) 836 (66.0%)  
 4-5 room  public apartment or private or  
 landed house  
1057 (37.5%) 1760 (62.5%)  
History of chronic diseases    <0.001 
 No history  383 (34.6%) 724 (65.4%)  
 History of one or two chronic diseases  878 (37.3%) 1478 (62.7%)  
 History of three or more chronic diseases 459 (30.2%) 1061 (69.8%)  
Physical activity    <0.001 
 Once a month or less  104 (24.9%) 313 (75.1%)  
 Once a month to once a week  617 (30.0%) 1438 (70.0%)  
 Once a week or more  987 (39.8%) 1493 (60.2%)  
Social, productive and fitness activities
 
 10.26  4.42 8.84  4.13 <0.001 
Dependency in pIADL   0.002 
 Yes 231 (29.7%) 547 (70.3%)  
 No 1485 (35.4%) 2712 (64.6%)  
Dependency in cIADL   0.014 
 Yes 28 (23.7%) 90 (76.3%)  
 No 1688 (34.8%) 3169 (65.2%)  
GDS score 1.44  2.38 1.31  2.25 0.053 
MMSE score 27.77  2.45 27.41  2.68 <0.001 
To be continued on the next page 
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Cont. Table 3.5    
Forward Digit Span 11.60  3.13 11.28  3.35 0.026 
Backward Digit Span 2.75  1.24 2.71  1.27 0.536 
Block design 25.61  10.25 24.30  10.26 0.017 
RAVLT short memory 4.62  2.01 4.40  1.92 0.011 
RAVLT total learning  43.50  10.44 41.51  10.62 <0.001 
RAVLT total recognition percent 89.56  10.30 87.29  11.86 <0.001 
    
Herbal medicine usage is more common among younger Chinese female highly 
educated participants who are more physically and socially active and stay in bigger 
houses. Having one or two chronic medical conditions would increase the likelihood of 
using herbal medicine while more medical conditions had the opposite effect. Using 
herbal medicine was less common among participants who were physically or 
cognitively dependent. The GDS score was slightly higher in medicinal herbs users 
while such participants had a better performance in almost all cognitive assessments 
(except backward digit span). 
To adjust these associations with other potential variables, a logistic regression 
model was built using “enter” method. Similar to the model created for composite CAM 
usage, minor neurocognitive assessments were excluded from the model to improve its 
stability by removing multicollinearity (Table 3.6). Accordingly, age, history of chronic 
disorders, cognitive and physical IADL dependency, and MMSE score lost their 
association with the usage of herbal medicine and the effect of housing type became 
marginal. Since herbal medicine is the most common type of CAM, most discussion 
used for association of CAM with different factors is applicable to usage of herbal 
medicine, too. The trend of usage and associated factors were also almost the same in 
composite CAM usage and herbal medicine usage. The only differences were in the 
association of housing type and having positive history of chronic medical conditions. 
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Table 3.6. Adjusted association of demographic and neurocognitive factors to use 
of herbal medicine 
Factor Odds ratio 95% CI P value 
Age 0.99 0.98 – 1.00 0.235 
Female gender 1.97 1.71 – 2.28 <0.001 
Ethnicity   <0.001 
 Chinese  1   
 Malay  0.92 0.51 – 0.166 <0.001 
 Indian  0.19 0.11 – 0.32 <0.001 
 Others 0.45 0.21 – 0.97 0.042 
Educational level   <0.001 
 Nil  1   
 Primary or secondary  1.62 1.34 – 1.96 <0.001 
 Pre-university or university degree  2.13 1.63 – 2.79 <0.001 
Housing type    0.052 
 1-2 room public apartment 1   
 3 room public apartment 1.28 1.05 – 1.57 0.016 
 4-5 room  public apartment or private or  
 landed house  1.14 0.95 – 1.38 0.155 
History of chronic diseases    0.066 
 No history  1   
 History of one or two chronic diseases  1.10 0.94 – 1.29 0.231 
 History of three or more chronic diseases 0.93 0.77- 1.11 0.418 
Physical activity    <0.001 
 Once a month or less  1   
 Once a month to once a week  1.35 1.04 – 1.75 0.022 
 Once a week or more  1.79 1.39 – 2.31 <0.001 
Social, cognitive and religious activity level
  1.04 1.02 – 1.06 <0.001 
Dependency in pIADL 1.07 0.88 – 1.31 0.467 
Dependency in cIADL 0.74 0.46 – 1.18 0.201 
GDS score 1.04 1.01 – 1.07 0.009 
MMSE score 0.99 0.96 – 1.02 0.592 
    
Housing type which is a reflection of financial status and was positively associated 
with usage of CAM had marginal or no association with usage of herbal medicine. Since 
herbal medicine is sometimes believed to be a cheaper alternative to conventional drugs 
(Foroncewicz et al., 2011), it can be used more than other CAM types by older adults 
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with relative financial problems. This higher usage rate by people with financial 
problems can attenuate the overall positive association of financial status with usage of 
CAM. On the other hand, having positive history of chronic medical conditions had no 
association with usage of herbal medicine after taking into account other variables in 
the logistic regression model while it kept its association with CAM usage in the 
regression model. It can be because of pharmacological properties of medicinal herbs, 
which can be both protective and therapeutic. Therefore, both healthy participants and 
those affected by chronic medical conditions would use herbal medicine with similar 
prevalence. Considering the diversity of medicinal herbs used by participants, a more 
sophisticated and detailed study on herbal medicine can provide more comprehensive 
results. 
3.4.1.5. Factors affecting usage of qigong 
After herbal medicine, qigong was the most common CAM practice reported by 
our participants. Qigong users were mostly female Chinese older adults staying in larger 
houses and having better physical and social activities. Although qigong users were 
more independent in cognitive IADL, none of neurocognitive assessment scores was 
associated with the usage of qigong. Other demographic and life style factors were not 
associated with the usage of qigong, either (Table 3.7). 
Creating a logistic regression model (enter method) we tried to adjust the 
association of these factor with qigong usage to other demographic, life style and 
neurocognitive factors. Similar to composite CAM and herbal medicine usage, minor 
neurocognitive tests were excluded to stabilize the model (Table 3.8). 
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Table 3.7. Unadjusted association of demographic and neurocognitive factors to 





Age 66.7  6.7 66.2  7.7 0.079 
Gender   <0.001 
 Female 549 (17.8%) 2533 (82.2%)  
 Male 200 (10.9%) 1630 (89.1%)  
Ethnicity   <0.001 
 Chinese  731 (16.3%) 3746 (83.7%)  
 Malay  12 (5.0%) 228 (95.0%)  
 Indian  3 (1.9%) 153 (98.1%)  
 Others 3 (7.7%) 36 (92.3%)  
Educational level   0.177 
 Nil  143 (14.9%) 814 (85.1%)  
 Primary or secondary  501 (14.9%) 2860 (85.1%)  
 Pre-university or university degree  104 (17.9%) 478 (82.1%)  
Housing type    <0.001 
 1-2 room public apartment 69 (7.9%) 807 (92.1%)  
 3 room public apartment 139 (11.1%) 1116 (88.9%)  
 4-5 room  public apartment or private or  
 landed house  
540 (19.5%) 2233 (80.5%)  
History of chronic diseases    0.199 
 No history  148 (13.6%) 942 (86.4%)  
 History of one or two chronic diseases  359 (15.5%) 1955 (84.5%)  
 History of three or more chronic diseases 242 (16.0%) 1266 (84.0%)  
Physical activity    <0.001 
 Once a month or less  3 (0.7%) 409 (99.3%)  
 Once a month to once a week  152 (7.5%) 1875 (92.5%)  
 Once a week or more  589 (24.1%) 1854 (75.9%)  
Social, productive and fitness activities
 
 11.71  4.37 8.91  4.13 <0.001 
Dependency in pIADL   0.403 
 Yes 114 (14.9%) 653 (85.1%)  
 No 633 (15.3%) 3505 (84.7%)  
Dependency in cIADL   0.004 
 Yes 8 (6.8%) 109 (93.2%)  
 No 739 (15.4%) 4049 (84.6%)  
GDS score 1.38  2.14 1.35  2.32 0.781 
MMSE score 27.37  2.66 27.56  2.60 0.062 
To be continued on the next page 
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Cont. Table 3.7    
Forward Digit Span 11.10  3.06 11.43  3.33 0.086 
Backward Digit Span 5.29  2.25 5.39  2.34 0.461 
Block design 24.36  9.23 24.80  10.43 0.529 
RAVLT short memory 4.56  2.03 4.46  1.95 0.418 
RAVLT total learning  42.33  10.85 42.14  10.52 0.759 
RAVLT total recognition percent 88.10  11.03 88.01  11.51 0.894 
    
Despite composite CAM and herbal medicine usage, usage of qigong was more 
common among older participants and those suffering from more chronic medical 
conditions. It can be because of its simplicity that it can be used by even very old 
participants while younger participants can be involved in more energetic exercises 
such as yoga and tai chi. Therefore, some of younger participants who are trying to use 
exercise based remedies may be interested in those practices while the majority of older 
participants will try qigong. 
Consistent with other types of CAM, usage of qigong was more common among 
female Chinese older adults and those who were more physically and socially active. 
The possible explanations for such associations have been presented in previous 
sections (sections 3.4.1.3 and 3.4.1.4). Since qigong is a physical exercise which is 
usually performed in groups, it is predictable that qigong users are more physically and 
socially active. Among neurocognitive tests, MMSE showed statistical association with 
usage of qigong. However, this statistical association was not much clinically 
significant. The mean MMSE score of qigong users (27.33  2.66) was slightly less 




Table 3.8. Adjusted association of demographic and neurocognitive factors to use 
of qigong 
Factor Odds ratio 95% CI P value 
Age 1.03 1.01 – 1.04 <0.001 
Female gender 1.67 1.36 – 2.04 <0.001 
Ethnicity   <0.001 
 Chinese  1   
 Malay  0.36 0.20 – 0.67 0.001 
 Indian  0.12 0.04 – 0.40 <0.001 
 Others 0.29 0.08 – 1.02 0.053 
Educational level   0.485 
 Nil  1   
 Primary or secondary  1.16 0.90 – 1.50 0.260 
 Pre-university or university degree  1.09 0.76 – 1.57 0.639 
Housing type    <0.001 
 1-2 room public apartment 1   
 3 room public apartment 1.27 0.92 – 1.75 0.150 
 4-5 room  public apartment or private or landed 
house  
2.09 1.56 – 2.79 <0.001 
History of chronic diseases    0.027 
 No history  1   
 History of one or two chronic diseases  1.10 0.88 – 1.38 0.390 
 History of three or more chronic diseases 1.38 1.07 – 1.78 0.013 
Physical activity    <0.001 
 Once a month or less  1   
 Once a month to once a week  9.47 2.98 – 30.06 <0.001 
 Once a week or more  31.42 9.98 – 98.85 <0.001 
Social, cognitive and religious activity level
 
 1.12 1.09 – 1.14 <0.001 
Dependency in pIADL 1.05 0.81 – 1.35 0.740 
Dependency in cIADL 0.34 0.15 – 0.73 0.006 
GDS score 1.01 0.97 – 1.05 0.800 
MMSE score 0.92 0.89 – 0.96 <0.001 
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3.4.1.6. Factors affecting usage of acupuncture 
Acupuncture can be consider as the most globally adapted TCM practice (Melchart 
et al., 1997; Robinson et al., 2011; Yang et al., 2002). Availability and applicability to 
almost all groups of people has made it the second most common TCM practice in 
general population worldwide after herbal medicine (Mann, 1992; Xue et al., 2010; 
Yesilada, 2011). In our study, acupuncture was the third common CAM practice used 
by 10% of participants.  
Among our participants, acupuncture users were female Chinese ones who lived in 
bigger houses and were suffering from more chronic medical conditions. They had 
better physical and social activities. The association of physical activity with 
acupuncture was small and complicated. Participants who did exercise rarely and those 
who did regularly were using acupuncture more than those who were moderately 
involved in physical activity. Such complicated association needs further investigation 
to be explained. The average GDS score of acupuncture users was higher than that of 
non-users. However, age, educational level, cognitive and physical IADL dependency 
and neurocognitive assessments rather than GDS were not associated with the usage of 




Table 3.9. Unadjusted association of demographic and neurocognitive factors to 





Age 65.9  6.9 66.4  7.6 0.145 
Gender   <0.001 
 Female 359 (11.6%) 2730 (88.4%)  
 Male 134 (7.3%) 1705 (92.7%)  
Ethnicity   <0.001 
 Chinese  484 (10.8%) 4007 (89.2%)  
 Malay  3 (1.2%) 238 (98.8%)  
 Indian  2 (1.3%) 955 (98.7%)  
 Others 4 (10.3%) 35 (89.7%)  
Educational level   0.395 
 Nil  103 (10.7%) 860 (89.3%)  
 Primary or secondary  324 (9.6%) 3044 (90.4%)  
 Pre-university or university degree  65 (11.1%) 520 (88.9%)  
Housing type    0.001 
 1-2 room public apartment 59 (6.7%) 828 (93.3%)  
 3 room public apartment 131 (10.4%) 1127 (89.6%)  
 4-5 room  public apartment or private or landed house  303 (10.9%) 2472 (89.1%)  
History of chronic diseases    0.002 
 No history  82 (7.5%) 1010 (92.5%)  
 History of one or two chronic diseases  235 (10.1%) 2088 (89.9%)  
 History of three or more chronic diseases 176 (11.6%) 1337 (88.4%)  
Physical activity    0.007 
 Once a month or less  39 (9.5%) 372 (90.5%)  
 Once a month to once a week  174 (8.5%) 1871 (91.5%)  
 Once a week or more  277 (11.3%) 2165 (88.7%)  
Social, productive and fitness activities
 
 9.97  4.15 9.26  4.30 <0.001 
Dependency in pIADL   0.181 
 Yes 85 (11.0%) 689 (89.0%)  
 No 408 (9.8%) 3739 (90.2%)  
To be continued on the next page 
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Cont. Table 3.9    
Dependency in cIADL   0.402 
 Yes 13 (11.0%) 105 (89.0%)  
 No 480 (10.0%) 4323 (90.0%)  
GDS score 1.98  2.89 1.29  2.21 <0.001 
MMSE score 27.48  2.63 27.53  2.61 0.690 
Forward Digit Span 11.47  3.24 11.38  3.30 0.662 
Backward Digit Span 5.34  2.20 5.37  2.33 0.836 
Block design 25.08  10.56 24.66  10.24 0.615 
RAVLT short memory 4.51  1.88 4.47  1.97 0.747 
RAVLT total learning  43.00  10.06 42.07  10.62 0.209 
RAVLT total recognition percent 88.42  11.65 87.97  11.41 0.578 
    
Similar to other CAM practices, a logistic regression model was built for factors 
associated with the usage of acupuncture to adjust such associations with other 
variables (Table 3.10). After taking into account other studied factors, the association 
or lack of association in all variable was unchanged except for physical activity, which 
lost its minimal association. 
Table 3.10. Adjusted association of demographic and neurocognitive factors to use 
of acupuncture 
Factor Odds ratio 95% CI P value 
Age 0.99 0.98 – 1.00 0.168 
Female gender 1.58 1.26 – 1.99 <0.001 
Ethnicity   <0.001 
 Chinese  1   
 Malay  0.12 0.04 – 0.37 <0.001 
 Indian  0.11 0.03 – 0.45 0.002 
 Others 0.65 0.20 – 2.15 0.481 
To be continued on the next page 
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Cont. Table 3.10    
Educational level   0.527 
 Nil  1   
 Primary or secondary  0.99 0.75 – 1.31 0.926 
 Pre-university or university degree  1.18 0.78 – 1.77 0.434 
Housing type    0.023 
 1-2 room public apartment 1   
 3 room public apartment 1.59 1.13 – 2.22 0.007 
 4-5 room  public apartment or private or landed 
house  1.46 1.07 – 2.00 0.018 
History of chronic diseases    <0.001 
 No history  1   
 History of one or two chronic diseases  1.35 1.03 – 1.77 0.029 
 History of three or more chronic diseases 1.79 1.34 – 2.41 <0.001 
Physical activity    0.284 
 Once a month or less  1   
 Once a month to once a week  1.02 0.70 – 1.51 0.909 
 Once a week or more  1.20 0.82 – 1.76 0.340 
Social, cognitive and religious activity level
  1.03 1.00 – 1.01 0.021 
Dependency in pIADL 1.14 0.86 – 1.52 0.364 
Dependency in cIADL 0.98 0.52 – 1.85 0.949 
GDS score 1.11 1.07 – 1.14 <0.001 
MMSE score 0.99 0.94 – 1.03 0.596 
    
Higher usage of acupuncture among female Chinese participants is similar to other 
CAM practices and has been discussed before. In addition, since it is one of basic and 
well-known TCM practices which does not need any specific training or knowledge 
from the users, educational level may have little or no effect on its prevalence of usage. 
On the other hand, ethnic beliefs may have the most important effect on the attitude 
toward this practice. Considering the several traditional therapeutic applications of 
acupuncture (Mann, 1992), it is understandable that being suffering from multiple 
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chronic disorders may increase the likelihood of using acupuncture (as well as other 
CAM practices) as an alternative remedy to conventional medical treatment (Kim et al., 
2013). One of these chronic conditions can be depression. There are several reports of 
effectiveness of acupuncture in depression treatment (Dirmaier et al., 2012; Sniezek et 
al., 2013; Wu et al., 2012c). Therefore, it is explainable why participants with higher 
GDS scores tend more to use acupuncture. On the other hand, no association was 
observed between usage of acupuncture and cognitive tests. Although controversial in 
some cases, there are different reports of usage of acupuncture for different types of 
cognitive impairment (Avisar et al., 2012; Johnston et al., 2007; Lu et al., 2011). It can 
be suggested that not only those suffering from mild cognitive problems use 
acupuncture to improve their condition, but also the cognitively healthy participants use 
this method to prevent development of cognitive dysfunction. Therefore, both groups 
of participants use acupuncture and there is minimal difference in their usage. 
Since acupuncture is applied by a trained practitioner and it does not need any 
special activity from the users, all participants with different levels of physical 
independency and in different ages can benefit from its usage. Therefore, we did not 
observe any association between acupuncture usage and age, physical or social activity 
or cognitive or physical IADL dependency. 
3.4.2. Four-year follow-up data 
Among 2680 adults older than 60 years old participating in baseline recruitment for 
SLAS I, 748 subjects participated in follow-up cognitive assessment. Among them, 709 
participants had baseline MMSE scores greater than or equal to 24. Those with MMSE 
scores less that 24 were excluded because they were suffering from some degrees of 
 99 
 
cognitive impairment at the baseline. By this way, the risk of cognitive decline was 
assessed in a cohort of normocognitive older adults. The demographic information of 
included participants is presented in Table 3.11.   
During the follow-up visit, MMSE, RAVLT, block design and forward and 
backward digit span assessments were tested. The only test that was completed for all 
participants was MMSE. Other tests were conducted for only a small proportion of 
participants (16 – 91 persons). Additionally, since there were very few participants from 
minor ethnic groups all these groups were pooled together as non-Chinese for ease of 
analysis. 
Table 3.11. Demographic distribution of participants in 4-year follow-up study 
Factor Number Percentage (%) 
Gender   
 Female 430 60.6 
 Male 279 39.4 
Race   
 Chinese 679 95.8 
 Malay 11 1.6 
 Indian 13 1.8 
 Others 6 0.8 
Educational level   
 Nil 98 13.8 
 Primary or secondary 494 69.7 
 Pre-university or university degree 117 16.5 
Housing type   
 1-2 room public apartment 46 6.5 
 3 room public apartment 166 23.4 
           4-5 room  public apartment or private or landed house  497 70.1 
Total 709 100 
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3.4.2.1. Decline in MMSE score 
Out of 709 participants, 95 (13.4.0%) developed decline in MMSE scores after four 
years. The association of demographic and psychological factors to development of 
cognitive decline in MMSE score is presented in Table 3.12. 
Table 3.12. Unadjusted association of demographic and life style factors to the 
development of cognitive decline in MMSE score 
Factor 
Changes in MMSE score 
P value 
Sustained Declined 
Age 67.4  5.5 70.4  7.2 <0.001 
Gender   0.259 
 Female 61 (14.2%) 369 (85.8%)  
 Male 34 (12.2%) 245 (87.8%)  
Ethnicity   0.202 
 Chinese 590 (86.9%) 89 (13.1%)  
 Others 24 (80.0%) 6 (20.0%)  
Educational level   <0.001 
 Nil  72 (73.5%) 26 (26.5%)  
 Primary or secondary  435 (88.1%) 59 (11.9%)  
 Pre-university or university degree  107 (91.5%) 10 (8.5%)  
Housing type    0.362 
 1-2 room public apartment 37 (80.4%) 9 (19.6%)  
 3 room public apartment 142 (85.5%) 24 (14.5%)  
 4-5 room  public apartment or private or  
 landed house  
435 (87.5%) 62 (12.5%)  
History of chronic diseases    0.399 
 No history  134 (89.9%) 15 (10.1%)  
 History of one or two chronic diseases  301 (85.5%) 51 (14.5%)  
 History of three or more chronic diseases 179 (86.1%) 29 (13.9%)  
Physical activity    0.746 
 Once a month or less  85 (84.2%) 16 (15.8%)  
 Once a month to once a week  66 (86.8%) 10 (13.2%)  
 Once a week or more  461 (87.0%) 69 (13.0%)  
Social, productive and fitness activities
 
 9.90  4.37 9.28  4.40  
Dependency in pIADL   0.040 
 Yes 110 (81.5%) 25 (18.5%)  
 No 503 (87.8%) 70 (12.2%)  
To be continued on the next page 
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Cont. Table 3.12.    
Dependency in cIADL   0.239 
 Yes 5 (71.4%) 2 (88.6%)  
 No 608 (86.7%) 93 (13.3%)  
Baseline GDS score 1.54  2.47 2.02  2.79 0.085 
Baseline MMSE score 28.02  1.61 27.95  1.91 0.739 
Baseline Forward Digit Span 10.53  2.79 9.29  1.99 0.038 
Baseline Backward Digit Span 5.38  2.01  4.46  1.82 0.036 
Baseline Block design 22.81  11.25 33.00  NA NA 
Baseline RAVLT short memory 4.49  1.80 4.36  2.75 0.770 
Baseline RAVLT total learning  43.37  9.34 40.23  14.81 0.343 
Baseline RAVLT total recognition percent 89.24  10.99 88.70  12.64 0.841 
    
Development of cognitive decline in MMSE test was more common among older 
less educated participants who were dependent in their physical IADL and performed 
poorer in forward and backward digit span. Other variables had no association with 
development of cognitive decline in MMSE score. The association of age, educational 
level and IADL to the risk of developing cognitive decline is consistent with the 
available literature (Bennett et al., 2013; Fjell et al., 2014; Gold, 2012). Additionally, 
association of forward and backward digit span and none of other neurocognitive 
assessment tests suggest these simple tests to have positive predictive value for 
development of cognitive decline, which needs further investigation. To evaluate the 
positive predictive value of these tests, further investigation with larger sample sizes is 
necessary. 
The association of the usage of composite CAM and specific CAM types with the 




Table 3.13. Unadjusted association of CAM usage and its subtypes to the 
development of cognitive decline in MMSE score 







Composite CAM use    0.002 0.52 0.34 – 0.80 
 Yes 45 (10.3%) 390 (89.7%)    
 No 50 (18.2%) 224 (81.8%)    
Herbal medicine    0.404 0.90 0.54 – 1.51 
 Yes 22 (12.6%) 152 (87.4%)    
 No 73 (13.8%) 456 (86.2)    
 Ginseng    0.122 0.44 0.14 – 1.46 
 Yes 3 (6.7%) 42 (93.3%)    
 No 92 (13.9%) 572 (86.1%)    
 Ginkgo    0.578 0.97 0.40 – 2.35 
 Yes 6 (13.0%) 40 (87.0%)    
 No 89 (13.4%) 574 (86.6%)    
 Lingzi    0.084 - - 
 Yes 0 (0.0%) 17 (100.0%)    
 No 95 (13.7%) 596 (86.3%)    
 Evening primrose oil    0.145 0.47 0.14 – 1.54 
 Yes 3 (7.0%) 40 (93.0%)    
 No 92 (13.8%) 573 (86.2%)    
 Garlic    0.520 0.75 0.17 – 3.32 
 Yes 2 (10.5%) 17 (89.5%)    
 No 93 (13.5%) 596 (86.5%)    
 Tianqi    0.209 2.19 0.58 – 8.25 
 Yes 3 (25.0%) 9 (75.0%)    
 No 92 (13.2%) 605 (86.8%)    
 Herbal tonics    0.127 0.38 0.09 – 1.60 
 Yes 2 (5.7%) 33 (94.3%)    
 No 93 (13.8%) 580 (86.2%)    




Cont. Table 3.13       
Qigong    0.035 0.56 0.31 – 1.02 
 Yes 14 (9.0%) 142 (91.0%)    
 No 81 (14.9%) 463 (85.1%)    
Acupuncture    0.313 0.79 0.39 – 1.58 
 Yes 10 (11.2%) 79 (88.8%)    
 No 85 (13.9%) 528 (86.1%)    
Tai chi    0.477 1.07 0.54 – 2.11 
 Yes 11 (14.3%) 66 (85.7%)    
 No 84 (13.5%) 540 (86.5%)    
Massage    0.322 0.73 0.31 – 1.76 
 Yes 6 (10.5%) 51 (89.5%)    
 No 89 (13.8%) 555 (86.2%)    
Reflexology    0.123 0.37 0.09 – 1.58 
 Yes 2 (5.7%) 33 (94.3%)    
 No 93 (14.0%) 573 (86.0%)    
Yoga    0.414 0.49 0.06 – 3.75 
 Yes 1 (7.1%) 13 (92.9%)    
 No 94 (13.7%) 593 (86.3%)    
Others3     0.591 1.01 0.29 – 3.48 
 Yes 3 (13.6%) 19 (86.4%)    
 No 91 (13.3%) 594 (86.7%)    
1 p values were calculated using chi-square test;  
2 odds ratios were calculated using cross-table test;  
3 others includes acupressure, moxibustion, Jamu, Ayurveda, chiropractic, spirit medium healing, 
homeopathy, osteopathy, meditation, hypnotherapy and aromatherapy each of which has less than 
10 users among included participants 
 
The use of composite CAM and practicing qigong were negatively associated with 
developing cognitive decline.  To evaluate the effect of other confounding factors on 
these associations, a set of sequential logistic regression models was used (Table 3.14). 
After finding composite CAM and qigong associated with the lower risk of developing 
cognitive decline in the unadjusted measurements (chi square in model 1), the first 
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logistic regression model was built to adjust their associations to the main confounders 
of developing cognitive decline, age and educational level (model 2).  To develop the 
2nd regression model (model 3), dependency in pIADL, the other statistically associated 
variable to the development of cognitive decline in unadjusted measurements, was 
added to the regression model. Due to high level of multicolinearity between 
neurocognitive tests and small proportion of participants with complete results, these 
tests were not included in the model. Then, gender, race, physical and social activities, 
dependency in cIADL and housing type were added to the regression model to build 
the model 4. Finally by adding baseline MMSE and GDS scores and self-report of any 
history of cardiovascular, metabolic or cerebrovascular disorders to the logistic 
regression model, the complete regression model (model 5) was developed. Some of 
our participants were using more than one CAM type. To evaluate whether the 
association of qigong with lower risk of developing cognitive decline is affected by 
concomitant other CAM types used, an additional regression model (model 6) was 
developed by adding the usage of other CAM types including particular herbs, 
acupuncture, tai chi, massage, etc. to the model 5 only for qigong usage. Since usage of 
any type of CAM had strong multicollinearity with usage of composite CAM, the last 
model was not applicable to usage of CAM. 
Usage of CAM kept its significant association with sustained cognition throughout 
several steps of regression while qigong usage lost its association with sustained 
cognitive status after taking into account the effect of age and educational level. This 
borderline non-significant association was unchanged during subsequent steps of 
regression model building. This can be due to small sample size and is worth to be 
reevaluated in future studies. After removing the effect of other CAM types by adding 
 105 
 
them to the regression model, the usage of qigong regained its statistically significant 
association with the lower risk of developing cognitive decline.  
Table 3.14. Sequential logistic regression models of association between 
developing cognitive decline in MMSE score to CAM and qigong usage 
Modela 
 CAM usage  Qigomg usage 
 




1  0.002 0.52 0.34 – 0.80   0.035 0.56 0.31 – 1.02 
2  0.013 0.57 0.36 – 0.89  0.058 0.56 0.30 – 1.02 
3  0.013 0.57 0.36 – 0.89  0.062 0.56 0.30 – 1.03 
4  0.013 0.55 0.34 – 0.88  0.063 0.54 0.28 – 1.03 
5  0.013 0.55 0.34 – 0.88  0.059 0.53 0.28 – 1.02 
6  NA NA NA  0.045 0.49 0.28 – 0.99 
a Model 1: unadjusted values 
Model 2: adjusted to age and educational level 
Model 3: adjusted to age, educational level and pIADL dependency  
Model 4: adjusted to age, educational level, pIADL dependency, gender, race, physical and social 
activities, cIADL dependency and housing type 
Model 5: adjusted to age, educational level, pIADL dependency, gender, race, physical and social 
activities, cIADL dependency, housing type, baseline MMSE and GDS scores and self-
reporting history of any cardiovascular, metabolic or cerebrovascular disorders 
Model 5: adjusted to age, educational level, pIADL dependency, gender, race, physical and social 
activities, cIADL dependency, housing type, baseline MMSE and GDS scores, self-
reporting history of any cardiovascular, metabolic or cerebrovascular disorders and usage 
of other CAM types. 
 
In this study, for the first time we report the lower risk of developing cognitive 
decline in composite CAM and qigong users suggesting potential protective effects of 
CAM practices on mental status. Qigong as a combination of moderate physical 
exercises and meditation (Lauche et al., 2013) is easy to learn and practice for most 
older adults whose ability for more intense exercises like tai chi and yoga is limited 
(Yost et al., 2013). All physical, social and emotional benefits of qigong together can 
be involved in its protective effects against development of cognitive decline (Tsang et 
al., 2002; Tsang et al., 2008). Our results showed that none of the individual factors of 
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physical activity, social activity or baseline mood or cognitive status of participants had 
any association with final outcome of developing cognitive decline. Moreover, 
adjusting to these factors (physical and social activity and baseline neurocognitive 
assessment) caused no change in the association of qigong with lower risk of 
developing cognitive decline. Both together indicate that qigong as a whole has some 
effects more than the sum of its physical, social and psychological parts.  
Such association was not observed between development of cognitive decline and 
other CAM practices close to qigong (yoga and tai chi). It can be due to more 
complexity of such practices which limits their usage to those who are physically fit 
enough to perform such intense physical activities. Since ageing is associated with a 
significant decrease in physical abilities, there are not enough tai chi and yoga users to 
have a reasonable sample size. In addition, physical activity is a major confounding 
bias for these CAM activities.  
On the other hand, similar to other CAM practices, qigong usage was higher in 
more educated participants. This association caused some confounding effects on the 
lower risk of developing cognitive decline in qigong users because higher educational 
degrees have well-studied protective effects against cognitive decline. However, 
qigong kept its borderline association with lower risk of cognitive decline after 
adjusting for age and educational level. Furthermore, such an association with higher 
educational level can also be observed in other CAM practices which were not 
associated with lower risk of developing cognitive decline. After removing the 
confounding effect of concomitant usage of other CAM practices (model 5) qigong 
regained its significance association with lower risk of cognitive decline. It provides 
another evidence for a possible protective effect for qigong. Such effect needs further 
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investigation to be proved. Difficulties in designing animal models for qigong practice 
are major limitation for an evidence-based study. Therefore, longitudinal observational 
studies and clinical trials are the only available methods of investigation for future 
research. 
In conclusion, although the association of qigong practice and sustained cognitive 
status was marginal and was partially affected by age and educational level, this result 
makes it a promising available exercise for elderly all around the world to maintain 
their cognitive function. Hence, it is important to encourage older adults to use qigong 
as a potential preventive method against cognitive decline. Additionally, it opens new 
ways of research to investigate the possible mechanisms of actions of qigong against 
development of cognitive decline. 
3.4.2.2. Decline in other neurocognitive assessment tests 
The follow-up data for neurocognitive assessment tests other than MMSE was 
available for a small proportion of participants. The number of participants with 
available data has been presented in Table 3.15. 
The association of developing cognitive decline in any of these tests with different 
demographic and life style factors, usage of composite CAM and specific CAM 
practices and baseline neurocognitive assessment results was evaluated similar to what 





Table 3.15. The number of participants participating in follow-up neurocognitive 
assessment for musing RAVLT, Digit Span and Block Design tests 
Test  Sustained Declined  Total 
RAVLT      
 Short memory  66 19  85 
 Total learning  70 15  85 
 Recognition percentage  68 15  83 
Forward digit span  65 26  91 
Backward digit span  58 29  87 






Among RAVLT outputs, decline in short memory test (trial 1) was associated with 
dependency in physical IADL (OR = 6.13; CI 1.84 – 20.38; p = 0.004), usage of tai chi 
(OR = 4.917; CI 1.23 – 19.67; p = 0.030) and baseline short memory results (mean 
baseline short memory result equal to 5.63  2.09 vs. 4.15  1.81 for those who 
developed decline in short memory vs. those who sustained their short memory 
respectively, p = 0.003).  
Developing cognitive decline in total learning test was more common among 
participants with better performance in baseline RAVLT short memory test (mean 
baseline short memory test equal to 5.53  2.67 vs. 4.26  1.72 for those who developed 
decline in short memory vs. those who sustained their short memory respectively, p = 
0.021) and total learning result (mean baseline total learning result equal to 49.00  
12.19 vs. 41.56  9.10 for those who developed decline in short memory vs. those who 
sustained their short memory respectively, p = 0.008).  
Additionally, the risk of developing decline in recognition test (RAVLT trial 9) was 
higher in older participants (mean age 69.4  4.5 for those who developed decline vs. 
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66.30  4.17 for those who sustained their cognitive results in recognition test, p = 
0.013) who were suffering from more chronic medical conditions (p = 0.013), 
performed worse in baseline total learning test (mean baseline total learning result equal 
to 37.93  8.54 vs. 44.26  10.03 for those who developed decline vs. those who 
sustained their results respectively, p = 0.026) and reported using ginkgo (OR = 8.25; 
CI 1.24 – 54.72; p = 0.039). 
Developing decline in forward digit span test was associated with better 
performance in baseline forward digit span test (mean baseline forward digit span result 
equal to 12.54  2.78 vs. 9.88  2.35 for those who developed decline vs. those who 
sustained their results respectively, p < 0.001). In addition, usage of composite CAM 
(OR = 12.38; CI 2.70 – 56.71; p <0.001), herbal medicine (OR = 4.25; CI 1.62 – 11.15; 
p = 0.003) and ginseng (OR = 4.55; CI 1.66 – 12.46; p = 0.003) increased the risk of 
developing cognitive decline in forward digit span test. 
Participants with better performance in baseline backward digit span (mean 
baseline backward digit span result equal to 6.48  2.05 vs. 4.97  1.74 for those who 
developed decline vs. those who sustained their performance respectively, p = 0.001) 
were more susceptible to develop decline in backward digit span test. However, usage 
of acupuncture (OR = 0.13; CI 0.02 – 1.03; p = 0.021) decreased the risk of developing 
cognitive decline in this test. 
Since the sample sizes for these tests were very small the statistical analyses were 
not powerful enough to detect reliable associations. Further investigations using bigger 
study populations can be useful to investigate the clinical relevance of these 




The aim of this part of the study was to obtain detailed information about usage of 
complementary and alternative medicine among older adults in Singapore including the 
prevalence of usage, reasons for usage, forms of usage and factors associated with the 
usage. Among the associated factors, we focused on neurocognitive assessments and 
evaluated the changes in the neurocognitive performance of participants using four-
year follow-up studies. 
During two phases of participant recruitment, 4985 participants fitting to our 
inclusion criteria were recruited on whom the baseline study was performed. After four 
years, 709 of them participated in follow-up study where the neurocognitive assessment 
was repeated to investigate any decline in neurocognitive performance. 
The analysis of baseline data revealed a high prevalence of CAM usage among 
older adults in Singapore (54%), which showed a significant increase compared to 
previous reports (Feng et al., 2010). Most of our participants were using CAM to 
improve their general health rather than for specific medical purposes. Consistent with 
available literature, demographic factors such as gender, ethnicity and educational level 
were the most important predictors of higher prevalence of using them (Kennedy, 2005; 
Kim et al., 2004a; Zhang et al., 2008a). Among various types of CAM, herbal 
medicines, qigong and acupuncture were used by more participants than other subtypes.  
Usage of CAM and its subtypes had minimal association with cognitive and 
depressive status of participants. This lack of strong association could be because of the 
cross-sectional nature of this study. Clinical trials with prospective nature such as 
cohort studies may be more accurate in detecting any potential association. 
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After four years, 13.4% of included participants in follow-up study developed 
cognitive decline based on their MMSE scores. Besides well-known demographic 
factors, younger age and higher educational level, usage of composite CAM and qigong 
showed promising protective effects against development of cognitive decline. To the 
best of our knowledge, it is the first report of such protective effects in longitudinal 
observational studies. By repeating similar longitudinal studies in other settings and 
other countries, this association should be reexamined. If such association is observed 
in other studies, the next step can be large-scale randomized clinical trials to prove the 
protective effects. Although their association with lower risk of decline in MMSE score 
needs further investigation to be applied in clinical practice, this finding (if proved by 
other investigations) can be useful for both public and clinical practitioners to 
encourage older adults to use available, safe and easy CAM practices to promote their 
mental health and prevent cognitive impairment. 
SLAS II is actually the continuation of participant recruitment for SLAS I. Instead 
of being two different survey, they are two phases of participant recruitment for the 
same study. The questionnaires used for these two phases are almost the same and the 
recruitment procedure is very similar. By merging these two, a bigger sample size is 
obtained. Furthermore, a bigger geographical territory in Singapore is covered by the 
merged study. Both these two factors can improve the validity of results. However, 
there are some difference in prevalence rate of usage of CAM and its subtypes between 
these two recruitment phases. Such difference can be due to changes in the trend of 
CAM usage by the time since there is a 4-year gap between two phases of the study. 
Participants of SLAS I were recruited from South West Singapore while the ones of 
SLAS II were from South Central and South East areas. In addition, participants in 
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SLAS I were different from those in SLAS II regarding their demographic information. 
Participants in SLAS I were younger, more physically and socially active and at a 
higher risk of depression and cognitive impairment compared to SLAS II participants. 
Proportion of participants who lived in bigger houses, had higher degrees of education 
and were from Chinese ethnicity were higher in SLAS I compared to SLAS II. These 
demographic differences can be due to different geographic territory where the 
participants were recruited from. Some of these differences were in favor of higher 
prevalence of CAM usage and some were in favor of lower prevalence. To avoid 
complicated discussion of the effect of differences in demographic factors on different 
CAM usage among participants in SLAS I and SLAS II, this data was removed from 
the thesis. However, merging two datasets can make a more homogenized study 
population which is more representative of older adults in Singapore. 
Having a big sample size makes the baseline data a reliable source of information 
about the medical and cognitive health of older adults in Singapore where the society 
is ageing fast and geriatric problems can be the health issue of near future. Such 
information can be useful for clinical practitioners to keep in mind the possibility of 
usage of CAM by their patients in order to avoid any potential adverse effects and 
improve their mutual relationship with their patients. In addition, promising protective 
effects of composite CAM and qigong which are presented for the first time in a 
longitudinal observational study are very important for all sectors involved in the health 
maintenance of older adults. 
The focus of this study was on the usage of CAM practices such as qigong. 
Therefore, participants with severe cognitive impairment or physical inabilities during 
baseline assessment were excluded to avoid the bias of limitation in practices and study 
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a normocognitive cohort of older adults. Furthermore, the hospitalized and other 
physically and mentally ill older adults were not included in this study. Such exclusion 
may affect the predictability of results for general population of older adults. 
Having no information about the non-examiners is another limitation of the study. 
The data was collated in 2003-2008 and such information was not recorded. Therefore, 
it is impossible to compare different factors between respondents and non-respondents. 
Without such comparison it is difficult to generalize the results of the study to the whole 
population. 
The other limitation of this study is the difference between demographic 
distribution of Singapore population and that of participants in the study. In this study 
62.3% of participants are female while based on the latest Singapore census, 53.9% of 
above-60-year population are female (Wong, 2010). Additionally, among Singapore 
population older than 60, 83.3% are Chinese, 9.3% are Malay, 6.0% are Indian, and 
1.4% belong to other ethnicities (Wong, 2010) while these proportions are 95.2%,  
2.1%, 1.9% and 0.8% in our participants respectively.  
Finally, the information about usage of CAM and its subtypes were collate as a part 
of a big questionnaire. Such method of data collating may affect the accuracy of data 
in some points. For example, the usage of herbal medicine was based on the most 
common local names of few herbs, which failed to clarify the exact species in most 
cases.  
Further investigation can be directed to collate more focused data on usage of CAM 
and its types such as herbal medicine. It is important to improve the sampling method 
to have a study sample more consistent with the local population distribution. 
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Additionally, better encouragement of participant to participate in follow-up studies can 
provide valuable information about the changes in the physical and mental health of 




CHAPTER 4. Usage of herbal medicine among older adults in 
Singapore 
4.1. Introduction  
Herbal medicine is the most commonly used CAM practice all around the world 
from western to eastern countries and in different diseases and age groups (Asadi-Pooya 
et al., 2014; Barnes et al., 2008; Corey et al., 2014; Italia et al., 2014; Robinson et al., 
2011; Sait et al., 2014). The first part of our study also revealed that 34.5% of older 
adults in Singapore use one or more herbs for their medical ailments or general health, 
which makes herbal medicine the most commonly CAM practice used by this age group 
in Singapore (section 3.4.1.1.1). 
Despite its common usage, herbal medicine can be considered as the most 
dangerous CAM practice because of the higher risk of side effects, herb-drug or herb-
herb interaction and inappropriate dosage (Corey et al., 2014; Yang et al., 2009a). 
Additionally, there is always the risk of contamination with other herbs and toxic 
material such as pesticides and soil pollutions (Awodele et al., 2013; Koh et al., 2000; 
Kong et al., 2014). Such health risks might be even more in older adults who are at high 
risk of being suffering from multiple chronic disorders and organ failure (Frohlich et 
al., 2014; Willison et al., 2004). 
Relative high prevalence of usage, promising therapeutic effects and risks 
associated with its usage make herbal medicine an important topic for geriatric research. 
There are several reports on promising effects of different herbs on neuropsychological 
disorders such as depression, anxiety, cognitive dysfunction, etc. in different age groups 
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(Dos Santos-Neto et al., 2006; Sarris et al., 2011). However there is a shortage of 
population based observational studies assessing the prevalence of herbal medicine 
usage among older adults and its association with their neurocognitive status. Therefore 
this part of study was conducted to deepen our understanding about usage of herbal 
medicine among older adults in Singapore and factors associated to it. 
4.2. Hypothesis and objectives 
Since herbal medicine is the most common CAM practice in different reports 
(Robinson et al., 2011) and there are some herbs with known positive effects on 
neurocognitive status (Chang et al., 2008; CPC, 2010; Qi et al., 2011), we hypothesize 
that the usage of herbal medicine among older adults in Singapore is common and the 
usage of specific herbs are associated with demographic and health factors including 
the neurocognitive status of users. Therefore, the objectives of this part of study are to 
collate the information on usage of any medicinal herb in past 12 months by a 
population of older adults in Singapore and factors associated with their usage. 
4.3. Methods  
The participants were from the Jurong Ageing Study (JAS) who had given written 
consent to be recontacted if needed. The demographic data and neurocognitive 
assessment from JAS was merged with collated information about usage of herbal 
medicine obtained from follow-up telephone interview to evaluate the factors 
associated with the usage of composite herbal medicine and specific herbs. 
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4.3.1. Participants  
JAS is an ongoing population based study started in 2011 in Jurong territory (South 
West area) of Singapore inviting older adults aged 60 years or more to participate by 
door to door census. The sampling was based on consecutive method to recruit as many 
participants as possible. Visiting each house, the older adults are recognized and invited 
to participate in the study. From each housing unit, only one resident older than 60 is 
invited to participate in the study, if there are more. The older adults are voluntarily 
invited to participate in the study by signing an informed consent. All study parts are 
approved by NUS Institutional Review Board (NUS-IRB). 
4.3.2. Main questionnaire 
The detailed demographic information is collated based on self-reporting using a 
questionnaire. The questionnaire includes several multiple choice questions to collect 
the details of personal information, date of birth, educational level, etc., which are 
completed by trained interviewers. 
4.3.3. Physical and social, cognitive and religious activities 
Physical activity assessment is based on participants’ self-reporting of involvement 
in active sports and physical activities such as swimming, intense walking or other 
sports. Accordingly, participants would score 2 for involvement in activities more than 
once a week, 1 for once a month to once a week or 0 for less than once a month. The 
similar scoring was used for social, cognitive and religious activities. Then, the scores 
from social, cognitive and religious activities was summed to make a single variable 
named social, cognitive and religious activity, which ranged from 0 to 6. 
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4.3.4. Neurocognitive assessment 
Trained interviewers examined the neurocognitive status of participants using 30-
itemed MMSE, 15-itemed GDS, 10-itemed Elderly Cognitive Assessment 
Questionnaire (ECAQ) and 20-itemed geriatric anxiety inventory (GAI). The first two 
have been described before (section 3.3.2.4). 
Geriatric anxiety inventory is a list of 20 agree/disagree questions introduced by 
Pachana in 2007. In this list, the self-assessment of stress feelings and perceptions about 
daily life is used to measure the susceptibility to anxiety disorders (appendix 4). The 
cutoff point for detection of general anxiety disorders is 11 (Pachana et al., 2007). 
Elderly Cognitive Assessment Questionnaire is a locally developed short cognitive 
assessment questionnaire derived from MMSE and Geriatric Mental State Schedule 
tests introduced by Kua and Ko in 1992. This short 10-itemed test has three sets of short 
answered questions assessing the memory, orientation and information and memory 
recall (Kua et al., 1992; Lim et al., 2003). 
4.3.5. Telephone interview 
Those participants who had agreed to be recontacted if needed were chosen to be 
called via provided phone number to collate detailed information regarding usage of 
herbal medicine. At the beginning, the information on a verbal informed consent form 
(Appendix 1) was read to them by a trained interviewer who was able to fluently speak 
in English and Chinese (Mandarin) to get their permission to participate in this part of 
study. If agreed, a multiple choice detailed questionnaire was used to collate the 
information about usage of any herb in last 12 months (Appendix 2). There were 
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specific questions about the herbs used in SLAS I and II to know the exact type of herb 
used, preparation type, duration of usage, frequency of usage, source of information 
about the usage, reason of usage (including specific health issue if applicable) and 
satisfaction from usage. For herbs not included in SLAS studies, the same information 
was collated and recorded in a blank paper.  
4.3.6. Inclusion and exclusion criteria 
Any participant who had agreed to be re-contacted was chosen for telephone 
interview. After that, all contacted participants who gave verbal permission to be 
involved in this part of study were included. Any participant who could not be reached 
by telephone (after three attempts) or could not speak on phone because of cognitive or 
hearing issues or those who could not complete the phone interview because of being 
too much busy (after three attempts) was excluded. 
4.3.7. Statistical analysis 
All collated information about usage of herbs was entered into a predesigned 
database, which was later merged with demographic and neurocognitive assessment 
data to evaluate the usage of herbs. To study the herbs, any herb with at least 20 users 
was included in the study to evaluate the trend of usage and factors affecting the usage 
of each herb. 
The associations were assessed using chi square, student t-test and regression 
models where applicable. All the statistical analyses were performed using SPSS-21 
software (Statistical Package for Social Sciences, SPSS Inc, Chicago, IL, USA). The 
detailed statistical analyses were similar to those presented in section 3.3.4. 
120 
 
4.4. Results and discussion 
The Jurong Ageing Study is an ongoing project (Still recruiting). Among recruited 
participants, 209 were contacted for the telephone interview. Eleven participants were 
excluded because of disagreeing to participate in the telephone interview (10) or 
hearing problems limiting the communication on the phone (1). Therefore the response 
rate was 198/209 (94.7%). The mean age of included participants was 68.2 ± 5.9 years. 
The demographic information of participants is presented in Table 4.1. 
Table 4.1. Demographic distribution of participants in telephone interview 
Factor Number Percentage (%) 
Gender   
 Male 51 25.8 
 Female 147 74.2 
Race   
 Chinese 193 97.5 
 Malay 1 0.5 
 Indian 4 2.0 
Educational level   
 Nil 43 21.7 
 Primary or secondary 136 68.7 
 Pre-university or university 19 9.6 
Usage of herbal medicine in past 12 months 134 67.7% 
   
The usage of herbal medicine was much higher than what reported before. In this 
study 134 participants (67.7%, 95% CI: 61.2% - 74.2%) reported usage of one or more 
herbs. This proportion was 34.5% in first part of the study based on the SLAS data. A 
possible explanation for this difference is changes in the trend of usage by the time. 
SLAS data was collated in 2003 to 2008 (2003 – 2004 for SLAS I and 2007 – 2008 for 
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SLAS II) while the data used for this part of the study was collected in 2013-2014. 
Usage of herbal medicine was 40.2% in SLAS I and 27.9% in SLAS II (p < 0.001). 
Since the usage of herbal medicine was statistically decreased from 2003 – 2004 to 
2007 – 2008, it is unlikely to be three folds more only after 6 years. The other possibility 
for such a huge change is the differences in the method of data collection. The usage of 
herbal medicine in SLAS was collected as a small part of a big questionnaire while the 
data collection for telephone interview was focused on the usage of herbal medicine. It 
means that during telephone interview, the only information collated was the trend of 
the usage of herbal medicine. It makes it more possible to gather accurate information 
about usage of herbs.  
To prove that the differences in method of data collection are responsible for the 
different results from SLAS and telephone interview, we considered the information 
about usage of herbal medicine collated during baseline interview in JAS. In JAS main 
questionnaire, there is a section asking about any usage of supplement usage including 
herbal medicine similar to the same part in SLAS questionnaire. Figure 4.1 shows the 
distribution of supplement usage based on the baseline data from JAS in comparison to 
usage of herbal medicine in the same participants based on telephone interview. 
Based on data collected by JAS, only 10.1% of participants reported using some 
form herbal medicine (67.7% in the same participants based on telephone interviews). 
This difference in the results emphasizes the importance of focused and well-designed 





Figure 4.1. Comparison between the results of baseline interviews in JAS and 
telephone interviews regarding the usage of herbal medicine among 
same participants. Only 10.1% of participants reported using any 
herb in baseline JAS interviews (A) while 67.7% of them were using 
some kinds of herbs reported to telephone interviews. 
A total of 44 medicinal herbs were reported to be used by participants (Table 4.2). 
The scientific name of each herb was obtained from various sources (Blumenthal et al., 
2000; BPC, 2013; CPC, 2010). Some participants were using more than one herb 
concurrently. Therefore, the number of herb users is less than the sum of users of 
individual herbs.  
Table 4.2. Herbs reported by participants in telephone interview  
No. Common name Scientific name Number of users Rank 
1 American ginseng Panax quinquefolium 69 1 
2 Wolfberry Lycium barbarum 39 2 
3 Chinese ginseng Panax ginseng 36 3 
4 Codonopsis Codonopsis pilosula 30 4 
5 Red date Ziziphus jujube 25 5 
6 Notoginseng / tianqi Panax notoginseng 24 6 
7 Lingzhi Ganoderma lucidum 24 6 
8 Chinese Yam Dioscorea opposite 17 8 
9 Ginkgo Ginkgo biloba 12 9 
10 Angelica (Dangqui) Angelica sinensis 10 10 
11 Lotus seeds Nelumbo nucifera 9 11 
12 Bei Qi or Huang qi Astragalus onobrychis 9 11 
  To be continued on the next page 
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Cont. Table 4.2   
13 Astragali Astragalus propinquus 8 13 
14 Cordyceps 
Cordyceps sinensis renamed now 
to Ophiocordyceps sinensis 
7 14 
15 Longan Dimocarpus longan 7 14 




Polygonatum kingianum  6 16 
18 Poria Wolfiporia extensa 5 18 
19 Dropberry (Yu Zhu) 
Polygonatum multiflorum or P. 
odorati 
5 18 
20 Chrysanthemum Chrysanthemum indicum 5 18 
21 Gorgon Euryale Euryale ferox 4 21 
22 Barley Hordeum vulgare 4 21 
23 Luo Han guo Siraitia grosvenorii 4 21 
24 Eucommia (Duzhong) Eucommia ulmoides 4 21 
25 Garlic Allium sativum 3 25 
26 Honey date Phoenix dactylifera 2 26 
27 Licorice Glycyrrhiza glabra 2 26 
28 Lily 
Lilium pumilum and other species 
of Lilium genus 
2 26 
29 White fungus Tremella fuciformis 2 26 
30 Cassia Cinnamomum verum 2 26 
31 Chuan xiong Ligusticum wallichii 2 26 
32 Mulberry 
Morus alba and other morus 
species 
1 32 
33 Shou wu Fallopia multiflora 1 32 
34 Tian ma Gastrodia elata 1 32 
35 Black bean Phaseolus vulgaris 1 32 
36 Cranberry Vaccinium erythrocarpum 1 32 
37 Baizhu Atractylodes macrocephala 1 32 
38 Di huang Rehmannia glutinosa 1 32 
39 Bai Shao Paeoniae alba 1 32 
40 Ginger Zingiber officinale 1 32 
41 Soya bean Glycine max 1 32 
42 Haw chorn Crataegus pinnatifida 1 32 
43 Shi Hu Dendrobium nobile 1 32 
44 Pear Pyrus species 1 32 
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Consistent with other reports (Ali-Shtayeh et al., 2011; Quan et al., 2008; 
Tangkiatkumjai et al., 2013), the main source of information about the herbal products 
was recommendations from family and friends (75, 66.4%) followed by self-study (34, 
30.1%), consultation with TCM practitioners (21, 18.6%) and advertisements on media 
(19, 16.8%)1. None of our participants reported consulting with conventional (western) 
practitioners about the usage of herbal medicine. Considering the better access of 
conventional clinical practitioners to the scientific sources of information, they can be 
one of the best sources of reliable information. Furthermore, since clinical practitioners 
are responsible for prescription of conventional drugs and there is a risk of drug-herb 
interaction for undisclosed herbs used, it is very important to improve the physician-
patient communication about the usage of herbal medicine (section 1.1.4) 
In addition to changes in the prevalence of overall usage of herbal medicine in this 
study compared to what observed in SLAS data (chapter 3), the prevalence of usage of 
each herb was also different from what found in SLAS data analysis (Table 3.2). These 
different prevalence rates can be due to the changes in the trend of usage which can be 
under influence of commercial advertisement in media and advices from friends and 
family members (main sources of information about usage of herbal medicine based on 
reports by the participants). Furthermore, the methods of data collection about usage of 
herbal medicine were different between SLAS and our telephone interview. In SLAS, 
                                                 
1 A total of 113 participants reported their source of information about the herbs 
they used. Since some of the participants reported different sources of information for 
different herbs they were using concurrently, the sum of percentages is more than 100. 
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the data were collected based on questions about seven selected herbs (Table 3.2) 
while, in the current study, any history of usage of any herb in last 12 months were 
collected and documents. This way of data collection provides more freedom in 
reporting usage of herbal medicine to our participants in telephone interview and makes 
the results more reliable and comprehensive. 
Among participants who reported their reason for using herbal medicine, majority 
(67, 57.8%) used these products for general health improvement. Thirty one (26.7%) 
used it for medical purposes and 18 (15.5%) used some herbs for medical purposes and 
some other herbs for general health improvement. Among medical purposes reported 
by our participants, using herbs for health conditions based on TCM concepts was the 
most common purpose (38 participants) followed by neurological and musculoskeletal 
problems (22 and 10 participants respectively). 
4.4.1. Factors associated with usage of composite herbal medicine 
To evaluate factors associated with usage of herbal medicine, chi square test and 
student t-test were used for categorical and continuous factor respectively. Among 
factors, only age, gender and housing type had statistically significant association with 
usage of herbal medicine. Usage of herbal medicine was more common among younger 





Table 4.3. Unadjusted association of demographic and neurocognitive factors with 
the usage of herbal medicine. 
Factor Herbal medicine usage P value 
Yes No 
Age 67.4  5.6 69.8  6.4 0.008 
Gender   <0.001 
 Female 112 (76.2%) 35 (23.8%)  
 Male 22 (43.1%) 29 (56.9%)  
Ethnicity   0.193 
 Chinese  132 (68.4%) 61 (31.6%)  
 others 2 (40.0%) 3 (60.0%)  
Educational level   0.839 
 Nil  29 (67.4%) 14 (32.6%)  
 Primary or secondary  91 (66.9%) 45 (33.1%)  
 Pre-university or university degree  14 (73.7%) 5 (26.3%)  
Housing type    0.034 
 1-2 room public apartment 1 (20.0%) 4 (80%)  
 3 room public apartment 23 (60.5%) 15 (39.5%)  
 4-5 room  public apartment or private or  
 landed house  109 (70.8%) 45 (29.2%)  
History of chronic diseases    0.210 
 No history  18(64.3%) 10 (35.7%)  
 History of one or two chronic diseases  61 (62.9%) 36 (37.1%)  
 History of three or more chronic diseases 55 (75.3%) 18 (24.7%)  
Physical activity    0.766 
 Once a month or less  93 (66.0%) 48 (34.0%)  
 Once a month to once a week  7 (77.8%) 2 (22.2%)  
 Once a week or more  24 (66.7%) 12 (33.3%)  
Social, cognitive and religious activity level
  3.5  1.7 3.6  1.6 0.693 
GDS score 0.96 ± 1.13 1.03 ± 1.46 0.688 
GAI score 0.75 ± 1.68 0.61 ± 1.82 0.583 
MMSE score 28.65 ± 1.73 28.75 ± 2.10 0.727 
ECAQ score 9.61 ± 0.75 9.57 ± 0.64 0.711 
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Then a logistic regression model was built to adjust the association of these 
variables with usage of herbal medicine to other demographic factors. Using the enter 
method to include all demographic factors, the Negelkerke R square was 0.281. After 
taking into account all factors together, age and housing type lost their association with 
the usage of herbal medicine and the only factor with statistically significant association 
was female gender (Table 4.4). Higher usage of herbal medicine in women compared 
to men is consistent with available literature (Eardley et al., 2012; Hughes et al., 2013; 
Picking et al., 2011).  
None of neurocognitive assessment tests (GDS, MMSE, ECAQ and GAI) was 
significantly associated with usage of herbal medicine either in unadjusted 
measurements or adjusted ones. The lack of statistically significant associations in this 




Table 4.4. Logistic regression model for association of demographic and 
neurocognitive factors with the usage of herbal medicine 
Factor Odds ratio 95% CI P value 
Age 0.95 0.88 – 1.03 0.199 
Female gender 5.91 2.54 – 13.79 <0.001 
Ethnicity    
 Chinese  1   
 Malay  NA NA  
 Indian  0.20 0.02 – 2.38 0.204 
Educational level   0.956 
 Nil  1   
 Primary or secondary  0.93 0.32 – 2.72 0.897 
 Pre-university or university degree  1.12 0.22 – 5.58 0.892 
Housing type    0.132 
 1-2 room public apartment 1   
 3 room public apartment 5.13 0.42 – 62.14 0.199 
 4-5 room  public apartment or private or landed house  8.72 0.79 – 96.98 0.078 
History of chronic diseases    0.285 
 No history  1   
 History of one or two chronic diseases  0.84 0.28 – 2.49 0.751 
 History of three or more chronic diseases 1.64 0.51 – 5.33 0.407 
Physical activity    0.393 
 Once a month or less  1   
 Once a month to once a week  4.17 0.45 – 38.47 0.208 
 Once a week or more  0.97 0.37 – 2.55 0.958 
Social, cognitive and religious activity level
  0.98 0.79 – 1.23 0.888 
GDS score 0.93 0.68 – 1.27 0.629 
GAI score 1.04 0.81 – 1.34 0.751 
MMSE score 0.87 0.68 – 1.12 0.281 
ECAQ 1.36 0.71 – 2.59 0.355 
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4.4.2. Usage of American ginseng and factors associated with it 
American ginseng (P. quinquefolium) was the most commonly used herbal 
medicine reported by 69 (35.2%) participants. As mentioned in section 1.3.1.5, this 
plant is one of Panax species with well-studied pharmacological activities. In our study, 
most “American ginseng” users used this herb once a month to once a week (23, 33.3%) 
as herbal soup with chicken or pork (31, 44.9%) (Figure 4.2). 
 
Figure 4.2. Details of usage of American ginseng by participants in telephone 
interview: A) the percentage of different forms of American ginseng 
used by participants, B) the different sources of information about the 
usage of American ginseng reported by participants, C) the frequency 
of usage of American giseng reported by participants, D) the duration 




The main source of information about usage of American ginseng reported by 
participants was an unreliable source, family and friend. None of participants had 
consulted with a western medical practitioner regarding the usage of this herb and only 
15% had discussed with TCM practitioners.  
Most participants used American ginseng for general health improvement 
(Table 4.5). Among those who reported using it for specific medical purposes, majority 
used it for conditions determined in traditional medicine context. Since the theories and 
concepts in traditional medicine are different from those in conventional medicine, it 
may be difficult to categorize and explain them based on conventional scientific 
knowledge. Besides, five participants used it for neurological conditions. Panax 
quinquefolium is a known neuomodulator with memory enhancing, anti-Alzheimer and 
anti-Parkinsonism effects (Qi et al., 2011). A participant reported using it for 
musculoskeletal problems and another reported using it for urinary disorders. Usage of 
American ginseng for urinary problems is consistent with available literature. It has 
been used to improve Candida albicans urogenital infestation (Trammell et al., 2012). 
Furthermore, P. quinquefolium extract has proved renal protective effects via anti-
oxidant activities or other mechanisms (Kim et al., 2007; Park et al., 2010).  However, 
to the best of our knowledge, there is no published evidence for its effects on 
musculoskeletal issues. There is only a beverage containing American ginseng and 
many other ingredients patented to be used for soft tissue inflammation (Martin et al., 
2005). Although, report of using this herb for musculoskeletal problems by a single 
participant may not have a great scientific value, such anecdotal report can open new 
windows for further investigations. Generally, 76.8% of American ginseng users were 
satisfied from its effects. 
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Description Number of  reports Percent 
General health improvement 48 73.8 
Specific medical 
purposes 
Disorders based on TCM1 concepts 10 15.5 
Neurologic conditions 5 7.7 
Musculoskeletal problems 1 1.5 
Urological problems 1 1.5 
1 TCM: Traditional Chinese Medicine 
 
American ginseng was used almost uniformly by different groups of study 
participants. Using unadjusted measurement, it was found that usage of American 
ginseng was higher in younger female participants and none of other demographic, life 
style or neurocognitive factors showed statistically significant association (Table 4.6).  
To assess if association of age and gender with usage of American ginseng can be 
affected by other demographic, life style and neurocognitive factors, a logistic 
regression model was built. After taking into account these factors, the effect of age 
was disappeared and the effect of female gender became marginal (Table 4.7). 
This lack of association of usage of American ginseng with different demographic 
factors together with high prevalence of its usage among older adults emphasizes the 
common uniform usage of this medicinal herb by the population. American ginseng is 





Table 4.6. Unadjusted association of demographic and neurocognitive factors to 
use of American ginseng 
Factor 
Herbal medicine usage 
P value 
Yes No 
Age 66.7 ± 5.3 69.0 ± 6.1 0.010 
Gender   0.001 
 Female 61 (41.5%) 86 (58.5%)  
 Male 8 (16.3%) 41 (83.7%)  
Ethnicity   0.691 
 Chinese  68 (35.6%) 123 (64.4%)  
 Others  1 (20.0%) 4 (80%)  
Educational level   0.808 
 Nil  13 (31.0%) 29 (69.0%)  
 Primary or secondary  49 (36.3%) 86 (63.7%)  
 Pre-university or university degree  7 (36.8%) 12 (63.2%)  
Housing type    0.205 
 1-2 room public apartment 1 (20.0%) 4 (80.0%)  
 3 room public apartment 9 (24.3%) 28 (75.7%)  
 4-5 room  public apartment or private or  
 landed house  59 (38.6%) 94 (61.4%)  
History of chronic diseases    0.388 
 No history  9 (32.1%) 19 (67.9%)  
 History of one or two chronic diseases  38 (40.0%) 57 (60.0%)  
 History of three or more chronic diseases 22 (30.1%) 51 (69.9%)  
Physical activity    0.800 
 Once a month or less  11 (30.6%) 25 (69.4%)  
 Once a month to once a week  3 (33.3%) 6 (66.7%)  
 Once a week or more  51 (36.4%) 89 (63.6%)  
Social, cognitive and religious activity level
  3.5 ± 1.8 3.5 ± 1.7 0.952 
GDS score 0.87 ± 1.1 1.03 ± 1.30 0.383 
GAI score 0.55 ± 1.4 0.78 ± 1.9 0.378 
MMSE score 28.74 ± 1.72 28.63 ± 1.94 0.100 
ECAQ score 9.62 ± 0.73 9.59 ± 0.71 0.738 
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Table 4.7. Adjusted association of demographic and neurocognitive data with 
usage of American ginseng 
Factor Odds ratio 95% CI P value 
Age 0.94 0.87 – 1.01 0.078 
Female gender 2.76 1.08 – 7.11 0.035 
Ethnicity    
 Chinese  1   
 Malay  NA NA NA 
 Indian  0.60 0.05 – 6.91 0.678 
Educational level   0.948 
 Nil  1   
 Primary or secondary  1.17 0.45 – 3.07 0.743 
 Pre-university or university degree  1.15 0.28 – 4.80 0.846 
Housing type    0.268 
 1-2 room public apartment 1   
 3 room public apartment 0.74 0.06 – 8.93 0.811 
 4-5 room  public apartment or private or  
 landed house  1.59 0.15 – 16.90 0.700 
History of chronic diseases    0.676 
 No history  1   
 History of one or two chronic diseases  1.14 0.42 – 3.15 0.796 
 History of three or more chronic diseases 0.82 0.28 – 2.40 0.713 
Physical activity    0.722 
 Once a month or less  1   
 Once a month to once a week  1.57 0.28 – 8.96 0.611 
 Once a week or more  1.44 0.58 – 3.58 0.435 
Social, cognitive and religious activity level
  1.00 0.81 – 1.24 0.975 
GDS score 0.95 0.68 – 1.33 0.770 
GAI score 0.91 0.70 – 1.20 0.507 
MMSE score 0.98 0.78 – 1.23 0.858 
ECAQ 0.85 0.45 – 1.58 0.600 
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4.4.3. Usage of wolfberry and factors associated with it 
Wolfberry was the second most commonly used medicinal herb reported by 
participants in telephone interview (39, 19.9%). It is the fruit of Lycium barbarum 
(Gouqizi 寧夏枸杞), a small red berry full of anti-oxidants, amino acids and trace 
minerals. It has been used traditionally as an immunomodulator and anti-ageing agent 
and to prevent cancer (CPC, 2010; Watson et al., 2008). Based on Chinese 
Pharmacopoeia, its action is to nourish liver and kidney and replenish essence to 
improve vision and its indications are pain in lower back and knees, dizziness and 
tinnitus, seminal emission, blood deficiency, blurred vision, etc. (CPC, 2010). 
Among participants in telephone interviews, most wolfberry users used it as a part 
of herbal soups for general health improvements and 69.2% of users were satisfied of 
its effects. Figure 4.3 and Table 4.8 show the details of usage of wolfberry. 
Similar to American ginseng, the main source of information about usage of 
wolfberry is the unreliable information from family members and friends. Participants 
reported various trends of usage but most of them were using it for more than two years. 
Most participants used wolfberry for general health improvement. Among those who 
used it for specific medical purposes, usage for disorders based on TCM context was 





Figure 4.3. Details of usage of wolfberry by participants in telephone interview: 
A) the percentage of different forms of usage of wolfberry by 
participants, B) the different sources of information about its usage 
reported by participants, C) the frequency of usage of wolfberry 
reported by participants, D) the duration of usage. 
Table 4.8. Reasons for usage of wolfberry reported by participants in telephone 
interviews 
Reasons for usage Description Number of  reports Percent 
General health improvement 20 54.1 
Specific medical 
purposes 
Disorders based on TCM1 concepts 8 21.6 
Neurologic conditions 3 8.1 
Ophthalmologic conditions 3 8.1 
Musculoskeletal problems 2 5.4 
Dermatologic disorders 1 2.7 
1 TCM: Traditional Chinese Medicine 
136 
 
Using wolfberry for neurological and ophthalmologic conditions is consistent with 
availabnle literature. L. barbarum has well-studied anti-stroke, anti-Alzheimer’s and 
neuroprotective effects (Chang et al., 2008; Ho et al., 2010; Wang et al., 2014a). Its 
positive effects on glaucoma and protection of retinal ganglia cells are also reported 
(Chan et al., 2007). Additionally, its high carotenoid content has made it a known herbal 
remedy for ophthalmologic problems (Watson et al., 2008), which is consistent with its 
traditional usage to improve vision and cure blurred vision (CPC, 2010). Two of our 
participants used this herb for musculoskeletal problems. Although it has been 
traditionally used for low back pain and knee pain (CPC, 2010), there is a shortage of 
available scientific literature supporting its musculoskeletal effects. On the other hand, 
Amagase and colleagues reported that 2-week treatment by wolfberry had no effect on 
the musculoskeletal problems of their participants (Amagase et al., 2008). Usage of this 
herb for dermatologic issues is also consistent with reports showing its anti-oxidant and 
anti-apoptotic effects leading in dermal protection as well as protective effects against 
ultra violet light induced cell proliferation in fibroblasts (Wang et al., 2011c; Zhao et 
al., 2005). 
The next step in analyzing the usage of wolfberry was to study factors associated 
with its usage. Table 4.9 reports the factors associated with the usage of wolfberry. As 
can be seen, none of demographic or neurocognitive tests was significantly associated 
with the usage of wolfberry. Small sample size can be the cause of this lack of 
associations. Further studies with bigger sample sizes are recommended to improve our 
understanding of factors associated with its usage. Additionally, clinical trials or 
prospective follow-up observational studies may help to establish its possible 
pharmacological effects.  
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Age 67.3 ± 5.0 68.4 ± 6.1 0.310 
Gender   0.075 
 Female  33 (22.6%) 113 (77.4%)  
 Male 6 (12.0%) 44 (88.0%)  
Ethnicity   0.529 
 Chinese  39 (20.4%) 152 (79.6%)  
 Others 0 (0.0%) 5 (100%)  
Educational level   0.761 
 Nil  8 (19.5%) 33 (80.5%)  
 Primary or secondary  26 (19.1%) 110 (80.9%)  
 Pre-university or university degree  5 (26.3%) 14 (73.7%)  
Housing type    0.518 
 1-2 room public apartment 0 (0.0%) 5 (100%)  
 3 room public apartment 7 (19.4%) 29 (80.6%)  
 4-5 room  public apartment or private or  
 landed house  32 (20.8%) 122 (79.2%)  
History of chronic diseases    0.200 
 No history  9 (32.1%) 19 (66.9%)  
 History of one or two chronic diseases  16 (16.8%) 79 (83.2%)  
 History of three or more chronic diseases 14 (19.2%) 59 (80.8%)  
Physical activity    0.535 
 Once a month or less  6 (16.7%) 30 (83.3%)  
 Once a month to once a week  3 (33.3%) 6 (66.7%)  
 Once a week or more  28 (20.0%) 112 (80.0%)  
Social, cognitive and religious activity level
  3.6 ± 1.7 3.5 ± 1.7 0.731 
GDS score 1.21 ± 1.54 0.92 ± 1.15 0.280 
GAI score 0.92 ± 1.99 0.65 ± 1.66 0.378 
MMSE score 28.72 ± 1.64 28.67 ± 1.92 0.878 
ECAQ score 9.54 ± 0.89 9.63 ± 0.65 0.478 
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4.4.4. Usage of Chinese/Korean ginseng and factors associated with it 
Panax ginseng was the third most commonly used herb. People reported using it as 
white/raw Chinese, red/steamed Chinese or red Korean ginseng. Figure 4.4 shows the 
distribution of usage of these three types.  
 
Figure 4.4. Distribution of usage of different types of P. ginseng reported by 
participants in telephone interview 
Most Chinese ginseng users reported using this herb as an ingredient of herbal 
soups followed by commercially available end products containing P. ginseng. The 
trend of source of information was similar to what was observed among American 
ginseng and wolfberry users. Nobody got information from western practitioners and 
main source of information was word of mouth from family and friends (Figure 4.5). 
Among participants who reported their level of satisfaction from the usage of P. 
ginseng, 84.4% (27/32) mentioned that they are satisfied from its usage. 
Among Chinese ginseng users who mentioned their reason for usage of this herb, 
76.6% were using it for general health improvement. The remaining 8 participants were 
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using this herb for neurological, TCM based, cardiovascular, musculoskeletal or 
reproductive conditions (Table 4.10). 
 
Figure 4.5. Details of usage of P. ginseng by participants in telephone interview: 
A) the percentage of different forms of usage of P. ginseng by 
participants, B) the different sources of information about its usage 
reported by participants, C) the frequency of usage of P. ginseng 
reported by participants, D) the duration of usage. 
The available literature on the effectiveness of P. ginseng for these medical 
condition has been reviewed briefly in section 1.3.1.2. There are several reports of the 
possible neurological effects of Chinese ginseng from memory enhancing to prevention 
and treatment of stroke and other effects (Cheon et al., 2013; Geng et al., 2010; Lee et 
al., 2013; Lee et al., 2011b). Therefore, it is not unexpected to have neurological 
conditions as the top of the list of medical purposes for usage of P. ginseng. In addition, 
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beneficial cardiovascular properties of this herb have been investigated extensively (Jia 
et al., 2012; Zheng et al., 2012). Although the number of publications reporting 
musculoskeletal properties of Chinese ginseng is limited, it has been shown to be an 
effective treatment for myalgia in some cases (Kim et al., 2014a; Kim et al., 2014b). 
Such effects have been reported for both ginsenoside and non-ginsenoside components 
of this P. ginseng (Kim et al., 2014a; Wang et al., 2013a). Chinese ginseng has been 
also tried in treatment of some reproductive issues such as erectile dysfunction. 
However the effect is still controversial (Ho et al., 2011; Jang et al., 2008; Moyad et 
al., 2012). 
Table 4.10. Reasons for usage of P. ginseng reported by participants in telephone 
interviews 
Reasons for usage Description Number of  reports Percent 
General health improvement 26 76.6 
Specific medical purposes 
Neurological conditions 3 8.8 
Disorders based on TCM1 concepts 2 5.9 
Cardiovascular disorders 1 2.9 
Musculoskeletal problems 1 2.9 
Reproductive system disorders 1 2.9 
1 TCM: Traditional Chinese Medicine 
To investigate the demographic, life style and neurocognitive predictors of usage 
of Chinese ginseng, the association of these factors to its usage was studied using chi 
square and student t-test (Table 4.11). None of the studied factors showed any 
statistically significant association. This lack of association can be because of small 
sample size. Although the positive cognitive effects of P. ginseng has been shown 
previously, the lack of association of its usage with neurocognitive performances can 
be due to usage of this herb for both treatment of mild cognitive impairment by 
subclinical patients and prevention of decline by cognitively normal participants. 
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Table 4.11. Association of demographic and neurocognitive factors to use of P. 
ginseng 
Factor 
Chinese ginseng usage 
P value 
Yes No 
Age 67.1 ± 5.8 68.4 ± 6.0 0.235 
Gender   0.248 
 Female  29 (19.7%) 118 (80.3%)  
 Male 7 (14.0%) 43 (86.0%)  
Ethnicity   0.564 
 Chinese  36 (18.8%) 156 (81.2%)  
 Others 0 (0.0%) 5 (100%)  
Educational level   0.326 
 Nil  11 (26.2%) 31 (73.8%)  
 Primary or secondary  22 (16.2%) 114 (83.8%)  
 Pre-university or university degree  3 (15.8%) 16 (84.2%)  
Housing type    0.462 
 1-2 room public apartment 1 (20.0%) 4 (80.0%)  
 3 room public apartment 4 (10.8%) 33 (89.2%)  
 4-5 room  public apartment or private or 
 landed house  30 (19.5%) 124 (80.5%)  
History of chronic diseases    0.576 
 No history  5 (17.9%) 23 (82.1%)  
 History of one or two chronic diseases  15 (15.6%) 81 (84.4%)  
 History of three or more chronic diseases 16 (21.9%) 57 (78.1%)  
Physical activity    0.801 
 Once a month or less  6 (16.7%) 30 (83.3%)  
 Once a month to once a week  1 (11.1%) 8 (88.9%)  
 Once a week or more  27 (19.1%) 114 (80.9%)  
Social, cognitive and religious activity level
  3.4 ± 1.8 3.6 ± 1.7 0.620 
GDS score 0.83 ± 0.91 1.00 ± 1.30 0.466 
GAI score 0.67 ± 1.76 0.71 ± 1.72 0.897 
MMSE score 28.74 ± 1.61 28.66 ± 1.91 0.818 
ECAQ score 9.64 ± 0.59 9.59 ± 0.74 0.732 
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4.4.5. Usage of Codonopsis and factors associated with it 
Codonopsis Radix (Dangshen) is the dried root of Codonopsis pilosula which is 
natural (neither warm nor cold) and tastes sweet. Based on Chinese Pharmacopoeia, its 
action is to fortify the spleen and replenish lung, nourish blood and engender fluid. In 
addition, it has been traditionally used for fatigue, cough, dyspnea, qi and blood 
deficiency, palpitation, shortness of breath, etc. (CPC, 2010). Its pharmacological 
effects have been studied in stimulating the immune system, affecting neuroendocrine 
system, enhancing memory and preventing stress induced peptic ulcer (Bensky et al., 
2004; Zhu, 1998). 
Thirty participants in this study reported using Codonopsis within the past 12 
months. Among participants who shared their level of satisfaction, 84.0% (21/25) were 
satisfied of its effects. Figure 4.6 and Table 4.12 show the details of usage of 
Codonopsis. This herb was mainly used as a part of herbal soup and most of its users 
were using it for several years. Similar to other herbs, family and friends had the highest 
impact in choosing Codonopsis as a medicinal herb by our participants. 
Most C. pilosula users used this herb for general health improvement (74.1%). 
Among seven participants who used it for specific medical purposes, only one was 
using it for any condition other than those based on TCM concepts. This only 
conventional medical purpose of use was ophthalmologic conditions. This particular 
participant was using Codonopsis in combination with wolfberry, extractum astragali 
and red date to prepare chicken soup. As mentioned in section 4.4.3, L. barbarum is a 
known ophthalmologic remedy. Therefore, the usage of this combination was most 




Figure 4.6. Details of usage of Codonopsis by participants in telephone interview: 
A) the percentage of different forms of usage of Codonopsis by 
participants, B) the different sources of information about its usage 
reported by participants, C) the frequency of usage of Codonopsis 
reported by participants, D) the duration of usage. 
Table 4.12. Reasons for usage of Codonopsis reported by participants in telephone 
interviews 
Reasons for usage Description Number of  reports Percent 
General health improvement 20 74.1 
Specific medical purposes 
Disorders based on TCM1 concepts 6 22.2 
Ophthalmologic problems 1 3.7 





Usage of Codonopsis was more common among female participants in telephone 
interview. Age had a marginal effects in a way that the users were slightly younger than 
nonusers. Other demographic, life style and neurocognitive factors were not associated 
with the usage of this herb (Table 4.13). 
To study whether the association of gender and age with Codonopsis usage is 
affected by other factors, a logistic regression model was built by the enter method. The 
Negelkerke R square for this model was 0.186 (Table 4.14). After taking into account 
all the studied variables, age lost its marginal association and the association of gender 
with the Codonopsis usage became marginal. Most probably, the lack of significant 
association is because of the small sample size, which can be improved by further 
bigger studies. To the best of our knowledge, there is no population based survey 
reporting factors affecting the prevalence of the usage of Codonopsis to compare the 




Table 4.13. Unadjusted association of demographic and neurocognitive 





Age 66.4 ± 4.3 68.5 ± 6.1 0.071 
Gender   0.023 
 Female  27 (18.5%) 119 (81.5%)  
 Male 3 (6.0%) 47 (94.0%)  
Ethnicity   0.629 
 Chinese  30 (15.7%) 161 (84.3%)  
 Others  0 (0.0%) 5 (100%)  
Educational level   0.823 
 Nil  5 (12.2%) 36 (87.8%)  
 Primary or secondary  22 (16.2%) 114 (83.8%)  
 Pre-university or university degree  3 (15.8%) 16 (84.2%)  
Housing type    0.590 
 1-2 room public apartment 0 (0.0%) 5 (100%)  
 3 room public apartment 5 (13.9%) 31 (86.1%)  
 4-5 room  public apartment or private or  
 landed house  25 (16.2%) 129 (83.8%)  
History of chronic diseases    0.107 
 No history  8 (28.6%) 20 (71.4%)  
 History of one or two chronic diseases  12 (12.6%) 83 (87.4%)  
 History of three or more chronic diseases 10 (13.7%) 63 (86.3%)  
Physical activity    0.159 
 Once a month or less  3 (8.3%) 33 (91.7%)  
 Once a month to once a week  3 (33.3%) 6 (66.7%)  
 Once a week or more  24 (17.1%) 116 (82.9%)  
Social, cognitive and religious activity level
  3.6 ± 1.7 3.5 ± 1.7 0.731 
GDS score 0.93 ± 1.14 0.98 ± 1.26 0.844 
GAI score 1.03 ± 1.87 0.64 ± 1.70 0.258 
MMSE score 28.67 ± 1.52 28.68 ± 1.92 0.965 
ECAQ score 9.73 ± 0.45 9.59 ± 0.74 0.300 
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Table 4.14. Adjusted association of demographic and neurocognitive factors to the 
usage of Codonopsis 
Factor Odds ratio 95% CI P value 
Age 0.97 0.87 – 1.07 0.503 
Female gender 4.24 0.95 – 18.84 0.058 
Ethnicity    
 Chinese  NA NA NA 
 Malay  NA NA NA 
 Indian  NA NA NA 
Educational level   0.962 
 Nil  1   
 Primary or secondary  1.18 0.32 – 4.33 0.805 
 Pre-university or university degree  1.27 0.20 – 8.20 0.799 
Housing type    0.917 
 1-2 room public apartment 1   
 3 room public apartment NA NA NA 
 4-5 room  public apartment or private or landed 
house  NA NA NA 
History of chronic diseases    0.261 
 No history  1   
 History of one or two chronic diseases  0.38 0.11 – 1.25 0.112 
 History of three or more chronic diseases 0.42 0.12 – 1.46 0.174 
Physical activity    0.155 
 Once a month or less  1   
 Once a month to once a week  8.05 0.96 – 67.81 0.055 
 Once a week or more  2.29 0.58 – 9.07 0.239 
Social, cognitive and religious activity level
  0.97 0.74 – 1.28 0.845 
GDS score 0.953 0.65 – 1.40 0.806 
GAI score 1.24 0.95 – 1.62 0.115 
MMSE score 0.91 0.67 – 1.24 0.532 
ECAQ 1.41 0.52 – 3.84 0.499 
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4.4.6. Usage of red date and factors associated with it 
Red date (Dazao or Chinese date) is a common herb used all around the world. It 
is the dried ripe fruit of Ziziphus jujube and is warm in nature and tastes sweet (CPC, 
2010). Based on the Chinese Pharmacopoeia, red date can tonify (make stronger) the 
middle energizer and qi, nourish blood and tranquilize the mind. It has been 
traditionally used for reduced food intake caused by spleen deficiency, (improper 
digestion), lack of strength, sloppy stool and hysteria in women (CPC, 2010). These 
neurological effects have been investigated scientifically as well (Dey, 2013; Han et al., 
2009; Jiang et al., 2007; Yeung et al., 2012). It has been used in TCM practice to treat 
asthma, hepatitis, diarrhea, dysuria, insomnia and joint pain (Watson et al., 2008). Its 
effects on asthma and joint pain can be partly due to its anti-inflammatory effects (Al-
Reza et al., 2010; Goyal et al., 2011; Yu et al., 2012). 
Usage of this herb was reported by 25 participants in the survey. Most of them used 
red date as a part of chicken or pork soup (21, 87%).  Similar to other herbs, information 
from family and friends had the highest impact on the usage of this herb (Figure 4.7).  
Most red date users reported using this herb for general health improvement. 
Among those using for specific medical conditions, the majority was usage for 
disorders based on TCM concepts (Table 4.15). Usage of this herb by a participant for 
neurologic conditions was consistent with its traditional action of tranquilizing the mind 
(CPC, 2010) and its indication to treat insomnia (Watson et al., 2008). Another 
participant used it for musculoskeletal problems. As mentioned before, Chinese date 
has been used traditionally for joint pain. The participant using this for ophthalmologic 
conditions was the one reported in section 4.4.5 who was using wolfberry, Codonopsis 
and red date to prepare his herbal chicken soup. As mentioned before, the herb affecting 
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his ophthalmologic condition was wolfberry. Among those who mentioned their level 
of satisfaction from its effects, the satisfaction rate was 76.2% (16/21). 
 
Figure 4.7. Details of usage of red date by participants in telephone interview: A) 
the percentage of different forms of usage of red date by participants, 
B) the different sources of information about its usage reported by 
participants, C) the frequency of usage of red date reported by 




Table 4.15. Reasons for usage of red date reported by participants in telephone 
interviews 
Reasons for usage Description Number of  reports Percent 
General health improvement 16 72.7 
Specific medical purposes1 
Disorders based on TCM concepts2 4 18.2 
Neurological disorders 1 4.5 
Ophthalmologic problems 1 4.5 
Musculoskeletal problems 1 4.5 
1 one of the participants reported using ginkgo for both cardiovascular and metabolic disorders. 
Therefore, the sum of reasons for usage is more than the sum of users. 
2 TCM: Traditional Chinese Medicine 
 
 
To study the factors associated with the usage of red date, chi square and student t-
test were used for the categorical and continuous variables respectively. As presented 
in Table 4.16, none of the studied factors was associated with the usage of this 
medicinal herb. As mentioned before, the lack of found association can be due to the 
small sample size, which should be addressed in further bigger studies. So far, there is 




Table 4.16. Association of demographic and neurocognitive assessment factors 
with the usage of red date 
Factor 
Red date usage 
P value 
Yes No 
Age 67.4 ± 5.1 68.3 ± 6.0 0.469 
Gender   0.389 
 Male 6 (12.0%) 44 (88.0%)  
 Female 19 (13.0%) 127 (87.0%)  
Ethnicity   0.699 
 Chinese  25 (13.1%) 166 (86.9%)  
 Others 0 (0.0%) 5 (100%)  
Educational level   0.569 
 Nil  8 (19.5%) 33 (80.5%)  
 Primary or secondary  15 (11.0%) 121 (89.0%)  
 Pre-university or university degree  2 (10.5%) 17 (89.5%)  
Housing type    0.499 
 1-2 room public apartment 0 (0.0%) 5 (100%)  
 3 room public apartment 7 (19.4%) 29 (80.6%)  
 4-5 room  public apartment or private or  
 landed house  18 (11.7%) 136 (88.3%)  
History of chronic diseases    0.273 
 No history  4 (14.3%) 24 (85.7%)  
 History of one or two chronic diseases  8 (8.4%) 87 (91.6%)  
 History of three or more chronic diseases 13 (17.8%) 60 (82.2%)  
Physical activity    0.309 
 Once a month or less  2 (5.6%) 34 (94.4%)  
 Once a month to once a week  2 (22.2%) 7 (77.8%)  
 Once a week or more  17 (12.1%) 123 (87.9%)  
Social, cognitive and religious activity level
  3.48 ± 1.47 3.54 ± 1.74 0.867 
GDS score 1.08 ± 1.64 0.96 ± 1.18 0.723 
GAI score 0.75 ± 1.96 0.70 ± 1.70 0.890 
MMSE score 28.33 ± 1.90 28.73 ± 1.86 0.331 
ECAQ score 9.54 ± 1.06 9.62 ± 0.64 0.612 
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4.4.7. Usage of notoginseng and factors associated with it 
Notoginseng is another species from Panax genus, which was the sixth most 
commonly used herb by the participants in the telephone interviews with 24 users. This 
herb was introduced in the section 1.3.1.3. Figure 4.8 demonstrates the detailed 
information about the usage of notoginseng by participants in the study.  
Despite other medicinal herbs discussed before, users of notoginseng usually took 
it as end product preparations such as tablets or capsules. Additionally, one participants 
used this herb topically. It was the only topical herbal medicine reported by our 
participants. 
Most notoginseng users were using it for specific medical conditions. It was unique 
for P. notoginseng since the main purpose of usage for all other herbs was to improve 
the general health. Among reported medical purposes, disorders based on TCM 
concepts were the most common reason for usage followed by neurological and 
musculoskeletal problems (Table 4.17). 
P. notoginseng is a known herbal remedy for prevention and treatment of 
cerebrovascular accident and its subsequent cognition impairment (Chuang et al., 2008; 
Gao et al., 2012; He et al., 2011; Zheng et al., 2008). There are also studies investigating 
its effect on other kinds of cognitive decline such as Alzheimer’s disease (Choi et al., 
2010; Hsieh et al., 2000; Zhong et al., 2011). The usage of this herb for musculoskeletal 
problems by 3 participants is consistent with its traditional indication for trauma 
management, which has been recently studied scientifically as well (CPC, 2010; Ng et 
al., 2008a; Peng et al., 2010). In addition to its usage for blood promoting to treat 
cardiovascular disorders for centuries (CPC, 2010; Han et al., 2013; Wang et al., 2012; 
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Zhang et al., 2011), the positive effects of using P. notoginseng on prevention and 
treatment of cardiovascular and cerebrovascular accidents can be due to its 
hypoglycemic effects as well. There are reports on usage of this medicinal herb as a 
hypoglycemic and anti-obesity remedy (Kim et al., 2009; Uzayisenga et al., 2014; Yang 
et al., 2010). It has also shown promising effects against hypertension in recent studies 
(Baek et al., 2009; Pan et al., 2012). Therefore, the usage of this herb for different 
medical purposes reported by our participants is consistent with available literature. 
Twenty out of 22 participants who explained their level of satisfaction about the usage 
of notoginseng were satisfied of its usage (90.9%).  
 
Figure 4.8. Details of usage of notoginseng by participants in telephone interview: 
A) the percentage of different forms of usage of notoginseng by 
participants, B) the different sources of information about its usage 
reported by participants, C) the frequency of usage of notoginseng 




Table 4.17. Reasons for usage of notoginseng reported by participants in telephone 
interviews 
Reasons for usage Description Number of  reports Percent 
General health improvement 9 37.5 
Specific medical purposes 
Disorders based on TCM1 concepts 6 25.0 
Neurological disorders 3 12.5 
Musculoskeletal problems 3 12.5 
Cardiovascular diseases 2 8.3 
Metabolic disorders 1 4.2 




To study the factors associated with usage of notoginseng, unadjusted methods 
were used, which is presented in Table 4.18. None of the studies factors showed 
statistically significant association with the usage of notoginseng. In this study, only 24 
participants reported using P. notoginseng and their purposes of usage were diverse. 
Therefore, it is not expected to observe any statistically significant association. Larger 




Table 4.18. Association of demographic and neurocognitive assessment factors to 





Age 67.1 ± 6.1 68.3 ± 5.9 0.357 
Gender   0.092 
 Female  21 (14.3%) 126 (85.7%)  
 Male 3 (6.0%) 47 (94.0%)  
Ethnicity   0.701 
 Chinese  24 (12.5%) 168 (87.5%)  
 Others 0 (0.0%) 5 (100%)  
Educational level   0.229 
 Nil  6 (14.3%) 36 (85.7%)  
 Primary or secondary  18 (13.2%) 118 (86.8%)  
 Pre-university or university degree  0 (0.0%) 19 (100%)  
Housing type    0.655 
 1-2 room public apartment 0 (0.0%) 5 (100%)  
 3 room public apartment 4 (10.8%) 33 (89.2%)  
 4-5 room  public apartment or private or  
 landed house  20 (13.0%) 134 (87.0%)  
History of chronic diseases    0.069 
 No history  2 (7.1%) 26 (92.9%)  
 History of one or two chronic diseases  17 (17.7%) 79 (82.3%)  
 History of three or more chronic diseases 5 (6.8%) 68 (93.2%)  
Physical activity    0.700 
 Once a month or less  3 (8.3%) 33 (91.7%)  
 Once a month to once a week  1 (11.1%) 8 (88.9%)  
 Once a week or more  19 (13.5%) 122 (86.5%)  
Social, cognitive and religious activity level
  3.7 ± 1.6 3.5 ± 1.7 0.744 
GDS score 0.79 ± 0.78 0.99 ± 1.29 0.454 
GAI score 0.54 ± 1.44 0.72 ± 1.76 0.631 
MMSE score 28.22 ± 2.09 28.74 ± 1.83 0.208 
ECAQ score 9.42 ± 1.14 9.63 ± 0.63 0.382 
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4.4.8. Usage of lingzhi and factors associated with it 
Lingzhi (Reishi) is the dried sporophore of Ganoderma lucidum, which is a 
mushroom endemic to East Asia. Its nature is natural (neither warm nor cold) and its 
taste is sweet. Lingzhi has been traditionally used to tonify qi and tranquilize the mind, 
suppress cough and relieve panting. Based on Chinese Pharmacopoeia, its indications 
are disquietude heart spirit, insomnia and palpitation, cough and panting, shortness of 
breath and lack of appetite (CPC, 2010).  
Among participants in our study, this herb was the sixth most commonly used 
medicinal herb sharing its rank with notoginseng with 24 users. Figure 4.9 and 
Table 4.19 show the details of its usage. Similar to P. notoginseng and despite other 
herbs studied in this survey, users of G. lucidum were usually using it as an ingredient 
of health supplement end products. However, similar to other herbs, the main source of 
information about its usage was family and friends recommendation. 
Most of lingzhi users used this herb for general health improvement and 5 
participants who reported using it for specific medical conditions reported using it for 
respiratory, neurologic, musculoskeletal, cardiovascular and reproductive disorders. 
Usage of G. lucidum for respiratory problems is consistent with its traditional uses 
(CPC, 2010). Furthermore, its therapeutic effects on asthma and bronchitis have been 
studied recently where its immune modulatory effects can be an important player (Batra 
et al., 2013; Jan et al., 2011; Kelly-Pieper et al., 2009). One participant used it for 
neurological conditions, which is consistent with its traditional usage for insomnia 
(CPC, 2010). Although the number of studies on this herb is limited, there are reports 




Figure 4.9. Details of usage of lingzhi by participants in telephone interview: A) 
the percentage of different forms of usage of lingzhi by participants, 
B) the different sources of information about its usage reported by 
participants, C) the frequency of usage of lingzhi reported by 
participants, D) its duration of usage. 
Table 4.19. Reasons for usage of lingzhi reported by participants in telephone 
interviews 
Reasons for usage Description 
Number of  
reports 
Percent 
General health improvement 19 79.2 
Specific medical 
purposes 
Respiratory problems 2 8.3 
Neurological disorders 1 4.2 
Musculoskeletal problems 1 4.2 
Cardiovascular diseases 1 4.2 
Reproductive system problems 1 4.2 
1TCM: Traditional Chinese Medicine 
2 One of the participants reported using lingzhi for both cardiovascular and respiratory problems. 
Therefore, the sum of reasons for usage is more than the sum of users. 
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Although there is no traditional musculoskeletal indication for lingzhi to support 
its usage by a participant for this reason, its analgesic and immunomodulatory effects 
(Lam et al., 2008; Li et al., 2007; Xi Bao et al., 2006) can suggest it as an alternative or 
complementary treatment for rheumatoid arthritis and similar disorders. Usage of this 
herb by a participant for cardiovascular problems is also consistent with both the 
traditional and scientific literature suggesting its benefits in the management of 
cardiovascular problems from palpitation to myocardial ischemia (Chu et al., 2012; 
CPC, 2010; Lasukova et al., 2008). One of the participants used a health supplement 
containing lingzhi and steamed Korean ginseng for his reproductive problem. To the 
best of our knowledge there is neither traditional nor new literature reporting any 
reproductive pharmacological benefits for lingzhi. On the other hand, P. ginseng has 
established beneficial effects for sexual dysfunction (Choi et al., 2013; Leung et al., 
2013). Therefore, it can be concluded that, the ingredient in the product which was 
effective for sexual problem was Korean ginseng and not lingzhi. The satisfaction rate 
for usage of lingzhi among participants was 58.3% (14/24). 
To study factors associated with usage of lingzhi, demographic, life style and 
mental assessment factors were studied individually using student t-test and chi square 
whichever applicable. None of the studied factors showed any statistically significant 





Table 4.20. Association of demographic and neurocognitive assessment factors 





Age 67.3 ± 3.6 68.3 ± 6.2 0.283 
Gender   0.593 
 Male 6 (12.0%) 44 (88.0%)  
 Female 18 (12.2%) 129 (87.8%)  
Ethnicity   0.701 
 Chinese  24 (12.5%) 168 (87.5%)  
 Others  0 (0.0%) 5 (100%)  
Educational level   0.880 
 Nil  5 (11.9%) 37 (88.1%)  
 Primary or secondary  16 (11.8%) 120 (88.2%)  
 Pre-university or university degree  3 (15.8%) 16 (84.2%)  
Housing type    0.655 
 1-2 room public apartment 0 (0.0%) 5 (100%)  
 3 room public apartment 4 (10.8%) 33 (89.2%)  
 4-5 room  public apartment or private or 
 landed house  20 (13.0%) 134 (87.0%)  
History of chronic diseases    0.426 
 No history  5 (17.9%) 23 (82.1%)  
 History of one or two chronic diseases  9 (9.4%) 87 (90.6%)  
 History of three or more chronic 
diseases 10 (13.7%) 63 (86.3%)  
Physical activity    0.567 
 Once a month or less  4 (11.1%) 32 (88.9%)  
 Once a month to once a week  2 (22.2%) 7 (77.8%)  
 Once a week or more  15 (10.6%) 126 (89.4%)  
Social, cognitive and religious activity level
  3.9 ± 1.9 3.5 ± 1.7 0.371 
GDS score 0.96 ± 0.96 0.97 ± 1.27 0.962 
GAI score 1.04 ± 1.81 0.65 ± 1.71 0.302 
MMSE score 28.83 ± 1.47 28.65 ± 1.91 0.661 
ECAQ score 9.67 ± 0.57 9.59 ± 0.73 0.636 
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4.5. Conclusion  
The main aim of this study was to collate detailed information about the usage of 
herbal medicine among older adults in Singapore. For this, 209 older adults 
participating in Jurong Ageing Study were invited to participate in a follow-up 
interview on phone. Among them, 198 agreed to participate and shared the information 
about their usage of medicinal herb in past 12 months, if any. The prevalence of usage 
of medicinal herbs was 67.7%, which was about twice the prevalence of medicinal 
herbs among SLAS participants. This significant increase could hardly be explained by 
the changes in the usage during the time. The best explanation could be the differences 
in study design and having a focused questionnaire for getting information about herbal 
medicine usage by telephone interviews.  
The top three common herbs used by participants were American ginseng, 
wolfberry and Chinese ginseng respectively. It was worth to note that three species from 
Panax genus were among the top six herbs used by our participants, namely P. 
quinquefolium (American ginseng), P. ginseng (Chinese ginseng) and P. notoginseng 
(notoginseng). It shows that Panax genus can be considered as the most commonly used 
group of medicinal herbs in this age group. This observation is consistent with other 
reports showing high prevalence of these herbs in different societies (Ayranci et al., 
2005; Froiland et al., 2004; Kim et al., 2004a; Tian et al., 2010). 
Most of our participants used to get the information about the usage of herbal 
medicine from family and friends. A small proportion obtained such information from 
TCM practitioners and nobody had consulted with a western practitioner regarding their 
use. It shows a huge gap of communication between health practitioners and older 
adults regarding the usage of herbal medicine, which is not only very commonly used 
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but also potentially a risk for herb-drug interaction and other dangerous adverse effects. 
Such a lack of proper communication has been reported by many other studies from 
different countries since several years ago (Asadi-Pooya et al., 2014; Koh et al., 2003; 
Smith et al., 2004) but the situation seems to be unchanged.  
General health improvement was the most common reason for usage of medicinal 
herbs. Among those who were using herbal medicine for specific medical purposes, 
health conditions based on TCM concepts was the most common purpose of usage 
followed by neurological conditions and musculoskeletal ones. It demonstrate the 
importance of investigating the usage of herbal medicine for neurological conditions in 
older adults, which is one of the most important health issues in this age group. 
Usage of herbal medicine was more common among younger female participants 
and those who lived in bigger houses in unadjusted measurements. However, after 
building a logistic regression model to consider the effect of other factors on these 
associations, only female gender kept its association. Such higher usage of herbal 
medicine by women has been reported before (Eardley et al., 2012; Hughes et al., 2013; 
Picking et al., 2011). 
The detailed information about usage of seven herb with more than 20 user was 
analyzed. Most of these herbs were used as a part of food preparations (usually herbal 
chicken or pork soup) except notoginseng and lingzhi, which were used as end product 
health supplements. The medical purposes for using these herbs were also compared to 
available literature, which showed almost complete consistency. 
The number of interviewed participants in this study is limited. This has led in the 
small number of users for each herb making it difficult to statistically evaluate the 
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correlation of using each herb to different factors. Additionally, although the detailed 
information on the usage of each herb (duration, frequency, etc.) was recorded, the 
number of participants in subgroups of herbal usage was very few. This fact made the 
statistical analysis of the association of duration and frequency of using each herb to 
different studied factors invalid. Recruiting more participants and continuation of the 
telephone interview can be helpful in preparing a better picture of their usage.  
The demographic information of non-respondent to the original study was not 
recorded. Having no data on non-respondents, makes it impossible to calculate the 
response rate and compare the respondents to the non-respondents. Such comparison is 
essential for generalization of the findings and validation of the results. Since the 
project is ongoing, this limitation has been reported to its principle investigator hoping 
to solve the problem for the rest of the study. 
The other limitation of the study was the ethnic distribution of participants. In this 
study, 97.5% of participants were Chinese, 2% were Indian and 0.5% were Malay. 
However, based on the latest national census, among Singapore population older than 
60, 83.3% are Chinese, 9.3% are Malay, 6.0% are Indian, and 1.4% belong to other 
ethnicities (Wong, 2010). This difference in ethnic proportions can negatively affect 
the generalizability of the results.  
Considering the high prevalence of herbal medicine as the most common 
complementary and alternative medicine with the highest risk of adverse effects and 
interactions, it is very important to improve our understanding of the trends of usage 
and factors associated with it. Such information can be useful for medical practitioners 
to improve their communication with their patients specially when dealing with high 
risk patients such as older adults. Simultaneously, policy makers, government bodies 
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and media producers should work together to improve the public knowledge and 
understanding about benefits and risks of using herbal medicine and to encourage the 




CHAPTER 5. Survey of the products containing the words 
“Panax” or “ginseng” in their label 
5.1. Introduction 
In Singapore, health supplements are not subjected to premarket approvals and 
licensing for their importation, manufacture, and sales (MOH, 2008a). The onus of 
responsibility for the safety and quality of health supplements rests with dealers and 
sellers (HSA, 2012b; MOH, 2008a). They must ensure that their product comply with 
the safety and quality requirements (HSA, 2012b). To the best of our knowledge, there 
are few available publications on their reliability and safety. Most studies done as a 
post-marketing surveillance have been focusing on adulterations, heavy metals, or 
poisonous ingredients in CPM products (Koh et al., 2000; Yee et al., 2005).  
Health products containing “ginseng” are among the best sold herbal products 
worldwide (Ayranci et al., 2005; Froiland et al., 2004; Kang et al., 2012; Smith et al., 
2004). Since most of these products are sold as general sale list medicines (GSL) or 
over the counter (OTC), the consumers may choose them based on their labeling while 
purchasing from retail shops. Therefore, the information provided in the labels is the 
most available source of information and plays a key role in the product selection and 
consumption by ordinary users. This information has to be reliable, clear, and 
understandable for the consumers to avoid misunderstandings and inappropriate usage 
of the products. Having realistic information from the labels of such products in 




5.2. Hypotheses and objectives 
We hypothesize that the information on labels of food and health products which 
are labeled with words “Panax” and/or “ginseng” and are available in Singapore market 
is clear and comprehensive. The objectives of this part of the study are to collate 
information of commercially available health and food products labeled with words 
“Panax” and/or “ginseng” in Singapore and to check if the product labels provide all 
information recommended by local legislations such as name, brand, expiry date, 
manufacturer, batch number, ingredients, dosage, indications and side effects. 
5.3. Methods 
During several visits to five different shops in Singapore, the information on all 
products having the words “Panax” and/or “ginseng” in their labels were collated and 
documented. The recorded information included names, brands, manufacturers, batch 
numbers, expiry dates, descriptions, actions and indications, dosage, contraindications, 
side effects, cautions, prices and any other available information. The shops visited for 
this purpose were “Sinchong Meheco”, “Unity Pharmacy, NTUC Healthcare Hougang 
mall Branch”, “Guardian Health and Beauty Lot 1 Shopper’s Mall Branch”, “GNC Lot 
1 Shopper’s Mall Branch”, and “Fairprice 24 hours, HDB Clementi Branch”. They 
actually consist of a wide range of shopping places providing OTC health products that 
may be chosen by ordinary people from general branched shopping centers (fairprice 
NTUC) to health product shops (Guardian, GNC, Unity Pharmacy) to specific TCM 
halls (Sinchong Meheco). 
Inclusion criteria were having the word “Panax” and/or “ginseng” on the packaging 
and being available in any of the shops mentioned above at the time of data collation. 
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The products were categorized into CPM, HS, or FS based on information provided by 
HSA website (the list of CPM products) (HSA, 2012c), the CPM labels on the products 
(MOH, 2002), or guidelines provided by HSA and AVA (HSA, 2012a, 2012b). After 
that, the ingredients listed on each product were studied to know the number of 
ingredients listed and the nature of them according to herbal, animal or other origins. 
The claimed indications of each product were compared to HSA legislations to find any 
incompliance with regulations. Other information available on the labels including 
recommended daily dosage, side effects, contraindications, cautions and interactions 
were also evaluated. 
5.4. Results and discussion 
The information on the package of products sold at five locations which were 
labeled with the words “Panax” or “ginseng” was documented (Table 5.1). In this study, 
the labeling information of 342 products was recorded in a database. The products with 
same name and brand were counted separately only if the ingredients, dosage forms, 
and/or usage information on packages were not the same. In the cases of different 
package sizes but same dose strength, ingredients and labeling, products were 
considered as repeated and only one of them was used for the study. Based on the 
mentioned criteria, 32 duplicate products and one which had no information in English 
on the labeling were excluded. The 309 included products were categorized in three 






Table 5.1. Number of products collated from each location 
Location Number of collated products 
Sinchong Meheco 270 
Unity Pharmacy, NTUC Healthcare Hougang Mall Branch 20 
Guardian Health and Beauty Lot 1 Shopper’s Mall Branch 18 
GNC Lot 1 Shopper’s Mall Branch 4 
Fairprice 24 hours, HDB Clementi Branch 30 
Total number of products 3421 
     1 Including 32 repeated (duplicate) products and a product with no information (except the 
name) in English. The other 309 products were included in analysis. 
 
Thirty six products which were not in the “end product preparation” form were 
categorized as food supplements including seasonings and ready-to-use herbal soups 
(HSA, 2012a). The remaining 273 products which were in end product preparation 
forms such as tablets, capsules, granules, powders, liniments, oral liquids, etc. were 
categorized into Chinese proprietary medicines or health supplements. A product was 
considered as Chinese proprietary medicine if it was listed in CPM list provided by 
HSA (HSA, 2012c) or it had the specific CPM label provided by HSA on its package 
(Figure 5.1). Among the collated products, 188 fulfilled the CPM criteria and the 
remaining 85 products were categorized as health supplements. 
 




5.4.1. Products composition 
As different plant species have different medicinal properties, it is very important 
to know the composition of each product. Hence, the products were further categorized 
based on the labeled composition of the Panax species or other herbs from other 
families referred as “ginseng” (Table 1.4 and Table 1.5 in section 0). Four species from 
Panax genus, namely P. ginseng, P. quinquefolium, P. notoginseng and P. 
pseudoginseng, and two species from other genera (E. senticosus and G. pentaphyllum) 
were found listed on product labels as ingredients. Figure 5.2 shows the number of 
collated products which listed each of these species in their ingredient lists.  
 
Figure 5.2. Presence of four Panax species (P. ginseng, P. notoginseng, P. 
quinquefolium and P. pseudoginseng), E. senticosus and G. 
pentaphyllum in the ingredient lists of products collated for this study. 
The majority of the products (125, 40%) contained P. ginseng. this species was 
named in different ways on products including P. ginseng (16, 5%), Radix ginseng (74, 
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24%), “Chinese ginseng” (1, <1%), and “Korean ginseng” (34, 11%). All of these 
names were considered as P. ginseng. The next most common species was P. 
notoginseng (73, 24%), followed by P. quinquefolium (45, 15%). Eleven products had 
Eleutherococcus senticosus (Siberian “ginseng”) listed as one of their ingredients. 
Another product (“7 Leaf Ginseng Natural Health Tea”) contained Gynostemma 
pentaphyllum, which is sometimes called as “five-leaf ginseng” (D'jang, 1999) but not 
“seven”-leaf ginseng (please see section 0, Table 1.5). Since they satisfied our inclusion 
criteria, they were included in this study and categorized as “no Panax” group.  
A discrepancy between the name of the product and the herbs listed in the 
ingredient list was observed in five products. They had the word “pseudoginseng” in 
their name but “notoginseng” in their ingredient list. These two species are considered 
different in some plant databases (Efloras; IPNI, 2012) and the same in some others 
such as Chinese pharmacopeia and plants database website (CPC, 2010; "Plants 
database," 2012). Although we had considered P. pseudoginseng as a separate species 
in this survey, in such cases of inconsistency between the name of product and the list 
of ingredients, the categorization was based on the ingredients list.  
Eighteen products contained two species of Panax genus or other species which 
were referred as “ginseng” and one product had a combination of “Korean ginseng”, 
“American ginseng” and “Siberian ginseng” (E. senticosus) in its ingredients list. 
It was found that, for 32 products, the ingredient was mentioned only as “ginseng” 
including a product which had listed P. pseudoginseng and “ginseng” in its ingredient 
list. The word “ginseng” is sometimes loosely used to refer to different species (section 
1.3). When it was not clear which specific species the products contained, they were 
separately categorized as “unknown Panax species”.  
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A product, “Yunnan Baiyao Capsules”, did not have the word “ginseng” or “Panax” 
on its package. Therefore, although it is a very famous product containing P. 
notoginseng with a protected formula, it was not included in our study. Another 
product, “Muscle relaxing Herbal Analgesic Oil”, had the word “Tian Qi” (San qi) on 
its labeling and no “Panax” or “ginseng”. This word refers to P. notoginseng in Chinese 
(CPC, 2010; Zhu, 1998). As it did not satisfy the inclusion criteria, it was not also 
included in this study. This shows that although most products have reported their 
Panax ingredients properly, there is still some room for improvement especially for few 
incomplete or misleading ingredient lists. 
5.4.2. Basic product label information 
The labeling requirements for CPM, HS and FS have already been presented in 
Section 1.2.2 (Table 1.1, Table 1.2 and Table 1.3). The basic information on the labels 
of collated products was compared to respective requirements and their compliance was 
evaluated. Table 5.2 summarizes the percentage of each group of products providing 
the relevant information.  
Considering the information which has to be present in the outer label of products 
(section 1.2.2), more than 96% of the CPM products, more than 84% of the health 
supplements, and more than 88% of the food supplements comply with the respective 
regulations. These results are consistent with a much smaller study in UK showing that 
87% of 68 products containing herbal ingredients had provided the basic information 
on their package or in the leaflets based on the local legislations (Raynor et al., 2011). 
It should be considered that the labeling requirements are applicable to the outer 
label, inner label and package insert. As some products are sealed, it is impossible to 
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have access to the inner label and package insert without opening the packages. For this 
study, all information has been based on whatever was available without damaging the 
packages. 
Table 5.2. List of required information on product labels and the number of 
products in different groups which provided the relevant information 
Information 
Number of products with the relevant information 
CPM HS FS Total 
Name 188(100%) 85(100%) 36(100%) 309(100%) 
Brand 187(99.5%) 81(95.3%) 30(83.3%) 298(96.4%) 
Batch number 182(96.8%) 72(84.7%) 17(47.2%) 281(90.9%) 
Manufacturer 182(96.8%) 79(92.9%) 36(100%) 297(96.1%) 
Expiry date 183(97.3%) 73(85.9%) 32(88.9%) 288(93.2%) 
Name of ingredients 187(99.5%) 76(89.4%) 35(97.2%) 298(96.4%) 
Recommended daily dosage 176 (96.2%) 51 (69.9%) NA 227 (88.7%) 
Indications 178(94.7%) 53(62.4%) 6(16.6%) 237(76.7%) 
Side effects 1(0.5%) 3(3.5%) 0(0%) 4(1.3%) 
Contraindications 91(48.4%) 12(14.1%) 3(8.3%) 103(33.3%) 
Cautions 37(19.7%) 9(10.6%) 0(0%) 46(14.9%) 
Interactions 38(20.2%) 0(0%) 1(1.2%) 39(12.6%) 
Total 188 85 36 309 
     
5.4.2.1. Name, brand, batch number, manufacturer information and expiry 
date 
As presented in Table 5.2, all collated products had their name on their packages 
and most of them (96.5%) had mentioned their brand. Although all of the labeling 
information has to be in English (MOH, 2008a), labels of twelve products were mostly 
in Korean. Therefore, the information on their packages was not understandable by the 
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majority of consumers in Singapore. Indeed, this fact could affect their marketing as 
well.  
About 10% of the products (28) had not reported their batch numbers in their labels. 
Batch number is a very important piece of information, which helps researchers and 
others track production series.  Information on manufacturer was reported in 96.1% of 
the collated products (297).  
Expiry date was generally present and was found to be missing in 5 CPMs (2.6%), 
12 health supplements (14%) and 4 food supplements (11.1%). It is an important piece 
of information especially for health and food supplement which are consumed for 
health or medical purposes. Since using expired products can be harmful, it is essential 
to report the expiry date. 
Absence of the basic information such as a proper name in English, batch number 
and expiry date makes the products difficult to track and susceptible to be harmful. It 
also increases the risk of misuse and potential adverse effects. 
5.4.2.2. Ingredients 
Among 309 collated products, 298 had listed their ingredients (Table 5.2). These 
ingredients could be herbal ingredients, animal originated ingredients, minerals or 
vitamins, or excipients. Figure 5.3 shows the number of listed ingredients on the 
products. The majority of products reported consisting of 5-10 ingredients in their 
labels. The maximum number of listed ingredient was 64 belonging to a product named 
“American Wisconsin Ginseng Root Tea” from Prince of Peace® brand. This CPM 




Figure 5.3. Number of listed ingredients on the collated products 
It should be kept in mind that in TCM, herb is a common word not only used for 
plants but also including animal products (Chang et al., 2000). Table 5.3 shows the 
animal originated ingredients listed in labels of collated products and the definition of 
each ingredient. The definitions were obtained from various sources (Bensky et al., 
2004; Clark et al., 1971; CPC, 2010; Wilson et al., 2005; Wu, 2005; Zhao, 2004). 
The number of listed ingredients excluding excipients is presented in Figure 5.4. It 
includes herbal or animal originated ingredients, minerals and vitamins. Processed 





Table 5.3. List of animal originated ingredients listed on the collated products  
Ingredient Remarks 
Agkistrodan / A. japonicae Snake 
Arisaema cum bile Arisaematis (herbal) + bile of oxen 
Beeswax  Bees wax 
Bombyx batryticatus Stiff silk worm 
Bombyx masculus Male silk worm 
Calculus bovis The gall stones of Oxen 
Carapax et Plastrum 
Testudinis 
The shell of Chinemys reevesii (a turtle) 
Carapax trionycis Water turtle shell 
Cauda cervi The tail of deer 
Colla Corii asini The skin of donkey 
Colla Cornus cervi The skin of horn of deer 
Concha Haliotidis Sea snail shell 
Concha Ostreae Oyster shell 
Cornu Bubali The horn of buffalo 
Cornu Cervi degelatinatum / 
Cornu Cervi pantotrichum 
Deer horn 
Cornu Cervi parvum Proximal part of horns of deer 
Cornu Saigae tataricae The horn of Saiga (an animal similar to horse) 
Dens draconis Fossilized teeth 
Eupolyphaga seu steleophaga Dried female beetle 
Foetus Cervi Deer fetus 
Formica fusca Ant 
Gecko Lizard 
 To be continued on the next page 
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Cont. Table 5.3  
Hirudo Leech, Blood sucking worm 
Honey Honey 
Ligamentium Cervi The tail of deer 
Lumbricus Earth worm 
Mel (feng mi) Honey 
Moschus Dried pungent secretion of a deer 
Ootecha mantidis Egg case of praying mantis (praying bug) 
Os draconis 
the skeleton fossil of prehistoric mammals like hipparion (ancient horse), 
rhinoceros, deer, oxen, etc.  
Os Sepia Cuttlefish skeleton 
Penis Canitis The reproductive organs of male dogs 
Penis Cervi The reproductive organs of male deer 
Penis Otariae The reproductive organs of male seals 
Periostracum Serpentis The skin of snake  
Pheretima Earthworm 
Propolis  A part of beehive 
Pullus Cum Osse Nigro Chicken egg 
Royal jelly The oral secretion of worker bees used as the diet of queen bee 
Scolopendra Centipede 
Scorpio Scorpion 
Sheng yu  Fish 
Snake gall Bile of snakes 
Testis et Penis Bovis The reproductive organs of male oxen 
Testis et Penis Canis The reproductive organs of male dogs 





Figure 5.4. Number of herbal and animal originated ingredients, minerals and 
vitamins listed on collated products 
In Traditional Chinese Medicine, fungi are often considered as plants (Bensky et 
al., 2004; Chang et al., 2000; Zhu, 1998). Based on this, all ingredients with plant or 
fungal origin (such as Poria, Glossy ganoderma, Astragalus membranaceus, 
Cordyceps, etc.) were also categorized as herbal ingredients. Two products had reported 
“Massa Fermentata” as one of their ingredients. As “Massa Fermentata” is actually 
made from 6 different herbal material including Polygonum hydropiper (or P. 
flaccidum), Artemisia annua, Xanthium sibiricum, Semen Armeniacae (Xing Ren), 
Semen Phaseoli (Chi Xiao Dou) and wheat (Chang et al., 2000; Hijikata, 2006), it was 
counted as 6 ingredients. By excluding excipients, ingredients with animal origin, 
vitamins, minerals and processed herbal ingredients (such as oils), Figure 5.5 shows the 




Figure 5.5. Number of listed herbal ingredients on the collated products (note that 
none of the products have more than 60 herbal ingredients). 
Having one single ingredient decreases the risk of potential herb-herb interactions. 
In this study, there were 43 products with one single listed ingredient, among which 36 
were in CPM category, 5 were HS and 2 products were categorized as FS. Figure 5.6 
shows the herbal ingredient of 41 single ingredient CPM and Health supplements. 
 
Figure 5.6. Presence of four Panax species (P. ginseng, P. notoginseng, P. 
quinquefolium and P. pseudoginseng), E. senticosus and G. 





Majority of single ingredient products contained P. notoginseng (20, 48.8%) 
followed by P. ginseng (13, 31.7%). Having one single ingredient lowers the risk of 
herb-herb and herb-drug interactions and ease the chemical analysis of the products for 
any research or legal purposes. 
5.4.2.3. Dosage forms and recommended daily dosages 
The majority of health products collated for this study were in solid oral dosage 
forms (200, 73%) and the most common solid oral forms were capsules followed by 
tablets (Table 5.4). One of the CPM products, named Yunnan Baiyao Tincture, could 
be used both orally and topically. Thus, it was counted twice, both as liniment and as 
oral liquid.  






Health products with 
single listed ingredients Category Form 
Oral solid 
Capsules 85 16 13 
Tablet, Caplet or Pill 40 19 8 
Powder 31 1 9 
Granule 4 0 0 
Slice 0 2 0 
Softgel 0 2 0 
Oral liquid 
Oral liquid 18 24 4 
Tea 3 9 5 
Sachet 2 0 2 
Topical 
Liniment 6 6 0 
Plaster 0 6 0 
Total 189* 85 41 
* There is a CPM product which can be used either orally or topically. 
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Dosage forms such as capsules and tablets facilitate proper dosing as they are 
convenient for consumption. On the other hand, powders and granules may cause some 
difficulties regarding the measurement of dosage. Among the collected products, 36 
were in powder or small granular forms and their dosages were within the range of 1.5-
6 grams per dose. Such dosing method can be very difficult to measure and may 
increase the risk of over-dosage or insufficient treatment. Providing spoons is a way to 
tackle this problem for powders and granules. Among 18 unsealed products in powder 
or granule forms, no one had provided any measuring tool. Since being provided in 
pharmaceutical presentations (dosage form) is one of the criteria used to differentiate 
health products from FSs (HSA, 2012a), food supplements were excluded from this 
part of study.  
More than 96% of oral CPMs had mentioned their recommended daily dosage 
while such information was stated in the labels of less than 70% of the health 
supplements. Under Singapore regulations, recommended daily dosage, which is 
required for CPMs and Health Supplements, is not applicable to Food supplements and 
the topical health products. Therefore, food supplements were excluded from this 
analysis. 
5.4.2.4. Indications: 
About 95% of CPM products had stated the indications of usage clearly. This 
proportion was 50% for health supplement and less than 14% for food supplements. 
Table 5.5 gives an overview of indications listed by products collated in this study. 
Eleven health supplements and one food supplement had mentioned their indications 
indirectly. It means that after explaining the traditional usage of some herbs, they had 
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mentioned that the product contains those specific herbs. In other words, they explained 
the traditional or pharmacological uses of some of the herbal ingredients rather than 
stating the direct indications for the whole product. 
A total of 636 indications were reported in all products. They are categorized in 
different groups in Table 5.5. Since traditional medicine is based on some theories and 
concepts (such as five element theory, qi concept, yin-yang theory) which are different 
from conventional medicine (Chen, 2004; Kefu, 2007), the indications were first 
categorized as based on traditional medicine or conventional medicine. Most products 
had claimed to be effective for some traditionally defined health problems such as 
improving yin-yang balance, nourishing different Zang-Fu organ systems, enhancing 
Qi, etc. These conditions are included under “suitable for traditionally defined diseases 
or general health” in this study. 
Stated indications which were based on conventional medicine were categorized 
based on a list adapted from international classification of diseases version 10 (ICD-
10) (WHO, 2010). Based on this categorization, improvement in circulatory system 
followed by analgesic effects was the most common reported conventional indications. 
The effect on “mental and behavioral disease and diseases of the nervous system” was 
the next most common indication stated by a total of 59 products.  
One of the most important issues in stating the indications was mixing the 
traditional and conventional medical approaches to diseases. In TCM approach, besides 
the differences in the main concepts and theories, the body-organ system (Zang-Fu) is 
different from conventional medicine (Yuen et al., 2012). In other words, although there 
are some similar words such as “spleen”, “kidney”, “heart”, “lung”, “blood”, etc. in 
both systems, the anatomical and physiological meanings of them in TCM may not be 
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the same (Chen, 2004; Kefu, 2007). In our study, regulation of blood circulation 
(categorized in circulatory system) was a very common claim in labels of products (52 
products out of 311), which can have different meanings in traditional and conventional 
medicines. Consequently, the mixture of traditional and western approaches on the label 
of a product can cause significant misunderstanding and confusion especially for 
consumers who are not familiar with these two medical systems and the differences in 
their approaches.  
Table 5.5. Indications listed on the product labels 
Indication  
Number of products 
CPM HS FS Total 
Suitable for traditionally defined diseases or general health 152 42 4 198 
Affecting the circulatory system 63 13 2 78 
Analgesia 50 12 0 62 
Affecting mental and behavioral condition and the nervous system 49 8 2 59 
Suitable for diseases of musculoskeletal system and connective tissue 39 17 0 56 
Affecting blood, blood forming organs & immune mechanisms 43 8 2 53 
Affecting the digestive system 28 2 0 30 
Affecting the genitourinary system 24 3 0 27 
Affecting the skin and subcutaneous tissue 17 5 0 22 
Affecting endocrine, nutritional and metabolism 18 3 0 21 
Affecting the respiratory system 9 1 0 10 
Affecting pregnancy, childbirth and the puerperium 6 2 0 8 
Against  certain infections or parasitic infestations 5 1 0 6 
Affecting the eye and adnexa 4 1 0 5 
Anti-neoplasm 0 1 0 1 
Total 507 119 10 636 
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5.4.2.4.1. Nineteen prohibited claims 
Based on Singapore legislations, CPM or HS should not make any claims regarding 
the 19 prohibited serious health conditions (sections 1.2.2.1 and 1.2.2.2). In this study, 
23 products were found to make direct or indirect referral to the mentioned conditions. 
Among them, two products had claimed to be effective for wasting and thirsting 
syndrome, which is a TCM definition for diabetes (Xiao Ke) (Tao et al., 2007). There 
was a claim regarding anti-cancer effect. It was written on a plaster used for contusion 
and musculoskeletal pain that the product has “antioncotic” effects. Such a claim can 
be seriously misleading and confusing for consumers. Few products had claimed to be 
effective on kidney diseases. Those products which had pure traditional approach to 
kidney (Chen, 2004) were not considered to have prohibited claims. Because, as 
mentioned before, the traditional approach to kidney is different from conventional one 
and HSA guidelines are based on conventional approaches. There was a CPM product 
claiming to be effective on “symptoms of pitting edema in the limbs and face, heaviness 
in the knees and abnormal urination due to kidney deficiency”. This claim was clearly 
indicating the conventional renal deficiency and was considered as a prohibited claim. 
There were 18 products claiming to have therapeutic effects on menstrual problems 
including 16 claims to regulate menstruation, 9 claims to treat leucorrhea and 6 claims 
to subside dysmenorrhea. Finally, one of the health supplements had claimed to 
improve “libido in men”.  
This result shows the importance of post-marketing surveillances by HSA. Based 
on HSA regulations, products which make any of these 19 claims will be recalled from 
sales by authorities. 
182 
 
5.4.2.4.2. Regulations specific to health supplements regarding their 
indications of use 
The actions and indications listed on 86 health supplements collated for this study 
were compared to Singapore regulations. As mentioned in section 1.2.2.2, any claim of 
therapeutic effects on any medical condition is prohibited for health supplements. 
Additionally they are not allowed to imply to be have any memory enhancing, anti-
ageing or sensual enhancing effects, etc. 
Among studied products, six had claimed therapeutic effects against specific 
medical conditions including rheumatism and arthritis, eczema, tinea and seborrhea 
capitis. Four products had claimed to improve memory or brain performance. Five 
products had referred to some anti-ageing effects and two products had referred to 
sexual function and relationship. Finally, two products had claimed to be safe or to have 
been safely used.  
Furthermore, among 31 objectionable terms and claims listed by HSA (HSA, 
2012b), the word “guaranteed” was found in two products, the word “effective” was 
found in one, the word “anti-ageing” in the labels of three HSs and “longevity” in two 
others. In addition, the phrase “boost immunity” was claimed by one and “enhance 
immunity” by two. Finally, “libido” was found in one of labels. 
5.4.2.4.3. Regulation specific to food supplements governed by AVA 
Based on AVA regulations, none of food products is supposed to have any 
therapeutic or other medical claims (AVA, 2011). There were three food supplements 
making claims to be effective for special health conditions. Two of them had claimed 
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improvement of blood circulation, immunity and body resistance and it was written in 
the label of a spice containing “ginseng” (the species was not specified) that the product 
can “enhance the memory and help relieve stress”. Although there are reports on 
memory enhancing and anxiolytic effects of Panax species (Jesky et al., 2011; Perry et 
al., 2011; Qi et al., 2011), such claims from a food supplement is not acceptable. 
5.4.2.5. Side effects, contraindications, cautions, and interactions: 
Information on the side effects, contraindications, and interactions (if any) should 
be presented on the labels of all CPM and HS products, based on Health Products Act 
(MOH, 2008a).  
Among 188 CPMs studied, 137 products (72.9%) had reported that “there is not 
any known side effect” or “side effects are not known”. On the other hand, three (1.6%) 
had claimed to be “free of side effects”. Only one product had reported a potential side 
effect, which was impairment of yin and blood by long-term usage of the product. The 
rest of products (47, 25%) had not mentioned side effects at all. Moreover, among 85 
health supplements, the majority (78, 91.8%) had not indicated any side effect, three 
(3.5%) had reported potential side effects including “transient flushing due to nicotinic 
acid ingredient” and “allergic reactions”, and 4 products (4.7%) had mentioned that 
“the side effects are not known”. Although the side effects of many natural products are 
not reported yet, it is important to state this uncertainty in the labels of products. Such 
statements may work as an alarm to consumers especially those with specific health 
conditions to be more cautious about any potential adverse effects. 
Some contraindications were reported in the labels of 48.1% of CPM products and 
14% of health supplement as well as 8.3% of food supplements (Table 5.6). Only three 
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CPMs had claimed to have no contraindication and the majority of products (51.1%) 
had not mentioned contraindications at all. In the labels of 21.7% of CPM products and 
2.3% of health supplements contraindications were mentioned as “unknown”, which 
may be the best form of reporting when there is no available data.  
Table 5.6. List of contraindications reported in the labels of surveyed products 
No. Contraindication Frequency 
1 Pregnancy, planning for pregnancy or lactation 77 
2 Cold, influenza, flu, common cold, fever or pyrexia 18 
3 Allergy, asthma or hypersensitivity to ingredients 10 
4 Liver dysfunction 8 
5 Kidney dysfunction 7 
6 TCM conditions such as yin deficiency, excess and heat syndrome, etc. 4 
7 Heart problems, heart attack or hypertension 4 
8 Childhood 2 
9 Acute bleeding 2 
10 Diarrhea 2 
11 
Others (during menstrual period, sturdy1 patients, diabetes mellitus or nose 
pharyngalgia) 
4 
1 muscular and fit! It is mentioned on one of products that “sturdy” (muscular) patients should avoid 
using the product. 
The precautions were also reported for 19.6% of CPM products and 10.5% of health 
supplements. Table 5.7 shows the precautions reported by the studied products. The 
most common precaution reported by products was pregnancy or planning for it. 
The possibility of any food-drug interactions was reported by 38 CPM products 
(20.1%) and one (1.2%) health supplement. The most common reported interactions 
were with specific types of food such as raw, sour, or cold foods (20 products), pungent 
or spicy foods (18 products), fried, greasy, or oily foods (10 products), sea foods (3 
products), broad bean, sugary foods and salt (2 products each), and peanut and irritant 
foods (one product each). Two products had mentioned possible interactions with 
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alcohol and cigarette while six products had listed conventional drugs or traditional 
herbs as possible interactions. The conventional drug reported for possible interaction 
was warfarin and the medicinal herbs, which were stated for potential interactions were 
Rhizome et radix veratri, Fructose gleditsiae, Faeces trogopterori and radish. 
Table 5.7. List of cautions reported on the labels of Chinese proprietary medicines 
and health supplements 
No. Caution Number of products 
1 Pregnancy, nursing or planning for pregnancy 23 
2 Childhood 11 
3 Allergy, hypersensitivity or asthma 4 
4 Hypertension 4 
5 Taking other medications 3 
6 Elderly 3 
7 Kidney problems 3 
8 Before surgery 2 
9 Long-term usage 2 
10 Gastrointestinal problems 2 
11 Menstrual problems 2 
12 
Others including skin problems, bleeding tendency, weakness, 
common cold, liver problem 
6 
   
In general, it was stated in the labels of most products that the side effects, 
contraindications, or interactions are not known. Such statement is acceptable since 
there is not enough evidence of safety or toxicity for most natural products and 
traditional medical formulas. However, claims to have no side effect, contraindication, 
cautions or interactions need more attention. It is worth considering that people 
generally hide their usage of complementary medicines to their physicians (Kang et al., 
2012; Tasaki et al., 2002). This lack of communication can cause major problems such 
as severe drug-herb interactions (Smith et al., 2004) especially when the potential side 
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effects are not reported in product labels, the main source of information for OTC 
products. 
These results highlighted a much better product labeling situation in Singapore 
market compared to few similar reports from other countries, although there is still 
room for improvement. In a similar but much smaller study done in the UK, among 7 
products containing P. ginseng, only one precaution was stated and none of them had 
reported any side effects or contraindications (Raynor et al., 2011). In another study in 
Brazil, 8 products containing “ginseng” were evaluated regarding their 
pharmacological claims. The authors found no homogeneity among products in their 
indications, adverse effects or interactions. In addition, the claims were not supported 
enough by available scientific data (Auricchio et al., 2007). 
5.4.3. Misleading claims and information on the labels of the products 
The products were also evaluated for misleading claims in their labels. Although 
such claims were not against any regulatory guidelines provided by HSA and AVA and 
they cannot be considered as illegal, it is possible that such claims cause 
misunderstanding and inappropriate usage. Here, some of misleading claims found in 
collated product labels are presented.  
One product had claimed that it can help subside the “stabbing pain in the anterior 
pectoral region” caused by “coronary heart diseases and angina pectoris”. In TCM, 
stabbing pain in chest is one of the symptoms associated with heart problems (Kefu, 
2007) while coronary heart diseases rarely present with stabbing pain based on 
conventional medicine (Nabel et al., 2012). Furthermore, a product in plaster form 
claimed to “cure rheumatism”. Rheumatoid arthritis is a chronic almost non-curable 
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inflammatory disease (McInnes et al., 2011). There are similar misleading and 
exaggerated claims such as “controlling body cells from being abnormal”; “regulation 
of the endocrine system”; “relieve from jaundice and other inflammation diseases”; 
being “effective for all types of constipation”, “effective for all kinds of inflammation, 
carbuncles and anonymous swelling boil”, “a safe and reliable remedy for the treatment 
of all skin diseases”, or “all kinds of skin pruritus”; or to treat “different kinds of 
hemorrhagic symptoms” or “gynecological diseases”. As everybody knows, each of 
these groups of diseases consists of many different disorders and it is hard to believe 
that one particular product can cure or be effective on all of them. 
Moreover, there were some other claims found on the labels that could mislead 
consumers. For example, “acceptability [is] tested by world class sports players”, “[the 
product is] used by professional sportsmen”, “film stars, singers, and models use [this 
product]” or “certain groups of people have a special need for [this particular product] 
including business men, office workers, the older adults, athletes and sportsmen”, etc. 
Even though this kind of claims is not prohibited by HSA, having misleading 
information on products would be dangerous for consumers who are unable to test the 
reliability of claims. Such claims and information can lead in wrong usage of products 
by consumers. It is always better to provide scientific reference if a product wants to 
make a specific claim.  
5.4.4. Price 
Among the collated products in our study, the most expensive one was a health 
supplement called “Il Hwa Korean Honeyed Ginseng” which costed S$338 for a box 
and the cheapest one was a spice (FS), named Nature`s Cool JiaJia Herbal Tea-Less 
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Sugar, costing just S$0.70. Because of differences in package sizes, the raw prices 
printed on the packages is not representative of their cost per day. Hence, the prices 
were normalized based on the package sizes and daily recommended doses. 
Furthermore, the topical products and those without recommended daily dosages were 
excluded from this normalization. For food supplements, the cost per day was 
considered as the cost per suggested serving unit.  
Based on this, the maximum cost per day was S$45.60 belonging to a CPM and the 
lowest one was S$0.24 for another CPM. The average cost per day was S$2.75 for CPM 
users, S$2.99 for HS users and S$3.53 for FS users. Table 5.8 shows the top ten 
expensive products after normalization to the package size. These results suggest that 
products containing “bird’s nest” or “cordyceps” are more expensive than others. In 
other words, the Panax species have less effect on the final price of the product rather 
than its other ingredients.  
Table 5.8. List of the top ten most expensive products after normalization to daily 
dosage 





1 CPM Ferragold 
Essence of Bird`s Nest Ginseng & 
Cordyceps 
45.60 22.80 
2 HS Ferragold 
Shen Yu Jing with Cordyceps, Wild 
Ginseng & Radix Astragali 
41.60 20.80 
3 CPM Mei Hua  Buyao Jing with Duzhong Cordyceps Baji 20.00 20.00 
4 CPM Mei Hua  
Cordyceps Essence with American 
Ginseng 
20.00 20.00 
5 Food E-Health 
Essence of Chicken with Ginseng and 
Cordyceps 
20.00 20.00 
6 Food Huiji 
Huiji® Fish Essence with American 





Jing Zhi Wu Ji Ren Shen Bai Feng Wan 12.00 6.00 




Bai Feng Wan Paoshen Chongcao 
(American Ginseng with Cordyceps pills) 
7.80 46.80 
10 Food Brand`s®  





Among the products with single ingredients, the highest price per product was 
S$176 for “Korean Red Ginseng Extract” from Korea Ginseng Corp.® followed by 
S$110 for “Radix Panacis Quinquefolii (D2470)” from Sanjiu Enterprise Group®. 
After normalizing to the package size, the most expensive product was still “Korean 
Red Ginseng Extract” costing S$5.33 per day followed by “Steamed Tienchi Tablets” 
from Camellia Brand costing S$3.2 daily. 
Price is one of the most important factors affecting the marketing of a product 
(Foroncewicz et al., 2011). Furthermore, there is a general belief that cheap products 
are not as good as expensive ones. In a study in the US, the information stated on the 
labels of the products were compared to the available literature. The label information 
was consistent with textbooks in only 43% of herbal products. They also found that the 
price per recommended daily dose was a significant predictor of consistency (Garrard 
et al., 2003). It can be a sign of good manufacture practice, which makes the products 
not only more reliable but also more expensive. However, this statement can hardly be 
generalized to most products. 
5.4.5. Typographical and grammatical errors 
The found typographical and grammatical errors were categorized into two types. 
The minor grammatical and spelling mistakes could hardly cause misunderstanding or 
promote improper usage of products. They just showed lack of good manufacture 
practice. On the other hand, significant errors could be misleading and confusing. They 
could also cause dangerous adverse effects by improper usage especially in less 
educated and more susceptible consumers like older adults.  
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Minor mistakes were found in a large number of products (93, 49.2% of CPMs, 31, 
36.0% of health supplements and 19, 52.8% of food supplements). For example “nad” 
instead of “and”, “palce” instead of “place”, “founction” instead of “function” or 
“prperation” instead of “preparation”, or grammatical errors such as “original” instead 
of “originally”, “relief” instead of “relieves”, “temperate” instead of “temperature” or 
“out of reached” instead of “out of reach”.  
Significant and potentially dangerous errors were found in fewer product labels. A 
mistake was found in the ingredient list of a product where “Radix Panax Rehmanniae” 
was listed as one of ingredients. Rehmannia glutinosa is a traditionally used plant 
belonging to Scrophulariaceae family (Zhang et al., 2008c), which is not related to 
Panax family. Since different herbs have different pharmacological actions and 
dissimilar adverse effects and potential interactions, it is very important to state the 
correct name of herbal ingredients. As mentioned in section 5.4.2.4.1, a plaster used for 
contusion, had claimed to be “antioncotic”. If it is a typographical error (which seems 
to be), it can be extremely misleading and dangerous. In another product, “calcium 
lactas” and “zinci gluconas” were reported in ingredient list. “Zinci glucanas” is the 
Latin word for “zinc gluconate” but the Latin word for calcium gluconate is “calcii 
gluconas”. 
It is very important to provide clear and understandable information on the labels 
of products. These labels should be free of major spelling and grammatical errors, even 
though minor mistakes can be ignored. In addition, the presence of typographical and 
grammatical errors indicates the lack of enough care and attention to details needed to 




The aim of this part of study was to collate and evaluate the information provided 
on the labels of 309 products containing the word “Panax” or “ginseng” in the 
Singapore market. With regards to local legislations, more than 96% of CPM products, 
more than 84% of health supplements, and more than 88% of food supplements comply 
with respective basic requirements. The only exception was the information on 
recommended daily dosage. Only about 69.9% of the oral health supplements provided 
such information on their labels. On the other hand, almost 10% of CPM products, 
about 30% of HS and 10% of FS had made some kind of claims, which is not 
recommended by regulations.  
Such products are among the most used supplements and herb based CAM products 
in the world and also in Singapore, studying them can give us a general information 
about the whole herb products in the market. The results of this study showed that 
although about half of products had minor errors in their labels, the overall information 
provided on packages was clear and understandable in most of products. Few products 
had more significant errors in their labeling, which could mislead the consumers. In 
addition, the public and health professionals can play an important part in reporting to 
the authorities any products with prohibited claims. At the same time, HSA and AVA 
will continue monitoring the market to help manufacturers provide more 
comprehensive information on their products and to improve safety and quality of 
products.  
In this work, five shops providing herbal products were visited to collect the 
selected products. There may be some other products in the market which were not 
present in these five shops. Such products were not included in this study. Another 
192 
 
limitation of this work is that, the information provided in inner label and package insert 
of sealed products were not recorded because it was out of scope and budget of the 
project to purchase all available products. The other limitation of the work was the time 
and budget limitation to evaluate the different claims of the products regarding their 
ingredients, indications and toxicity. Such studies can provide a better understanding 
of the reliability of information provided in the label of available herbal products in the 
market. 
Finally, since labels of OTC products have important effect on their public use, it 
is important to increase the public awareness about the importance of accuracy of the 
information provided on the labels of products in a way that they can wisely choose the 
products they use and prevent the inappropriate usage of a health product.  
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CHAPTER 6. The effects of ginsenoside Rg1 on medial prefrontal 
cortex 
6.1. Introduction  
As mentioned in the section 1.3.2.1.1 ginsenoside Rg1 is a known neurostimulatory 
saponin and one of the most abundant chemical constituents of Panax species, the most 
commonly used group of medicinal herbs among older adults in Singapore (CHAPTER 
4). Its pharmacological effects on different systems and diseases have been studied 
including the cardiovascular, metabolic, immune, genitourinary and neurologic systems 
and premature ageing, abnormal blood lipid profile, cancer, Parkinsonism and 
Alzheimer’s disease (Chang et al., 2000). Among them, its effects on the neurological 
system and neurocognitive disorders might be more important and interesting because 
of the high global burden of these diseases on the societies and the lack of proper 
curative and preventive treatments for most of them (Murray, 2013). 
Several studies have tried to explain the mechanisms of neurological actions of 
ginsenoside Rg1. Some researchers focused on its anti-inflammatory effects, which can 
protect neurons against environmental assaults (Chen et al., 2011b; Liu et al., 2011b; 
Tang et al., 2011). Others suggested some molecular pathways to be affected by Rg1 
such as caspase-3 (Wei et al., 2008), NF-B (Chen et al., 2012a) and ERK1/2 (Ge et 
al., 2010; Shi et al., 2009) pathways. In addition, there are a few in vivo 
electrophysiological studies available reporting its effects on neuronal and synaptic 
activities. Among them, Wang and Xu reported that Rg1 can stimulate the “perforant 
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path-dentate gyrus” pathway in the rat hippocampus (Wang et al., 2001b; Wang et al., 
2009c; Xu et al., 2007).  
Medial prefrontal cortex is a bilateral brain structure, which receives neuronal 
projections from various parts of the brain (Groenewegen et al., 1997). It has had the 
highest development during the evolution and is the main brain region differentiating 
humans from other animals (Wallis, 2012). This important brain region integrates 
complex information from different brain regions (cortex, hippocampus, brainstem, 
etc.) to maintain and modulate the emotion, cognition and reward processing (Lim et 
al., 2010a). In addition, decision making and integrating emotions with specific 
memories (working memory and fear memory) are performed in prefrontal cortex 
affected by direct projection from hippocampus (Farooq et al., 2013).  
The neurological activity of medial prefrontal cortex can be studied in vivo using 
electrophysiological analysis (section 1.5.2). This can be either by studying the 
spontaneous firing rate of medial prefrontal cortical neurons or by analyzing the 
neuronal projections from other brain regions such as the hippocampus (Farooq et al., 
2013).  
Furthermore, histochemical studies can also be used to evaluate the function of this 
brain region (Verma et al., 2007). In 1988, Halazonetis introduced the evaluation of 
expression of c-Fos as a potential histochemical indicator for analyzing cellular activity 
(Halazonetis et al., 1988). As mentioned in section 1.5.1, c-Fos is an immediate-early 
gene up-regulated rapidly and transiently upon stimulation of different cells 
(Durchdewald et al., 2009). This protein is involved in the transcription process 
(producing mRNA based on dsDNA sequences) and can be found in various activated 
cell lines including cancer, immune system, skin, bone and central nervous system 
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(Halazonetis et al., 1988; Kilberg et al., 2012). The expression of c-Fos in the central 
nervous system can be used to study the brain region specificity of drug effects 
(Rajkumar et al., 2013). It means that the brain regions which show significantly 
lower/higher c-Fos expression after administration of a drug compared to before it are 
considered as potential regions of effect of that drug.  
To the best of our knowledge, all neurological studies on Rg1 have been focused 
on hippocampus and no published report is available on its effect on prefrontal cortex. 
Since medial prefrontal cortex in functionally linked to this brain region and receives 
direct projections from it, a question remains whether medial prefrontal cortex is also 
affected by ginsenoside Rg1 and if affected, whether this effect can be studied by 
routine electrophysiological and histochemical methods. Accordingly, the purpose of 
this chapter is to evaluate the effect of systemic administration of ginsenoside Rg1 on 
electrophysiological and histochemical characteristics of medial prefrontal cortex 
including evoked field potential in hippocampal-prefrontal cortical pathway, 
spontaneous firing rate of neurons in medial prefrontal cortex and c-Fos expression of 
neurons in this brain region. The results of this study may explain some potential 
mechanisms of neurological actions of ginsenoside Rg1. It should open new windows 
to the study of natural products and may suggest new areas for research on the treatment 
of neurological disorders such as anxiety, cognitive impairment and depression.  
6.2. Hypotheses and objectives 
As there are several reports of neurostimulatory effects of ginsenoside Rg1 (Chen 
et al., 2008a; Wang et al., 2001b; Wang et al., 2009c; Xu et al., 2007), we hypothesize 
that systemic administration of ginsenoside Rg1 increases the neuronal activity of 
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medial prefrontal cortex. Therefore, the objective of this part of study was to evaluate 
the effect of systemic administration of ginsenoside Rg1 on medial prefrontal cortex 
using three animal based methods including two electrophysiological methods and one 
histochemical method. Starting with the study of the effect of ginsenoside 
administration on long-lasting potentiation and long-term potentiation in hippocampal-
medial prefrontal cortical pathway, we evaluate whether there is any effect on direct 
neuronal projection from hippocampus to medial prefrontal cortex. After that another 
electrophysiological and a histochemical method are utilized to assess if the potential 
site of effect is the medial prefrontal cortex. These methods include measuring the 
spontaneous firing rate of pyramidal cells in medial prefrontal cortex and expression of 
c-Fos in these cells.  
6.3. Material and methods 
6.3.1. The effect of systemic administration of ginsenoside Rg1 on 
hippocampal-prefrontal cortical pathway 
6.3.1.1. Animals  
Male Sprague-Dawley (SD) rats weighing 200 – 300 g were requested form 
InVivos to be delivered to the vivarium in Center for Life Science (CeLS). They were 
acclimatized in pairs there in room temperature (22 – 23 C) with 12hr cycles of 
day/night light (07:00 – 19:00) with free access to food and water for at least 48 hours 
before transporting to the experimental lab. All animal procedures were approved by 
institutional animal care and use committee (IACUC) of the National University of 
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Singapore (protocol number 007-11) and were conducted in accordance with 
International Guiding Principles for Animal Research (Howard-Jones, 1985). 
6.3.1.2. Chemicals 
Chloral hydrate powder from Sigma Aldrich (Germany) was dissolved in sterile 
normal saline from B Braun (Malaysia) to prepare 7% w/v solution. 95% pure 
Ginsenoside Rg1 from Nature Standard (Shanghai, China) was dissolved in sterile 
normal saline to prepare stock solution of 25 mg/ml. The solubility of Rg1 in saline was 
facilitated by the room temperature sonication using a Branson 1510 sonicator 
(Mexico). The required preparations of 1, 3 or 10 mg/ml were obtained by diluting this 
stock solution (kept in 4 C refrigerator) with sterile saline when needed.  
A solution of 0.9% w/v sodium chloride and 4% w/v paraformaldehyde (PFA) in 
phosphate buffer was used for animal perfusion. The 0.9% w/v sodium chloride was 
prepared by dissolving 18 g NaCl (Schedelco, Malaysia) in 2 liters of distilled water. 
Phosphate buffer was prepared by adding 23.005 g Na2PO4 (Merck, Germany) and 5.93 
g NaH2PO4.2H2O (Merck, Germany) to 1500 ml distilled water and mixing it using a 
magnetic stirrer for 30 minutes in room temperature. Then, it was transferred to a fume 
hood and 80 g PFA (Sigma Aldrich, Germany) powder was added to it. By heating it 
to 125C and stirring it with magnetic stirrer under fume hood for more than 2 hours, a 
clear solution was prepared. It was followed by filtration under negative pressure using 
a Cole Palmer (Korea) vacuum. The final volume was adjusted to 2 liters by adding the 
appropriate amount of distilled water. The 15% and 30% w/v sucrose in phosphate 
buffer saline (PBS) were prepared by adding 30 g and 60 g sucrose (Fisher Chemicals, 
UK) to 200 ml 10% PBS (1st Base, Singapore), respectively.  
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Ethanol 100% from Merck (Germany) was used to prepare 95% and 70% solutions 
by adding distilled water.  Cresyl violet 0.1% in acetic acid was from Sigma Aldrich 
(Germany) and xylene was purchased from QReC (Thailand). The Surgipath 
micromount mounting medium (IL, USA) was used to fix the slides. 
6.3.1.3. Animal preparation and surgery 
All electrophysiology experiments were started between 8 – 9 am and only one 
animal was used each day. A rat weighing 280 – 380 g was transferred from vivarium 
to electrophysiology room in a proper cage or transport box. The rat was kept in the 
electrophysiology room for 30 minutes to acclimatize to the room environment. Then, 
it was weighed using a rat weighing boat and a Cole Palmer (Korea) weighing machine. 
After that 400 mg/kg chloral hydrate (Flecknell, 2009) was injected intraperitoneally 
(IP)  as the loading dose. 
The animal was transferred back to its cage or box and left for 5 to 10 minutes 
waiting for induction of anesthesia. Once the animal was knocked down, its scalp fur 
was shaved using an Andis (USA) electronic shaver and it was mounted in a stereotaxic 
frame (Leica Biosystems, Germany). The head was fixed using ear bars and the incisors 
holders. The body temperature was maintained at 36.5  0.5C using a Harvard 
Apparatus (USA) thermal blanket with rectal thermometer. Then, the tail vein was 
cannulated using a GA22 BD Insyte angiocatheter (USA) for maintaining anesthesia 
and drug administration. The anesthesia was maintained by intravenous (IV) 
administration of 0.10 – 0.25 ml from chloral hydrate 7% w/v solution every 30 minutes 
since 1 hour after loading dose till the completion of the experiment. 
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A sagittal incision in the scalp exposed the skull. Any minor bleeding was stopped 
using an aluminum sulfate based hemostatic chalk (Clubman Pinaud, USA) and the 
area was cleaned using cotton swabs (Smith and Nephew, Singapore). Once the animal 
was stable and the bleeding was controlled, trephine burr holes were drilled bilaterally 
above the medial prefrontal cortex and ventral hippocampus (Figure 6.1) according to 
the atlas of The Rat Brain in Stereotaxic Coordinates (Paxinos et al., 2007) using a 
Marathon driller (Korea). The coordinates used for the ventral hippocampus were 6.3 
mm posterior and 5.5 mm medial/lateral to the bregma and the coordinates used for the 
medial prefrontal cortex were 3.3 mm anterior and 0.8 mm medial/lateral to the bregma. 
 
Figure 6.1. Schematic picture of the skull of rat adapted from (Paxinos et al., 2007). 
The oval (A) shows the exposed area during surgery, the black dots 
show the place used for drilling holes aiming medial prefrontal cortex 
(B) and ventral hippocampus (C). The distance between interaural line 
and bregma is aproximately 9 mm and the coordinates used for medial 
prefrontal cortex is +3.3 AP, +/-0.8 ML and the one for ventral 





A concentric bipolar Nickle-Chromium stimulating electrode (SNE-100, Kopf 
Instruments, Tujunga, CA, USA) (250 m outer diameter and 50 mm shaft and 500 m 
tip separation) was placed in the right CA1/subiculum region of the ventral 
hippocampus (AP: -6.3 mm, ML: 5.5 mm, DV: 3.5 mm). A monopolar extracellular 
stainless steel recording electrode (SNE-300, Kopf Instruments, Tujunga, CA, USA) 
(100 m diameter, 250 m recording tip length and 50 mm shaft) was lowered to the 
ipsilateral infralimbic area of medial prefrontal cortex (AP: 3.3 mm, ML: 0.8 mm, DV: 
4.2 mm) according to the atlas of The Rat Brain in Stereotaxic Coordinates (Paxinos et 
al., 2007) (Figure 6.2). 
 
Figure 6.2. Schematic representation of the position of the recording electrode in 
the infralimbic region of medial prefrontal cortex (A) and the 
stimulating electrode in the CA1/subiculum region of ventral 
hippocampus (B). Adapted from The Rat Brain in Stereotaxic 
Coordinates (Paxinos et al., 2007). A schematic projection from 
ventral hippocampus to the infralimbic region is drawn.  
It is known that electrical stimulation of the CA1/subicular region at a frequency 
of 0.01 – 0.1 Hz (50 – 500 s duration) evokes a characteristic monosynaptic negative-
going field potential with the peak latency of 18 – 24 ms (Lim et al., 2010a). By 
stimulating every 15 seconds with 300 mA current and 50 s duration, the depth of 
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recording and stimulating electrodes (4.2 – 4.7 mm and 3.5 – 7.2 mm from skull surface 
respectively) were adjusted to maximize the amplitude of the negative going field 
excitatory postsynaptic potential (Figure 6.3). Once electrode placement was complete, 
a 30 minutes period was allowed for signal stability with electrical stimulation every 
30 seconds.  
 
Figure 6.3. A representative prefrontal cortical postsynaptic potential elicited by 
single pulse stimulation of the CA1/subicular region in ventral 
hippocampus. Stimulation of this area evokes a characteristic 
negative-going field potential with the peak latency of 18-24 ms. The 
peak amplitude is also shown in the image. 
Once the signal was stable, the input-output characterization of each rat was 
established. To do so, starting from 100 mA stimulation, the stimulation intensity was 
increased every 3 minutes (6 signals) 50 mA each time to reach the maximum of 450 
mA stimulation. Then the input-output curve (IOC) was generated for each rat by 
averaging the amplitude of the negative-going field excitatory postsynaptic potential 




Figure 6.4. A representative input-output curve showing the increase in signal 
amplitude in infralimbic region of medial prefrontal cortex by 
increase in stimulation intensity in ventral hippocampus. 
 
The stimulus intensity which produced approximately 60% maximal response was 
chosen for the test stimuli. The test was performed using a 4-step protocol (Figure 6.5). 
First, the baseline recording was performed with chosen signal intensity by stimulating 
every 30 s with stimulation duration of 50 s to record 60 signals (30 minutes). After 
that, 1 ml/kg from the drug of choice (either normal saline or ginsenoside Rg1 
concentrations of 1, 3 or 10 mg/ml) was slowly infused intravenously (over 15 s). The 
signal recording was continued for another 60 signals (30 minutes). After that, high 
frequency stimulation (HFS) was introduced to produce long-term potentiation (LTP). 
For this, the same intensity stimuli were applied with higher frequency (250 Hz) for 5 
minutes. After that, the recording was continued with stimuli every 30 s similar to 




Figure 6.5. Schematic representation of experimental sequence used for evoked 
field potential study of ventral hippocampal medial prefrontal cortical 
pathway 
Electrical stimulation of hippocampus was presented using a square pulse 
stimulator (S8800, Grass Instrument Co., Astromed, USA) and stimulus isolator 
(PSIU6, Grass Instrument Co., Astromed, USA). Field potentials were amplified using 
2400 A extracellular preamplifier current pump (Dagan Corporation) and filtered by 
bandpass from 30 Hz to 3 kHz. Data collection and stimulus parameters were controlled 
using the Signal software (Version 5, Cambridge Electronic Design), running on a PC 
with a digitizing laboratory interface (Micro 1401 mk II, Cambridge Electronic 
Design). 
6.3.1.5. Histological verification of stimulation and recording sites 
At the end of each experiment, the rats were perfused transcardially with 300 ml 
normal saline followed by 400 ml 4% PFA in 0.1 M phosphate buffer. To do that, the 
rat would receive a dose of chloral hydrate to induce deep anesthesia. The depth of 
anesthesia was measured by the loss of pinch reflex. Then, the rat was mounted supine 
on a platform in the animal surgery fume hood. By a transverse incision in mid thoracic 
to mid abdominal area, the xiphoid process was exposed and pulled up to open up the 
rib cage by scissors. Then, the heart was completely exposed by carefully removing the 
pericardial tissue. While the heart was beating, a needle was inserted into the cardiac 
apex guided slowly toward aorta and normal saline was infused in. After few seconds, 
204 
 
the left ventricular wall was pale and right atrium was bulged. Cutting the right atrium 
caused a flush of blood out. The perfusion with saline was continued till there was no 
obvious blood stain dripping out from the heart. After that, the infusion system was 
shifted to PFA. Once PFA perfusion began, the rat would start shaking due to muscular 
fasciculation. By continuing the PFA perfusion, the rat became stiffed, which indicated 
a proper PFA perfusion. Then, the rat was decapitated by a guillotine, the scalp was 
completely removed and the skull was opened from sagittal suture. Brains were 
harvested and further fixed in 4% PFA for 2 – 7 days followed by 15% Sucrose in 
phosphate buffered saline (1PBS) for 4 – 10 days and 30% Sucrose in 1PBS for 
another 4 – 10 days. After that, the brains were cut in 45 m thick slices using a rotary 
microtome (Leica CM 3050, Germany) and attached to poly-L-lysine coated glass 
slides (Superfrost Ultra Plus, Thermoscientific, Germany). The glass slides were left in 
room temperature for 48 hours to be dried and kept in 4 C refrigerator for staining. 
The slides were cresyl violet stained by transferring them from 10 baths using the 
sequence presented in Table 6.1. Once completed, the slices were covered by mounting 
media and thin glass coverslip (CellPath, UK). Then, the covered slides were kept in 
room temperature for 24 hours to be dried and fixed with nail polish.  
A light microscope (BX5, Olympus, Japan) and a digital camera (Olympus DP 71, 
Japan) were used to see the electrode tracks in the tissue. Only animals with proper 
tracking were included in data analysis. 
6.3.1.6. Analyses and statistics: 
Postsynaptic potential amplitude is expressed as a percentage of the mean 
amplitude recording during baseline. All results are given as mean  SEM. All 
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statistical analyses were performed using SPSS-21 software (Statistical Package for 
Social Sciences, SPSS Inc, Chicago, IL, USA). Statistical tests were applied with a two-
tailed significance criterion of p<0.05. The one-way ANOVA test was performed to 
compare different groups. 






1 Ethanol 95% (20%) + Chloroform (80%) Room temperature 10 minutes 
2 Ethanol 95% Room temperature 2 minutes 
3 Ethanol 70% Room temperature 2 minutes 
4 Distilled water Room temperature <0.11 
5 Cresyl violet 0.1% in acetic acid 37 C 60 
6 Distilled water Room temperature <0.11 
7 Ethanol 70% Room temperature 1 minute 
8 Ethanol 95% Room temperature 1 minute 
9 Ethanol 100% Room temperature 1 minute 
10  Xylene Room temperature 2 minutes 
1 Dipped and rinsed. 
 
6.3.2. The effect of systemic administration of ginsenoside Rg1 on the 
spontaneous firing rate of pyramidal cells in medial prefrontal cortex 
6.3.2.1. Animals 
Male Sprague-Dawley (SD) rats weighing 200 – 300 g were requested form 
InVivos to be delivered to the vivarium in Center for Life Science (CeLS). They were 
acclimatized in pairs there in room temperature with 12-hour cycles of day/night light 
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with free access to food and water for at least 48 hours before transporting to 
experimental lab. 
6.3.2.2. Chemicals 
The pontamine sky blue (2% w/v) in 2M NaCl was prepared by dissolving 
pontamine sky blue (Alfa Aesar, Germany) and NaCl (Schedelco, Malaysia) in distilled 
water. 
6.3.2.3. Animal preparation and surgery 
A completely similar protocol as mentioned in section 6.3.1.3 was used to prepare 
the animal for single unit recording. The only difference was that in this set of 
experiments, only burr holes were drilled on medial prefrontal cortical area at AP: 3.3 
mm and ML: 0.8 mm (Figure 6.1). The hippocampal area was not drilled. 
6.3.2.4. Electrophysiology  
To produce glass microelectrodes, Starbore glass capillaries (Radnoti, USA) (150 
m inner diameter) were pulled using a micropipette puller (Narishige Instruments, PE-
21, Japan) with no magnetic pull force at 56.0% heating capacity to produce microtubes 
with head outer diameters of <10 m and 15 mm long slopes. The tubes were filled 
with 2% pontamine sky blue dye in 2M NaCl and kept for stability in room temperature 
for 30 minutes before the start of experiments. The impedance of electrodes was 
ranging from 28 to 38 M. All microelectrodes were prepared on the day of each 
experiment. They were subsequently fixed in a microdrive assembly (Inchworm 
Microdrive System 8200, EXFO, Mississauga, Ontario, Canada) and lowered into the 
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brain using Scientifica (UK) electrode micromover. This machine can push down the 
electrode in micrometer steps during the actual signal recording. On reaching the 
prelimbic area, the electrode was lowered at a very low speed (approximately 10 
m/min) to ensure detection of the slow firing pyramidal cells in the medial prefrontal 
cortex. 
Pyramidal cells in the medial prefrontal cortex have spontaneous firing, which can 
be differentiated from other electrical charges in the area by its specific biphasic shape, 
its voltage (0.5-5 mV), low frequency (0.1-4 Hz) and long duration (greater than 1.2 
ms) (Puig et al., 2005; Rolls et al., 2003). The electrode was pushed in slowly from 3 
to 7.2 mm deep from skull surface to seek for a proper spike (Figure 6.6). Once the 
signal was found, it was left for a period of stabilization for 15 – 30 minutes.  
 
Figure 6.6. A representative prefrontal cortical pyramidal cell spontaneous spike. 
The characteristic bipolar signal with 0.5 to 5 mV amplitude, 1.5-3 ms 
length and low frequency rate can differentiate it from other spikes in 
the region (mostly from interneurons) with higher frequencies and 
distinguishable shapes. 
If the signal stayed stable the recording was performed using single or accumulative 
doses administration of ginsenoside Rg1. In single dose experiments, after 3 minutes of 
baseline recording, 1 ml/kg sterile normal saline was infused. Three minutes later, 1 
ml/kg from proper ginsenoside Rg1 solution (1, 3 or 10 mg/ml) was infused. The 
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recording was continued for 21 minutes. In accumulative doses protocol, after 3 
minutes baseline, 100 lit sterile saline was infused followed by 4 sets of infusion of 
100 lit from 12.5, 12.5, 25 and 50 mg/kgmlit ginsenoside Rg1 respectively. The 
recording was continued for another 12 minutes. In both experiments a maintenance 
dose of anesthesia was administered 10 minutes before the start of recording and after 
a 27-minute complete recording, the last maintenance dose of chloral hydrate was 
infused to avoid both the early effect of chloral hydrate infusion on firing rate and the 
incomplete recording because of shallow anesthesia. The protocols of signal recording 
are summarized in Figure 6.7. 
 
Figure 6.7. Experimental protocol for single unit recording of spontaneous firing 
rate of pyramidal cells in medial prefrontal cortex: (A) shows the 
single dose study of either 1, 3 or 10 mg/kg and (B) shows the 
accumulative study of 1.25, 2.5, 5 and 10 mg/kg. The orange lines 
represent the cannula in the tail vein. 
The electrical charge of spontaneous firing of pyramidal cells in the medial 
prefrontal cortical region was acquired, amplified 100 times and band pass filtered to 
the range of 100-2000 Hz using ELC-03XS amplifier (npi Electronics, Tamm, 
Germany). The signal was filtered via a Humbug (Quest scientific, Vancouver, Canada) 
to remove 50-60 Hz noise, digitalized using Power 1401 MK2 interface (CED, 
Cambridge, UK) and viewed real time with Spike 2.7 software (CED, Cambridge, UK). 
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Later, the spikes were sorted to remove artefacts using the offline forced clustering and 
principal component analysis module of the Spike 2.7 software. 
6.3.2.5. Histological verification of stimulation and recording sites 
At the end of each experiment, the animal was transferred to the fume hood for 
perfusion as mentioned in section 6.3.1.5. Then, the brain harvesting, slicing and 
staining were performed accordingly. Only animals with proper tracking were included 
in the data analysis. 
6.3.3. The effect of systemic administration of ginsenoside Rg1 on c-Fos 
expression in medial prefrontal cortical area 
6.3.3.1. Animals  
Male Sprague-Dawley (SD) rats weighing 200 – 300 g were requested form 
InVivos to be delivered to the vivarium in Center for Life Science (CeLS). They were 
acclimatized in pairs there in room temperature with 12-hour cycles of day/night light 
and free access to food and water for at least 48 hours before transporting to 
experimental lab. 
6.3.3.2. Chemicals 
Cryoprotectant solution (Watson et al., 1986) was prepared by mixing 500 ml 0.1 
M phosphate buffer, pH 7.2 (50% v/v) including 1.59 g NaH2PO4.H2O (Merck, 
Germany), 5.47 g Na2HPO4 (Merck, Germany) and 9 g NaCl (Scheldelco, Malaysia) 
in 500 ml distilled water; 300 g sucrose from Fisherman (UK) (30% w/v), 300 ml 
ethylene glycol (30% v/v, from Sigma Aldrich, Germany) with final volume adjusted 
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to 1000 ml with distilled water. Triton X-100 (TTX) was purchased from Science Lab 
(USA) and mixed with PBS (1st BASE, Singapore) to prepare 0.3% v/v washing 
solution. Goat serum was obtained from Millipore, Germany. Primary antibody used in 
this experiment was rabbit anti-c-Fos antibody from Santa Cruz Biotechnology, CA, 
USA. The secondary antibody was Alexa Flour 555 goat anti-rabbit IgG (USA). 
Prolong Gold Anti-fade with DAPI (Alexa Flour, USA) was used as mounting media 
as well as dye to stain the nuclei.  
6.3.3.3. Animal handling 
Each day, 2 rats were transferred from vivarium to experimental room at 8 am. 
After leaving animals there for acclimatization for 30 minutes, an animal was weighed 
and received 1ml/kg either normal saline or ginsenoside Rg1 solution (1, 3 or 10 mg/ml) 
IP. After another 30 minutes, the other animal was injected by proper saline or 
ginsenoside Rg1 as well. After injections, the rats were transferred back to their cages 
and left in room temperature for 2 hours before transcardial perfusion and brain 
harvesting as explained in section 6.3.1.5.  
6.3.3.4. Tissue preparation  
The harvested brains were sequentially fixed in PFA and Sucrose as mentioned in 
section 6.3.1.5. Once fixed properly, the prefrontal cortical areas were serially sectioned 
using the rotary microtome in 45 m thick slices. The sections with approximately 300 
m distances were collected and transferred and freely floated into the well plates 
containing cryoprotectant anti-freeze solution (Hoffman et al., 2004; Watson et al., 
1986). The well plates were kept in -20 C to be preserved for staining. 
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To stain the preserved slices, the cryoprotectant solution content of well plates was 
replaced by PBS on the day of experiment. After that, the slices were washed by the 
washing mixture (0.3% v/v TTX in 1XPBS) for 4 rounds (5 minutes each). Then, the 
slices were incubated in the blocking solution (5% v/v goat serum in washing mixture) 
for 1 hour in the room temperature followed by being incubated overnight in 4 C in 
the primary antibody (rabbit anti-c-Fos antibody) titrated as 1:600 v/v in blocking 
solution.  
On the day after, the slices were washed by the washing mixture for 4 times (5 
minutes each) and transferred to the dark afterward. In the dark, they were incubated in 
room temperature in secondary antibody (555 goat anti-rabbit IgG) titrated as 1:200 v/v 
in blocking solution for an hour. The rest of experiment was continued in the dark. After 
an hour incubation, the slices were washed for 4 times (5 minutes each) with the 
washing mixture and mounted on the slides. The excess liquid was dabbed from the 
slide and the slices were covered by Prolong Gold Anti-fade with DAPI mounting 
media and cover-slipped. After 24 hours drying in the room temperature and fixation 
with the nail polish, the slides were studied under microscope or kept in -20 C for 
further investigation. Figure 6.8 schematically shows the process of slice staining for 
c-Fos expression. 
Under fluorescent enabled light microscope (BX50, Olympus, Japan), medial 
prefrontal cortex was evaluated. Using a 10 object lens, two photos were taken from 
each side of each slice, one from prelimbic area and the other from infralimbic area. 
The prelimbic photos were approximately from 200 m to 1100 m lateral to the 
midline and 2300 m to 2900 m ventral to the dural surface. The infralimbic photos 
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were approximately from 200 m to 1100 m lateral to the midline and 3300 m to 
3900 m ventral to the dural surface Figure 6.9. 
 
Figure 6.8. Schematic presentation of c-Fos activation and staining. The 
inactivated cells (A) will express c-Fos in their nuclei upon external 
stimulations (B). By treating these cells using washing mixture, the cell 
wall permeability will be increased (C) to allow transportation of 
proteins such as antibodies. By exposing cells to anti-c-Fos antibodies, 
the antibodies will attach to the c-Fos expressed in the cells (D). Now, 
the fluorescent secondary antibodies can attach to anti-c-Fos 
antibodies (E) and label the c-Fos expressing cells (F). 
 
Figure 6.9. Schematic presentation of the positions of pictures taken from 
prelimbic (P1) and infralimbic (P2) areas (A) adapted from The Rat 
Brain in Stereotaxic Coordinates (Paxinos et al., 2007) and a 
representative picture taken from infralimbic area (B). The yellow box 





6.3.3.5. Analyses and statistics 
Using ImageJ software, a 400 m  400 m square was drawn in each photo and 
the number of c-Fos positive cells in the square was counted for each area (Figure 6.9). 
The photo-taking and cell-counting were performed blinded to the animal treatment 
using numerical slide coding. The statistical analysis was performed using SPSS-21 
software (Statistical Package for Social Sciences, SPSS Inc, Chicago, IL, USA). 
Statistical tests were applied with a two-tailed significance criterion of p<0.05. The 
one-way ANOVA test was performed to compare the different groups.  
6.4. Results and discussion  
6.4.1. The effect of systemic administration of ginsenoside Rg1 on 
hippocampal-prefrontal cortical pathway 
Twenty five rats were included for the analysis based on the histological 
verification of the electrode position including 5 animals receiving normal saline, 7 
animals receiving 1 mg/kg ginsenoside Rg1, 6 animals receiving 3 mg/kg ginsenoside 
Rg1 and 7 animals receiving 10 mg/kg ginsenoside Rg1. 
Neither negative control (Normal Saline) nor any dose of ginsenoside Rg1 could 
induce long-lasting potentiation, a gradual increase in the amplitude of field-evoked 
potential, during 30 minutes post injection recording (Figure 6.10). On the other hand, 
high frequency stimulation (HFS) induced long-term potentiation (LTP) in all 
experimental groups manifested by the sudden increase in the amplitude of the negative 




Figure 6.10. Long-term potentiation in hippocampal prefrontal cortical pathway. 
(A): A representative increase in amplitude of post-synaptic potential. 
By increase in the amplitude, the latency will be shorter. (B): Average 
LTP observed in four experimental groups. Each point is the average 
of normalized potentiation in 5 minutes in animals of the group. Error 
bars represent the standard error of mean. After drug injections 
(black arrow) there is no change in baseline field-evoked potential. 
While after HFS (white arrow), long-term potentiation was observed 
in all groups. However, the potential was significantly suppressed by 
ginsenoside Rg1. (C): The average of every 30 minutes shows a 
significant increase in the potentiation after HFS which is suppressed 
by ginsenoside injection. Error bars represent the SEM and * 
represents p value <0.05 compared to normal saline group. 





However, in rats receiving any dose of ginsenoside Rg1 (1, 3, or 10 mg/kg), the 
long-term potential was suppressed (F3, 21 = 5.747, p = 0.005). By averaging every 30 
minutes, the effects of HFS and ginsenoside treatment was recalculated. Again, 
ginsenoside Rg1 treatment could significantly attenuate long-term potentiation in 
hippocampal-medial prefrontal cortical pathway (F3, 21 = 6.026, p = 0.004). Using post-
hoc analysis, all three doses were significantly different from saline treatment 
(p<0.005). However, there was no statistically significant difference between different 
doses of ginsenoside Rg1. The lack of observed dose-dependent response can be due to 
the small sample size. 
Ginsenoside Rg1 is generally known as a neurostimulatory substance responsible 
for the “warm” nature of Panax ginseng. on the other hand, Panax quinquefolium 
(American ginseng), which consists of more ginsenoside Rb1 than Rg1 (ginsenoside 
Rg1 is the third most abundant chemical constituent in P. quinquefolium after Rb1 and 
Re) (Chen et al., 2008a) is considered as “cold” in the nature. Here is the first report of 
neuroinhibitory effect of ginsenoside Rg1.  
Suppression of hippocampal medial prefrontal cortical pathway can be by 
suppression of either the origin of pathway (hippocampus) or the end of it (the medial 
prefrontal cortex). There are several reports of stimulatory effects of this chemical 
constituent on hippocampus (Wang et al., 2001b; Xu et al., 2007) while to the best of 
our knowledge there is no report on its effect on medial prefrontal cortex. The rest of 
this study is focused on its effect on this brain region. 
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6.4.2. The effect of systemic administration of ginsenoside Rg1 on the 
spontaneous firing rate of pyramidal cells in medial prefrontal cortex 
Among animals used for this study, 58 animals were included in the final analysis. 
The most common cause of exclusion from the study was unstable anesthesia, either 
dying or waking up during recording, which led in abortion of the study. Among the 
included animals, 18 were used for accumulative doses studies and the rest were used 
for single dose studies including 12 rats for 1 mg/kg, 20 rats for 3 mg/kg and 8 rats for 
10 mg/kg ginsenoside Rg1 experiments. The mean baseline firing rate of included 
spikes were 0.77, 1.85, 1.43 and 1.76 Hz for 1 mg/kg, 3 mg/kg, 10 mg/kg and 
accumulative doses respectively. 
In different groups, half of animals showed decrease in the firing rate of pyramidal 
cells in medial prefrontal cortex. Figure 6.11 shows the proportion of different 
responses in different treatment groups. 
 
Figure 6.11. Proportion of changes in spontaneous firing rate of pyramidal cells in 
medial prefrontal cortex in response to treatment with different doses 
of ginsenoside Rg1: 1 mg/kg (A), 3 mg/kg (B), 10 mg/kg (C) and 
accumulative doses of 1.25, 2.5, 5 and 10 mg/kg (D). 
The animals were grouped based on the response of recorded spike into the increase 
group, decrease group and no effect group for statistical analyses. In the increase group 
there were 6 animals receiving 1 mg/kg, 4 animals receiving 3 mg/kg and 3 animals 
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receiving 10 mg/kg ginsenoside Rg1. The observed increase in all the treatment groups 
was statistically significant (F8, 80 = 6.846, p < 0.001). There was no statistically 
significant difference between different dosage groups (F2, 10 = 3.680, p = 0.063) the 
only minor difference was between 3 and 10 mg/kg groups in 4th 3-minute period after 
ginsenoside Rg1 infusion (Figure 6.12). 
 
Figure 6.12. Average normalized spike firing rate in different treatment groups. 
At the left side graphs report spikes showing decrease in firing rate in 
response to 1mg/kg (A), 3 mg/kg (B), 10 mg/kg (C) or accumulative 
doses (D) of ginsenoside Rg1 infusion. At the right side graphs report 
spikes showing increase in firing rate in response to 1 mg/kg (E), 3 
mg/kg (F), 10 mg/kg (G), or accumulative doses (H) of ginsenoside Rg1 
infusion. Error bars represent the SEM, * represents p value <0.05, ** 




Totally, spikes from 20 animals receiving single dose of Rg1 showed a decrease in 
firing rate including 6 rats from 1 mg/kg group, 10 rats from 3 mg/kg group and 4 rats 
from 10 mg/kg group. The observed decrease in different groups was statistically 
significant (F8, 136 = 23.646, p < 0.001). There was also a significant difference between 
groups (F2, 17 = 4.389, p = 0.029). The difference was mainly between 1 and 3 mg/kg 
groups. In 3 and 10 mg/kg groups few spikes showed no response to infusion of Rg1 
(F8, 40 = 1.888, p = 0.090) and there was no difference between treatment groups (F1, 5 
= 1.168, p = 0.329). In animals receiving accumulative doses of ginsenoside Rg1, the 
same three patterns of response were observed. Generally, minor statistically significant 
difference was observed between different treatment groups receiving 1, 3 or 10 mg/kg 
ginsenoside Rg1. This lack of dose-dependent response could be due to small sample 
size.  
In addition, in both decreasing and increasing groups, the changes in the spike firing 
rate were irreversible. In other words, the firing rate of the spike never changed back to 
the baseline value. It can be due to our short recording time. Since the anesthesia drug 
used for this set of experiments was chloral hydrate which needs maintenance doses 
every 30 – 40 minutes and has immediate short effect on firing rate, the recording period 
was limited to anesthesia safe window (10 – 40 minutes after the last maintenance 
dose). Longer recording times can be achieved by recording in the awake animals or 
anesthetized animals with long-lasting agent such as urethane (Flecknell, 2009; Kohn, 
1997). 
This set of data suggests that there might be different populations of pyramidal cells 
in medial prefrontal cortex with different response patterns to ginsenoside Rg1 or the 
same population of cells is producing different responses. The presence of different 
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populations of neurons in medial prefrontal cortex have been proposed in different 
animals although nobody has reported any differences in their morphological 
characteristics. Gabbott and Rolls described three populations of neurons located in the 
medial prefrontal cortical area of macaque brain, which show distinct activity patterns 
during asleep and awake periods (Gabbott et al., 2013; Rolls et al., 2003). Similar 
differences in neuronal activity was reported for the populations of cells in the rat 
medial prefrontal cortex during working memory tasks (Bai et al., 2012; Hyman et al., 
2010), in response to stressful conditions (Jackson et al., 2006) or amphetamine 
administration (Gulley et al., 2010) or in mouse medial prefrontal cortex during 
spontaneous oscillation (Ruiz-Mejias et al., 2011). These functional differences can be 
due to diverse receptor expression. Using rat brain slices in vitro, Moore and colleagues 
showed that by dopamine administration, pyramidal neurons in medial prefrontal cortex 
with predominant D1 receptors will be severely suppressed while those mainly 
expressing D2 receptors will be significantly activated (Moore et al., 2011). These 
differences in characteristics of different populations of pyramidal cells in medial 
prefrontal cortex have been suggested to be involved in the tolerance and adaptive 
responses, which are important in the behavioral modification by the time (Jackson et 
al., 2006). 
To evaluate the possibility that these are different populations of cells which 
respond differently to ginsenoside Rg1, burst analysis in bigger sample sizes can be 
useful (Farooq et al., 2013; Zhang et al., 2010) to mathematically evaluate the 
characteristics of groups of spikes with specific patterns of response to the ginsenoside 
Rg1. If no difference is found in burst analysis, the different patterns of response can 
be explained by lateral inhibition effect of groups of cells. It means that once a group 
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of cells are affected by ginsenoside Rg1, the neighboring cells try to compensate the 
effect by changing their behavior. Therefore, at any time point, there are populations of 
cells showing direct response to the external stimulus (ginsenoside Rg1 in this case) 
and some other populations showing the reverse response. 
6.4.3. The effect of systemic administration of ginsenoside Rg1 on c-Fos 
expression in medial prefrontal cortical area 
Twenty four animals were grouped into 4 treatment groups randomly. The control 
group received 1 ml/kg from sterile normal saline and ginsenoside Rg1 groups received 
1 ml/kg from either 1, 3 or 10 mg/ml ginsenoside Rg1 solutions (IP) 2 hours before 
perfusion and harvesting the brains. From each animal, 12 brain slices from frontal lobe 
were collected for staining (Figure 6.13).  
 
Figure 6.13. Representative slides from infralimbic area of medial prefrontal 
cortex of animals receiving saline (NS) or ginsenoside treatments. The 
first row shows the c-Fos fluorescent stains (A) and the second row 
shows the DAPI stains from the same region (B). Consider that 
although the number of c-Fos positive cells is significantly different in 





Ginsenoside Rg1 treatment significantly decreased the number of c-Fos positive 
cells in medial prefrontal cortex (one-way ANOVA, F3, 326 = 87.791, p < 0.001). This 
effect was observed in both prelimbic (one-way ANOVA, F3, 326 = 48.887, p < 0.001) 
and infralimbic (one-way ANOVA, F3, 326 = 40.384, p < 0.001) areas. Additionally, the 
decreasing effect of ginsenoside Rg1 was dose-dependent in prelimbic (y = -23.45 x + 
192.63, R2 = 0.8659), infralimbic (y = -22.29 x + 185.35, R2 = 0.9645) and pooled 
prelimbic and infralimbic (y = -22.915 x + 189.04, R2 = 0.9382) areas (Figure 6.14). 
 
Figure 6.14. Average count of c-Fos positive cells in different treatment groups (n 
= 6 animals in each group) in medial prefrontal cortex (A), prelimbic 
area (B) and infralimbic area (C). Error bars represent the SEM. 
 
Since c-Fos staining was performed on free floating slices, it was impossible to 
differentiate the right and left sides of brain. All electrophysiological studies were 
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performed on the right medial prefrontal cortical nuclei while the 
immunohistochemistry was measured as the sum of right and left sides. The next step 
is to perform the staining on fixed slices attached to microscopic slides to examine any 
difference in c-Fos expression between right and left medial prefrontal cortical nuclei, 
which is not feasible with the current technologies.  
It is known that the number of c-Fos positive cells in medial prefrontal cortex 
(either prelimbic or infralimbic) has a diurnal rhythm with the highest peak in the 
evening (6pm) and the lowest peak in the morning (10 am) (Baltazar et al., 2013). To 
avoid the intereference of this natural rhythm to our results, all experiments were started 
at a particular time (8-8:30 am). Additionally, stress and handling have significant 
effects on c-Fos expression in medial prefrontal area (Adamec et al., 2012; Panhelainen 
et al., 2012). To avoid such effect, extreme care in animal handling was performed and 
all animals were solely handled by a single person (the author).  
c-Fos expression in the medial prefrontal cortex is increased by stress (Panhelainen 
et al., 2012; Silva et al., 2012) and has been used as a marker of anxiety, which shows 
immediate response to herbal and non-herbal anxiolytic agents (Shoji et al., 2013; 
Wislowska-Stanek et al., 2008). The changes in c-Fos expression in medial prefrontal 
cortex has also been shown to be associated with memory and cognition changes in 
different studies. Methamphetamine exposure could impair the memory and increase 
the c-Fos expression in medial prefrontal cortex simultaneously (Chiu et al., 2014). 
Furthermore, N-acetylcysteine, an anti-hallucinogenic agent, has been shown to 
decrease the c-Fos expression in the medial prefrontal cortex (Lee et al., 2014). 
Therefore, it can be suggested that ginsenoside Rg1 as a natural inhibitor of medial 
prefrontal cortex (our results) and stimulator of hippocampus (Mook-Jung et al., 2001; 
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Wang et al., 2001b; Xu et al., 2007) may help to improve cognition by decreasing 
anxiety via affecting medial prefrontal cortex. 
The dose-dependent decrease in number of c-Fos positive cells in combination to 
electrophysiological studies is consistent in indicating that the medial prefrontal cortex 
is mainly suppressed by ginsenoside Rg1. The lack of observed dose-dependent trends 
in electrophysiological studies may be due to small sample size or the nature of those 
procedures, which is less quantitative than the immunohistochemical analyses of cell 
activity such as c-Fos staining. 
6.5. Conclusion  
The main aim of this chapter was to investigate the effect of systemic 
administration of ginsenoside Rg1 on the medial prefrontal cortex. Three investigating 
methods were chosen including electrophysiological investigation of LTP induction in 
direct projection from hippocampus to medial prefrontal cortex and spontaneous 
neuronal firing of pyramidal cells in medial prefrontal cortex as well as histochemical 
study of cell activities in medial prefrontal cortex. 
The first set of experiments studied the effects of intravenous administration of 
ginsenoside Rg1 on synapse plasticity of hippocampal-medial prefrontal cortical (HP-
mPFC) pathway using long-lasting potentiation (LLP) and long-term potentiation 
(LTP) in this pathway. We observed that not only ginsenoside Rg1 failed to induce LLP 
in the HP-mPFC pathway, but also it attenuated the LTP induced by high frequency 
electrical stimulation. Similar effects were observed in all three doses used in the 
experiment (1, 3 or 10 mg/kg). 
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To the best of our knowledge, it is the first report of the effect of ginsenoside Rg1 
on hippocampal-medial prefrontal cortical pathway, which suggests neuroinhibitory 
effects. Since this method studies the projection form hippocampus to the medial 
prefrontal cortex, the suppression of the pathway may not specifically show whether 
the origin of the pathway (hippocampus) or the end point (medial prefrontal cortex) is 
affected. Neuroinhibitory effects of ginsenoside Rg1 seem to be in contrast with 
previously published data showing neurostimulatory effects of this natural product (Qi 
et al., 2009; Wang et al., 2001b; Xu et al., 2007). Nevertheless, it should be kept in 
mind that almost all these researchers have been studying the effects of Rg1 
administration on afferent pathways to the hippocampus while we investigated an 
efferent pathway originating from hippocampus toward medial prefrontal cortex. In the 
other words, although ginsenoside Rg1 is known to increase the hippocampal reaction 
to pathways originating from other brain nuclei, it suppresses the response of medial 
prefrontal cortex to stimulations from hippocampus. Such reaction can be due to a 
stronger suppressing effect of ginsenoside Rg1 on medial prefrontal cortex, which can 
modify its stimulatory effects on hippocampus. Therefore, it suggests that medial 
prefrontal cortex is one of the primary brain nuclei affected by this natural product. 
Therefore, the investigation of the effect of ginsenoside Rg1 on the spontaneous 
neuronal activity of medial prefrontal cortex and the histochemical analysis of neuronal 
activity affected by its administration could be helpful. The next two experimental sets 
attempted to investigate the effect of ginsenoside Rg1 on the medial prefrontal cortical 
cells. 
In the second set of experiments, we studied the in vivo effect of intravenous 
administration of ginsenoside Rg1 on the spontaneous firing rate of medial prefrontal 
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cortical neurons. Using either single dose of 1, 3 or 10 mg/kg or accumulative doses of 
1.25, 2.5, 5 and 10 mg/kg of ginsenoside Rg1 significantly decreased the frequency of 
spontaneous firing of almost half (50%) of the medial prefrontal cortical pyramidal 
cells. This result is in agreement with the findings of the previous set of experiments 
showing the attenuation of LTP induction in HP-mPFC pathway. Therefore, this 
finding suggests the neuroinhibitory effects of ginsenoside Rg1 by affecting the medial 
prefrontal cortex. However, the molecular mechanism of the effect remains elusive. 
Future pharmacological studies using antagonists are needed to figure out possible 
mechanisms. These studies can focus on drug, which might suppress the effect of Rg1 
on medial prefrontal cortex. One possible drug of choice is antalarmin, a blocker of 
corticotropin-releasing factor (Webster et al., 1996). Corticotropin-releasing factor is 
an endogenous hormone, which is involved in stress response. Its receptors have been 
found in medial prefrontal cortex (Seidel et al., 2011). It is known that administration 
of this hormone can induce similar effects in medial prefrontal cortex as what we 
observed from administration of ginsenoside Rg1 (Farooq et al., 2013). Therefore, 
corticotropin-releasing factor and its antagonist antalarmin can be considered to 
investigate the mechanism of action for the suppressing effect of Rg1 on medial 
prefrontal cortex. 
The third set of experiment was to investigate the effect of ginsenoside Rg1 on the 
cell activity in the medial prefrontal cortex using histological techniques. The brains of 
rats were harvested 2 hours after intraperitoneal administration of either normal saline 
(as control) or ginsenoside Rg1 (1, 3 or 10 mg/kg). The numbers of c-Fos expressing 
cells in medial prefrontal cortex were compared across different treatment groups. Rg1 
dose-dependently decreased the number of these cells in the treated animals compared 
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to control group. Consistent with previous findings, it showed that ginsenoside Rg1 can 
suppress the medial prefrontal cortical neurological activity. Presenting dose-dependent 
suppression is the most significant finding of this set of studies. However, the 
underlying mechanisms for the suppressing effect of Rg1 on medial prefrontal cortex 
remains unclear. Since the effect of Rg1 on the number of c-Fos expressing cells is 
dose-dependent, this method may serve better than the electrophysiology based ones to 
investigate the mechanism of action of Rg1 such as antagonistic studies. The effect of 
systemic administration of ginsenoside Rg1 on the other molecular changes related to 
c-Fos expression such as formation of c-Fos—c-Jun heterodimer and activator protein 
1 (AP-1) can be evaluated as the future work.  
In summary, these findings demonstrated for the first time that ginsenoside Rg1 
suppresses the medial prefrontal cortical activity using three different methods. 
Considering the available literature on neurostimulatory effects of this natural product 
on other brain regions especially hippocampus, the results presented in this report can 
open new windows to understanding the neurological activities of ginsenoside Rg1. 
However, the biomolecular mechanisms behind the effect of Rg1 on medial prefrontal 
cortex remains elusive, which should be addressed by future research using mechanistic 
studies such as antagonistic approaches. Based on the present report, histochemical 
analysis is a better experimental method compared to the electrophysiological analyses 
for future studies. 
As people use natural products orally, we only studied the systemic administration 
of the ginsenoside Rg1 and the local administration (ICV) was not evaluated here. 
Furthermore, the effects of its metabolites (ginsenosides Rh1, F, PPT) and the effects 
of ginsenoside Rg1 on other brain regions were beyond the scope of this study. Finally, 
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correlating our results with other methods of study including behavioral studies should 




CHAPTER 7. Conclusion 
The overarching aim of this study was to evaluate the usage of CAM with specific 
focus on neurological effects. First, we began with getting information about the usage 
of CAM from community dwelling older adults and its association with their 
neurocognitive status. Then, we surveyed on the usage of herbal medicine in the same 
age group. Collating information about available CAM products in the market was the 
third step. Finally, we moved to bench work by investigating the effect of an active 
component of Panax ginseng, ginsenoside Rg1, on the neuronal activity of medial 
prefrontal cortex, an important brain region involved in cognition, memory, decision 
making and other advanced neurological functions. 
In the first part of the study, the data from Singapore Longitudinal Ageing Study 
(SLAS I and II) was analyzed. A high prevalence of CAM usage among older adults in 
Singapore (53.4%) was found. This prevalence showed an increase compared to a 
previous reports from the same age group in Singapore (Feng et al., 2010). The most 
commonly used CAM practices were herbal medicine, qigong and acupuncture. The 
top three medicinal herbs used by participants were evening primrose oil, ginseng and 
ginkgo. Similar to available literature (Feng et al., 2010; Zhang et al., 2008a), CAM 
usage was more common among more educated Chinese female participants who were 
suffering from one or two chronic disorders and had better physical and social activities. 
On the other hand, age was not a significant factor in the prevalence of usage of CAM 
in contrast to other reports (Feng et al., 2010). Ageing is associated with both limitation 
in physical abilities (which decreases the usage of some forms of CAM) and increase 
in risk of suffering from multiple medical conditions (which increases the usage of 
CAM). Therefore, although the pattern of CAM usage changes by age, the overall 
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prevalence of CAM usage will not be changed significantly. Contrary to our 
predictions, CAM usage was not associated with cognitive or depressive status of 
participants. It is reported in clinical trials that CAM practices can improve both 
cognitive and depressive situations (Dennis et al., 2013; Dos Santos-Neto et al., 2006; 
Murray et al., 2004; Sarris et al., 2011). Since this study was a cross-sectional 
population based observational study, it could not differentiate those who use CAM to 
improve their cognitive and depressive situation from those whose cognition and mood 
is normal because of using CAM.  
To evaluate the association of cognitive decline with the usage of CAM, the data 
from 4-year follow-up of “SLAS I” was analyzed, which showed lower risk of 
developing cognitive decline among CAM users and qigong practitioners. Consistent 
with the available data showing their effects in improving cognitive status (Lee et al., 
2004c; Oh et al., 2012), our data suggest a positive protective role for these practices 
against cognitive decline for the first time as a longitudinal observational study. 
However, the effect of qigong was marginal. There is a need for more investigation in 
other well-designed longitudinal observations and randomized clinical trials to prove 
their role as promising preventive factors against cognitive decline in older adults.  
Since herbal medicine was the most commonly used CAM practice among 
participants in SLAS, the second part of the study was performed to collate more 
information about the usage of herbal medicine and factors associated with it. Re-
contacting 209 participants in Jurong Ageing Study to perform detailed telephone 
interview, we observed that the real prevalence of usage of herbal medicine is much 
higher than what was reported previously. Based on the results of telephone interviews, 
67.7% of older adults used one or more medicinal herbs, which was about twice 
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prevalent than SLAS results. This difference was not explainable by changes in the 
prevalence by time and was more due to a better and more accurate method of data 
collection. It shows the importance of using focused questionnaires in observational 
studies. The most commonly used herb was American ginseng followed by wolfberry 
and Chinese/Korean ginseng. Usage of herbal medicine was more common among 
younger female participants and no association was observed between most 
demographic and neurocognitive factors and usage of individual herbs. This lack of 
association could be due to small sample sizes. Three of top six common herbs belonged 
to Panax genus family, an important group of medicinal herbs, which are loosely named 
as “ginseng”. It was also observed that medicinal herbs are mainly used more for 
general health improvement rather than specific medical conditions. Among those who 
used medicinal herbs for medical conditions, the majority were using medicinal herbs 
for diseases and health conditioned defined based on traditional Chinese medicine 
followed by neurological conditions and musculoskeletal problems. The main source 
of information about the usage of medicinal herbs was by word of the mouth from 
family and friends. None of the participants had consulted a western (conventional) 
health practitioner to get knowledge about usage of medicinal herbs. It emphasizes the 
importance of improving physician-patient communication about the usage of herbal 
medicine to prevent the adverse effects of improper usage of herbs, which may lead in 
drug-herb and herb-herb interactions and other dangerous adverse effects. For such an 
observational study, the sample size was not big enough to detect any association of 
usage of individual herbs with studied factors including neurocognitive status. 




To improve our understanding of usage of medicinal herbs, the third part of the 
study was conducted to investigate the herbal products in the local market. Since three 
of six most commonly used herbs reported by participants in telephone interview 
belonged to Panax genus family, it was decided to survey herbal products in market, 
which have the words “Panax” or “ginseng” in their labels. For this part of study, 309 
products were collected from the market and the information provided in their labels 
was analyzed. These products are sold over the counter without any need for 
prescription. Consumers have access to them in the market and chose them mainly 
based on the information provided in their labels. Therefore, such information plays an 
important role in the public education and has a significant effect on their consumption. 
Comparing the information provided in the product labels with the local legislations, it 
was found that required information was provided by more than 84% of products in 
different categories, which was comparable to a similar study in the UK on 68 products 
containing “ginseng” (Raynor et al., 2011). Additionally, there were some prohibited 
claims of efficacy and safety, which could mislead the users. Reviewing the indications 
claimed by products, it was found that being effective for the traditionally defined 
diseases and general health is the most common claim on products followed by 
affecting circulatory system and having analgesic effects. Being effective for mental 
and behavioral conditions and the nervous systems was the fourth most commonly 
claimed indication. To prove or reject any claim of effectiveness, a complete set of 
translational research is needed to be conducted from in vitro studies to in vivo animal 
work to clinical trials, which is beyond the time limitations of a PhD project. 
The fourth part of the study was to investigate the effect of ginsenoside Rg1 on the 
medial prefrontal cortex. Ginsenoside Rg1 is one of the most abundant chemical 
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constituents of different Panax species. Studies had reported its positive effects on 
memory and cognition by stimulating hippocampus (Qi et al., 2009; Wang et al., 2001b; 
Wang et al., 2009c; Xu et al., 2007). To the best of our knowledge, there is no report 
on its effects on medial prefrontal cortex, an important brain region involved in 
memory, cognition, stress and decision making (Groenewegen et al., 1997; Lim et al., 
2010a). Three sets of in vivo and ex vivo studies were performed to investigate its effect 
on this brain region. Firstly, the effect of systemic administration of ginsenoside Rg1 
(1, 3 or 10 mg/kg) on the induction of long-lasting potentiation and long-term 
potentiation in hippocampal-medial prefrontal cortical pathway was investigated. None 
of the three tested doses could induce long-lasting potentiation in this pathway. 
Moreover, ginsenoside Rg1 treatment in all the three doses attenuated the high 
frequency electrical stimulation induced long-term potentiation. It is the first report of 
neuroinhibitory effects of ginsenoside Rg1. Since there are several reports of its 
stimulatory effects on hippocampus, our results of inhibiting hippocampal-medial 
prefrontal cortical pathway could suggest inhibition of medial prefrontal cortex by this 
ginsenoside. The second set of experiments assessed the effects of systemic 
administration of ginsenoside Rg1 on spontaneous firing rate of neuronal spikes in 
medial prefrontal cortex. Both single dose (1, 3 or 10 mg/kg) and accumulative doses 
(1.25, 2.5, 5 and 10 mg/kg) of this natural product could suppress almost half of the 
recorded neurons and had stimulating effects or no effects on the other half. This finding 
suggested that ginsenoside Rg1 has suppressing effects on some neuronal populations 
in medial prefrontal cortex, which is in favor of the previous findings in the same study 
showing attenuation of long-term potentiation in hippocampal-medial prefrontal 
cortical pathway. Small sample size and recording one single neuronal spike from each 
animal were the main limitations of this electrophysiological method in investigating 
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the neurological effects of ginsenoside Rg1. The third set of experiment was 
complementary to investigate the effect of ginsenoside Rg1 on medial prefrontal cortex 
where the effect of its systemic administration on the number of c-Fos positive cells in 
this cortical region was observed. Using immunohistochemical staining, it was shown 
that ginsenoside Rg1 dose-dependently decreases the number of c-Fos positive cells in 
medial prefrontal cortex, which is a reliable indicator of its inhibitory effects. The all 
three sets of experiments gave a general overview of inhibitory effects of ginsenoside 
Rg1 on medial prefrontal cortex. This is the first report of its effect on medial prefrontal 
cortex and the first report of its inhibitory effects. Such inhibition can improve learning 
and cognition by decreasing the stress and anxiety. However, the molecular mechanism 
of action needs further studies. Antagonistic studies can be suggested as potential paths 
for future investigations. Additionally, the behavioral effects of suppression of medial 
prefrontal cortex by ginsenoside Rg1 can shed more light on the neurological effects of 
this natural product. Additionally, since ginsenoside Rg1 has low bioavailability and 
will be metabolized to secondary ginsenosides (Rh1, F and finally PPT) and it has 
limited permeability through brain blood barrier (Cheng et al., 2005; Christensen, 
2009), the possibility of affecting medial prefrontal cortex via other metabolites should 
be considered for future research. 
In summary, a translational medical approach to the usage of CAM was performed 
in this work by obtaining the information from community dwelling population and 
available products in the market and evaluating some neurological effects of a 
commercially available natural product. A high prevalence of usage of CAM and its 
main subtype, herbal medicine, was observed among older adults in Singapore. 
Surveying the herbal products in the local market, we found that some of them have 
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improper information provided in their labels, an important source of information for 
most users. The high prevalence of usage and lack of reliability in sources of 
information should be considered by medical practitioners dealing with older adults 
who are more susceptible to the possible harms and risks of usage of CAM. The real 
effects and indications of the natural products need scientific assessment using different 
methods of translational medical approaches from in vitro studies to clinical trials. 
Our results highlight the important role of CAM practices (such as qigong) and 
products (such as herbal products containing “ginseng”) in the health maintenance of 
modern society and provide evidence for their potential protective and therapeutic 
neurocognitive effects. Considering the lack of proper communication between users 
of CAM and health providers, this work as a translational research improves the 
realistic understanding about CAM among the scientists, care providers and the public. 
Moreover, it helps maximize the benefits of its usage to the society and minimize 
potential risks. Further scientific evaluation of CAM facilitates its better integration 
into the conventional medical systems by providing reliable information about its 
safety, efficacy and the mechanism of action. Both the public and health systems will 
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